Background	Background	NN	0
The	The	DT	0
overuse	overuse	NN	B-NP
of	of	IN	0
antibiotics	antibiotics	NN	0
in	in	IN	0
the	the	DT	0
clinic	clinic	NN	0
and	and	CC	0
for	for	IN	0
agricultural	agricultural	JJ	B-NP
use	use	NN	I-NP
has	has	VBZ	0
resulted	resulted	VBN	0
in	in	IN	0
a	a	DT	0
tremendous	tremendous	JJ	0
antibiotic	antibiotic	JJ	B-NP
resistant	resistant	JJ	I-NP
bacterium	bacterium	NN	I-NP
selective	selective	JJ	I-NP
pressure	pressure	NN	I-NP
.	.	.	0
These	These	DT	0
bacteria	bacteria	NNS	0
become	become	VBP	0
resistant	resistant	VBN	0
by	by	IN	0
a	a	DT	0
number	number	NN	0
of	of	IN	0
mechanisms	mechanisms	NNS	0
,	,	,	0
such	such	JJ	0
as	as	IN	0
producing	producing	VBG	B-NP
enzyme	enzyme	NN	I-NP
that	that	IN	0
hydrolyze	hydrolyze	NN	B-NP
or	or	CC	0
inactivate	inactivate	VBG	0
the	the	DT	0
antibiotics	antibiotics	NN	0
,	,	,	0
producing	producing	VBG	B-NP
efflux	efflux	JJ	I-NP
pumps	pumps	NNS	0
that	that	WDT	0
transport	transport	VBZ	0
the	the	DT	0
antibiotic	antibiotic	NN	0
out	out	RP	0
of	of	IN	0
the	the	DT	0
cell	cell	NN	0
,	,	,	0
or	or	CC	0
modifying	modifying	VB	0
their	their	PRP$	0
cell	cell	NN	0
wall	wall	NN	0
components	components	NNS	0
so	so	IN	0
they	they	PRP	0
no	no	RB	0
longer	longer	JJR	0
bind	bind	NN	0
effectively	effectively	RB	0
to	to	TO	0
the	the	DT	0
antibiotics	antibiotics	NN	0
[	[	-LRB-	0
1	1	CD	0
2	2	CD	0
3	3	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
most	most	RBS	0
common	common	JJ	0
,	,	,	0
least	least	JJS	0
expensive	expensive	JJ	0
,	,	,	0
and	and	CC	0
effective	effective	JJ	0
antibiotics	antibiotics	NNS	0
are	are	VBP	0
the	the	DT	0
β-lactam	β-lactam	JJ	B-NP
containing	containing	JJ	0
antibiotics	antibiotics	NN	0
,	,	,	0
such	such	JJ	0
as	as	IN	0
the	the	DT	0
penicillins	penicillins	NN	0
,	,	,	0
cephalosporin	cephalosporin	NN	B-NP
,	,	,	0
and	and	CC	0
carbapenem	carbapenem	NN	B-NP
[	[	-LRB-	0
2	2	CD	0
4	4	CD	0
5	5	CD	0
]	]	-RRB-	0
.	.	.	0
These	These	DT	0
antibiotics	antibiotics	NNS	0
are	are	VBP	0
mechanism-based	mechanism-based	JJ	0
inhibitors	inhibitors	NN	0
of	of	IN	0
transpeptidase	transpeptidase	NN	B-NP
,	,	,	0
a	a	DT	0
bacterial	bacterial	JJ	B-NP
enzyme	enzyme	NN	I-NP
required	required	VBN	0
for	for	IN	0
the	the	DT	0
production	production	NN	0
of	of	IN	0
a	a	DT	0
strong	strong	JJ	0
viable	viable	JJ	0
cell	cell	NN	0
wall	wall	NN	0
[	[	-LRB-	0
6	6	CD	0
7	7	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
response	response	NN	0
to	to	TO	0
the	the	DT	0
widespread	widespread	JJ	0
use	use	NN	0
of	of	IN	0
β-lactam	β-lactam	JJ	B-NP
containing	containing	JJ	0
antibiotics	antibiotics	NN	0
,	,	,	0
bacteria	bacteria	NNS	0
have	have	VBP	0
acquired	acquired	VBN	0
the	the	DT	0
ability	ability	NN	B-NP
to	to	TO	0
produce	produce	VB	0
β-lactama	β-lactama	NN	B-NP
,	,	,	0
which	which	WDT	0
are	are	VBP	0
enzymes	enzymes	VBN	0
that	that	IN	0
hydrolyze	hydrolyze	NN	B-NP
and	and	CC	0
inactivate	inactivate	JJ	0
β-lactam	β-lactam	JJ	B-NP
containing	containing	JJ	0
antibiotics	antibiotics	NN	0
.	.	.	0
There	There	EX	0
are	are	VBP	0
over	over	IN	0
300	300	CD	0
distinct	distinct	JJ	0
β-lactama	β-lactama	NN	B-NP
known	known	VBN	0
,	,	,	0
and	and	CC	0
these	these	DT	0
enzymes	enzymes	NNS	0
have	have	VBP	0
been	been	VBN	0
grouped	grouped	VBN	0
by	by	IN	0
a	a	DT	0
number	number	NN	0
of	of	IN	0
classification	classification	JJ	B-NP
scheme	scheme	NN	I-NP
[	[	-LRB-	0
8	8	CD	0
9	9	CD	0
10	10	CD	0
11	11	CD	0
12	12	CD	0
13	13	CD	0
14	14	CD	0
15	15	CD	0
]	]	-RRB-	0
.	.	.	0
For	For	IN	0
example	example	NN	0
,	,	,	0
Bush	Bush	NNP	0
has	has	VBZ	0
developed	developed	VBN	0
a	a	DT	0
scheme	scheme	NN	0
,	,	,	0
based	based	VBN	0
on	on	IN	0
the	the	DT	0
enzymes	enzymes	NN	0
'	'	POS	0
molecular	molecular	JJ	B-NP
property	property	NN	I-NP
,	,	,	0
that	that	WDT	0
has	has	VBZ	0
four	four	CD	0
distinct	distinct	JJ	0
β-lactamase	β-lactamase	JJ	B-NP
group	group	NN	I-NP
[	[	-LRB-	0
10	10	CD	0
15	15	CD	0
]	]	-RRB-	0
.	.	.	0
One	One	CD	0
of	of	IN	0
the	the	DT	0
more	more	RBR	0
alarming	alarming	JJ	0
groups	groups	NNS	0
are	are	VBP	0
the	the	DT	0
Bush	Bush	NNP	0
group	group	NN	0
3	3	CD	0
enzymes	enzymes	NN	0
,	,	,	0
which	which	WDT	0
are	are	VBP	0
Zn	Zn	NNP	B-NP
(	(	-LRB-	I-NP
II	II	NNP	I-NP
)	)	-RRB-	I-NP
dependent	dependent	JJ	0
enzymes	enzymes	NN	0
that	that	WDT	0
hydrolyze	hydrolyze	VBP	0
nearly	nearly	RB	0
all	all	RB	0
known	known	VBN	0
containing	containing	VBG	B-NP
antibiotic	antibiotic	JJ	I-NP
β-lactam	β-lactam	JJ	I-NP
and	and	CC	0
for	for	IN	0
which	which	WDT	0
there	there	EX	0
are	are	VBP	0
no	no	RB	0
or	or	CC	0
very	very	RB	0
few	few	JJ	0
known	known	JJ	0
clinical	clinical	JJ	B-NP
inhibitor	inhibitor	NN	I-NP
[	[	-LRB-	0
9	9	CD	0
14	14	CD	0
16	16	CD	0
17	17	CD	0
18	18	CD	0
19	19	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
metallo-β-lactama	metallo-β-lactama	NN	B-NP
have	have	VBP	0
been	been	VBN	0
further	further	RB	0
divided	divided	VBN	0
by	by	IN	0
Bush	Bush	NNP	0
into	into	IN	0
subgroup	subgroup	NN	B-NP
based	based	VBN	0
on	on	IN	0
amino	amino	JJ	0
acid	acid	NN	B-NP
sequence	sequence	NN	I-NP
identity	identity	NN	I-NP
:	:	:	0
the	the	DT	0
Ba	Ba	JJ	B-NP
enzymes	enzymes	JJ	I-NP
share	share	NN	I-NP
a	a	DT	0
>	>	CD	0
23	23	CD	0
%	%	NN	0
sequence	sequence	NN	B-NP
identity	identity	NN	I-NP
,	,	,	0
require	require	VB	0
2	2	CD	0
zn(ii)	zn(ii)	NN	B-NP
ion	ion	NN	I-NP
for	for	IN	0
full	full	JJ	0
activity	activity	NN	0
,	,	,	0
prefer	prefer	VBP	0
penicillins	penicillins	VBN	0
and	and	CC	0
cephalosporin	cephalosporin	NN	B-NP
as	as	IN	0
substrates	substrates	NN	0
,	,	,	0
and	and	CC	0
are	are	VBP	0
represented	represented	VBN	0
by	by	IN	0
metallo-β-lactamase	metallo-β-lactamase	JJ	B-NP
CcrA	CcrA	NN	I-NP
from	from	IN	0
fragili	fragili	NN	B-NP
bacteroide	bacteroide	NN	I-NP
,	,	,	0
the	the	DT	0
Bb	Bb	JJ	B-NP
enzymes	enzymes	JJ	I-NP
share	share	NN	I-NP
a	a	DT	0
11	11	CD	0
%	%	NN	0
sequence	sequence	NN	B-NP
identity	identity	NN	I-NP
with	with	IN	0
the	the	DT	0
Ba	Ba	JJ	0
enzymes	enzymes	NN	0
,	,	,	0
require	require	VBP	0
only	only	RB	0
1	1	CD	0
Zn	Zn	NNP	B-NP
(	(	-LRB-	I-NP
II	II	NNP	I-NP
)	)	-RRB-	I-NP
ion	ion	NN	I-NP
for	for	IN	0
full	full	JJ	0
activity	activity	NN	0
,	,	,	0
prefer	prefer	VBP	0
carbapenems	carbapenems	VBN	0
as	as	IN	0
substrates	substrates	NN	0
,	,	,	0
and	and	CC	0
are	are	VBP	0
represented	represented	VBN	0
by	by	IN	0
the	the	DT	0
metallo-β-lactamase	metallo-β-lactamase	JJ	B-NP
imi	imi	NN	I-NP
from	from	IN	0
Aeromonas	Aeromonas	NNP	B-NP
sobria	sobria	NN	I-NP
,	,	,	0
and	and	CC	0
the	the	DT	0
bc	bc	NN	B-NP
enzyme	enzyme	NN	I-NP
have	have	VBP	0
only	only	RB	0
9	9	CD	0
conserved	conserved	CD	0
residues	residues	NNS	0
with	with	IN	0
the	the	DT	0
other	other	JJ	0
metallo-β-lactama	metallo-β-lactama	NN	B-NP
,	,	,	0
require	require	VB	0
2	2	CD	0
zn(ii)	zn(ii)	NN	B-NP
ion	ion	NN	I-NP
for	for	IN	0
activity	activity	NN	0
,	,	,	0
contain	contain	VBP	0
a	a	DT	0
different	different	JJ	0
metal	metal	NN	0
binding	binding	JJ	0
motif	motif	NN	B-NP
than	than	IN	0
the	the	DT	0
other	other	JJ	0
metallo-β-lactama	metallo-β-lactama	NN	B-NP
,	,	,	0
prefer	prefer	VBP	0
penicillins	penicillins	VBN	0
as	as	IN	0
substrates	substrates	NN	0
,	,	,	0
and	and	CC	0
are	are	VBP	0
represented	represented	VBN	0
by	by	IN	0
the	the	DT	0
metallo-β-lactamase	metallo-β-lactamase	JJ	B-NP
L1	L1	NN	I-NP
from	from	IN	0
Stenotrophomonas	Stenotrophomonas	NNP	B-NP
maltophilon	maltophilon	NN	I-NP
[	[	-LRB-	0
9	9	CD	0
]	]	-RRB-	0
.	.	.	0
A	A	DT	0
similar	similar	JJ	0
grouping	grouping	JJ	0
scheme	scheme	NN	0
(	(	-LRB-	0
B1	B1	NNP	0
,	,	,	0
B2	B2	NN	0
,	,	,	0
and	and	CC	0
B3	B3	CD	0
)	)	-RRB-	0
based	based	VBN	0
on	on	IN	0
metallo-β-lactama	metallo-β-lactama	NN	B-NP
structural	structural	JJ	I-NP
property	property	NN	I-NP
has	has	VBZ	0
recently	recently	RB	0
been	been	VBN	0
offered	offered	VBN	0
[	[	-LRB-	0
41	41	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
diversity	diversity	NN	0
of	of	IN	0
the	the	DT	0
group	group	NN	0
3	3	CD	0
β-lactama	β-lactama	NN	B-NP
is	is	VBZ	0
best	best	JJS	0
exemplified	exemplified	NN	0
by	by	IN	0
the	the	DT	0
enzymes	enzymes	NN	0
'	'	POS	0
vastly	vastly	FW	0
differing	differing	VBG	B-NP
efficacy	efficacy	NN	I-NP
towards	towards	FW	0
non-clinical	non-clinical	NN	B-NP
inhibitor	inhibitor	NN	I-NP
;	;	:	0
these	these	DT	0
differences	differences	NNS	0
predict	predict	VBP	0
that	that	IN	0
one	one	CD	0
inhibitor	inhibitor	NNS	0
may	may	MD	0
not	not	RB	0
inhibit	inhibit	VB	0
all	all	DT	0
metallo-β-lactama	metallo-β-lactama	NN	B-NP
[	[	-LRB-	0
18	18	CD	0
20	20	CD	0
21	21	CD	0
22	22	CD	0
23	23	CD	0
24	24	CD	0
25	25	CD	0
26	26	CD	0
27	27	CD	0
28	28	CD	0
29	29	CD	0
]	]	-RRB-	0
.	.	.	0
To	To	TO	0
combat	combat	VB	0
this	this	DT	0
problem	problem	NN	0
,	,	,	0
we	we	PRP	0
are	are	VBP	0
characterizing	characterizing	VBG	0
a	a	DT	0
metallo-β-lactamase	metallo-β-lactamase	JJ	B-NP
from	from	IN	0
each	each	DT	0
of	of	IN	0
the	the	DT	0
subgroup	subgroup	NN	B-NP
in	in	IN	0
an	an	DT	0
effort	effort	NN	0
to	to	TO	0
identify	identify	VB	0
a	a	DT	0
common	common	JJ	0
structural	structural	JJ	0
or	or	CC	0
mechanistic	mechanistic	JJ	B-NP
aspect	aspect	NN	I-NP
of	of	IN	0
the	the	DT	0
enzymes	enzymes	NN	0
that	that	WDT	0
can	can	MD	0
be	be	VB	0
targeted	targeted	VBN	0
for	for	IN	0
the	the	DT	0
generation	generation	NN	0
of	of	IN	0
an	an	DT	0
inhibitor	inhibitor	NN	0
.	.	.	0
It	It	PRP	0
is	is	VBZ	0
hoped	hoped	VBN	0
that	that	IN	0
this	this	DT	0
inhibitor	inhibitor	NN	0
,	,	,	0
when	when	WRB	0
given	given	VBN	0
in	in	IN	0
combination	combination	NN	0
with	with	IN	0
an	an	DT	0
existing	existing	JJ	0
antibiotic	antibiotic	NN	0
,	,	,	0
will	will	MD	0
prove	prove	VB	0
to	to	TO	0
be	be	VB	0
an	an	DT	0
effective	effective	JJ	0
therapy	therapy	NN	0
against	against	IN	0
bacteria	bacteria	NNS	0
that	that	WDT	0
produce	produce	VBP	0
a	a	DT	0
metallo-β-lactamase	metallo-β-lactamase	JJ	B-NP
.	.	.	0
This	This	DT	0
work	work	NN	0
describes	describes	VBZ	0
our	our	PRP$	0
efforts	efforts	NNS	0
on	on	IN	0
metallo-β-lactamase	metallo-β-lactamase	JJ	B-NP
L1	L1	NN	I-NP
from	from	IN	0
S.	S.	NNP	B-NP
maltophilia	maltophilia	NN	I-NP
.	.	.	0
S.	S.	NNP	B-NP
maltophilia	maltophilia	NN	I-NP
is	is	VBZ	0
an	an	DT	0
important	important	JJ	0
pathogen	pathogen	NN	0
in	in	IN	0
immunocompromised	immunocompromised	JJ	B-NP
patient	patient	JJ	I-NP
nosocomial	nosocomial	JJ	I-NP
infection	infection	NN	I-NP
suffering	suffering	VBG	0
from	from	IN	0
cancer	cancer	NN	0
,	,	,	0
cystic	cystic	JJ	B-NP
fibrosis	fibrosis	NN	I-NP
,	,	,	0
drug	drug	NN	B-NP
addition	addition	NN	I-NP
,	,	,	0
AIDS	AIDS	NNP	0
and	and	CC	0
in	in	IN	0
patients	patients	NNS	0
with	with	IN	0
organ	organ	JJ	B-NP
transplant	transplant	NN	I-NP
and	and	CC	0
on	on	IN	0
dialysis	dialysis	NN	0
[	[	-LRB-	0
30	30	CD	0
31	31	CD	0
32	32	CD	0
]	]	-RRB-	0
.	.	.	0
This	This	DT	0
organism	organism	NN	B-NP
is	is	VBZ	0
inherently	inherently	RB	0
resistant	resistant	JJ	0
to	to	TO	0
most	most	RBS	0
antibiotics	antibiotics	JJ	0
due	due	JJ	0
to	to	TO	0
its	its	PRP$	0
low	low	JJ	0
outer	outer	JJ	0
membrane	membrane	JJ	0
permeability	permeability	NNS	0
[	[	-LRB-	0
33	33	CD	0
]	]	-RRB-	0
and	and	CC	0
to	to	TO	0
containing	containing	VBG	B-NP
antibiotic	antibiotic	JJ	I-NP
β-lactam	β-lactam	JJ	I-NP
due	due	JJ	0
to	to	TO	0
the	the	DT	0
production	production	NN	0
of	of	IN	0
a	a	DT	0
chromosomally	chromosomally	NN	0
expressed	expressed	VBD	0
group	group	NN	0
2e	2e	NNP	0
β-lactamase	β-lactamase	NNP	0
(	(	-LRB-	0
L2	L2	NNP	0
)	)	-RRB-	0
and	and	CC	0
a	a	DT	0
group	group	NN	0
3c	3c	NNP	0
β-lactamase	β-lactamase	NNP	0
(	(	-LRB-	0
L1	L1	NNP	0
)	)	-RRB-	0
[	[	-LRB-	0
34	34	CD	0
35	35	CD	0
]	]	-RRB-	0
.	.	.	0
L1	L1	NNP	0
has	has	VBZ	0
been	been	VBN	0
cloned	cloned	VBN	0
,	,	,	0
over-expressed	over-expressed	NNP	0
,	,	,	0
and	and	CC	0
partially	partially	RB	0
characterized	characterized	VBN	0
by	by	IN	0
kinetic	kinetic	NN	0
and	and	CC	0
crystallographic	crystallographic	JJ	B-NP
study	study	NN	I-NP
[	[	-LRB-	0
36	36	CD	0
37	37	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
enzyme	enzyme	NN	B-NP
exists	exists	VBZ	0
as	as	IN	0
a	a	DT	0
ca	ca	NN	B-NP
homotetramer	homotetramer	NN	I-NP
118	118	CD	0
kDa	kDa	NN	B-NP
in	in	IN	0
solution	solution	NN	B-NP
and	and	CC	0
in	in	IN	0
the	the	DT	0
crystalline	crystalline	JJ	B-NP
state	state	NN	I-NP
.	.	.	0
The	The	DT	0
enzyme	enzyme	NN	B-NP
tightly	tightly	RB	0
binds	binds	CD	0
two	two	CD	0
zn(ii)	zn(ii)	NN	B-NP
ion	ion	NN	I-NP
per	per	FW	0
subunit	subunit	NN	B-NP
and	and	CC	0
requires	requires	VBZ	0
both	both	DT	0
zn(ii)	zn(ii)	NN	B-NP
ion	ion	NN	I-NP
for	for	IN	0
full	full	JJ	0
catalytic	catalytic	JJ	B-NP
activity	activity	NN	I-NP
.	.	.	0
The	The	DT	0
Zn	Zn	NNP	B-NP
1	1	CD	0
site	site	NN	0
has	has	VBZ	0
3	3	CD	0
histidine	histidine	CD	B-NP
residue	residue	NN	I-NP
and	and	CC	0
1	1	CD	0
bridging	bridging	JJ	0
hydroxide	hydroxide	NN	B-NP
as	as	IN	0
ligand	ligand	NN	B-NP
,	,	,	0
and	and	CC	0
the	the	DT	0
Zn	Zn	NNP	B-NP
2	2	CD	0
site	site	NN	0
has	has	VBZ	0
2	2	CD	0
histidine	histidine	NN	B-NP
,	,	,	0
1	1	CD	0
aspartic	aspartic	JJ	B-NP
acid	acid	NN	I-NP
,	,	,	0
1	1	CD	0
terminally-bound	terminally-bound	JJ	B-NP
water	water	NN	I-NP
,	,	,	0
and	and	CC	0
the	the	DT	0
bridging	bridging	JJ	0
hydroxide	hydroxide	NN	B-NP
as	as	IN	0
ligand	ligand	NN	B-NP
.	.	.	0
Spencer	Spencer	NNP	0
and	and	CC	0
coworkers	coworkers	VB	0
used	used	VBN	0
the	the	DT	0
crystal	crystal	NN	0
structure	structure	NN	0
and	and	CC	0
modeling	modeling	JJ	0
studies	studies	NNS	0
to	to	TO	0
propose	propose	VB	0
a	a	DT	0
substrate	substrate	JJ	0
binding	binding	JJ	0
model	model	NN	0
and	and	CC	0
identified	identified	VBN	0
several	several	JJ	0
active	active	JJ	0
site	site	NN	0
residues	residues	NNS	0
that	that	WDT	0
were	were	VBD	0
involved	involved	VBN	0
in	in	IN	0
substrate	substrate	JJ	0
binding	binding	NNS	0
(	(	-LRB-	0
Figure	Figure	NNP	0
1	1	CD	0
)	)	-RRB-	0
[	[	-LRB-	0
37	37	CD	0
]	]	-RRB-	0
.	.	.	0
However	However	RB	0
,	,	,	0
this	this	DT	0
model	model	NN	0
has	has	VBZ	0
not	not	RB	0
been	been	VBN	0
tested	tested	VBN	0
experimentally	experimentally	RB	0
.	.	.	0
In	In	IN	0
order	order	NN	0
to	to	TO	0
prepare	prepare	VB	0
tight	tight	JJ	0
binding	binding	JJ	0
inhibitors	inhibitors	NN	0
of	of	IN	0
the	the	DT	0
metallo-β-lactama	metallo-β-lactama	NN	B-NP
,	,	,	0
knowledge	knowledge	NN	0
about	about	IN	0
how	how	WRB	0
substrate	substrate	JJ	B-NP
bind	bind	NN	I-NP
to	to	TO	0
the	the	DT	0
enzymes	enzymes	NN	0
is	is	VBZ	0
needed	needed	VBN	0
so	so	RB	0
that	that	IN	0
all	all	DT	0
substrate-enzyme	substrate-enzyme	JJ	B-NP
binding	binding	JJ	0
contacts	contacts	NNS	0
can	can	MD	0
be	be	VB	0
maintained	maintained	VBN	0
in	in	IN	0
any	any	DT	0
proposed	proposed	JJ	0
inhibitor	inhibitor	NN	0
.	.	.	0
This	This	DT	0
work	work	NN	0
describes	describes	VBZ	0
our	our	PRP$	0
efforts	efforts	NNS	0
at	at	IN	0
understanding	understanding	NN	0
how	how	WRB	0
substrates	substrates	JJ	B-NP
bind	bind	NN	I-NP
to	to	TO	0
metallo-β-lactamase	metallo-β-lactamase	JJ	B-NP
L1	L1	NN	I-NP
.	.	.	0
Several	Several	JJ	0
site-directed	site-directed	JJ	0
mutant	mutant	NN	B-NP
of	of	IN	0
L1	L1	NNP	0
were	were	VBD	0
generated	generated	VBN	0
and	and	CC	0
characterized	characterized	VBN	0
,	,	,	0
and	and	CC	0
the	the	DT	0
results	results	NNS	0
from	from	IN	0
these	these	DT	0
studies	studies	NNS	0
reveal	reveal	VBP	0
that	that	DT	0
none	none	NN	0
of	of	IN	0
the	the	DT	0
active	active	JJ	0
site	site	NN	0
residues	residues	NNS	0
predicted	predicted	VBD	0
from	from	IN	0
earlier	earlier	RBR	0
computational	computational	JJ	B-NP
study	study	NN	I-NP
[	[	-LRB-	0
37	37	CD	0
]	]	-RRB-	0
are	are	VBP	0
essential	essential	JJ	0
for	for	IN	0
tight	tight	JJ	0
substrate	substrate	JJ	0
binding	binding	NN	0
.	.	.	0
Results	Results	NNP	0
Wild	Wild	NNP	0
type	type	NN	B-NP
L1	L1	NNP	I-NP
Wild-type	Wild-type	NNP	I-NP
L1	L1	NNP	I-NP
was	was	VBD	0
over-expressed	over-expressed	JJ	0
in	in	IN	0
Escherichia	Escherichia	NNP	B-NP
cus	cus	NN	I-NP
and	and	CC	0
purified	purified	NN	0
as	as	IN	0
previously	previously	RB	0
described	described	VBN	0
[	[	-LRB-	0
36	36	CD	0
]	]	-RRB-	0
.	.	.	0
This	This	DT	0
procedure	procedure	NN	0
produced	produced	VBD	0
an	an	DT	0
average	average	NN	0
of	of	IN	0
50-60	50-60	CD	0
mg	mg	NN	B-NP
of	of	IN	0
>	>	CD	0
90	90	CD	0
%	%	NN	0
pure	pure	NN	0
,	,	,	0
active	active	JJ	0
protein	protein	NN	B-NP
per	per	IN	0
4	4	CD	0
L	L	NNP	0
of	of	IN	0
growth	growth	NN	B-NP
culture	culture	NN	I-NP
.	.	.	0
circular	circular	JJ	B-NP
dichroism	dichroism	JJ	I-NP
spectrum	spectrum	NN	I-NP
were	were	VBD	0
collected	collected	VBN	0
on	on	IN	0
wild-type	wild-type	JJ	B-NP
sample	sample	NN	I-NP
to	to	TO	0
ensure	ensure	VB	0
L1	L1	NNP	0
expressed	expressed	VBD	0
using	using	VBG	0
the	the	DT	0
pET26b	pET26b	JJ	0
expression	expression	NN	0
system	system	NN	0
had	had	VBD	0
the	the	DT	0
correct	correct	JJ	0
secondary	secondary	JJ	B-NP
structure	structure	NN	I-NP
.	.	.	0
The	The	DT	0
CD	CD	NN	0
spectrum	spectrum	NN	B-NP
of	of	IN	0
wild	wild	JJ	0
type	type	NN	B-NP
L1	L1	NN	I-NP
showed	showed	VBD	0
an	an	DT	0
intense	intense	JJ	0
,	,	,	0
broad	broad	JJ	0
feature	feature	NN	0
at	at	IN	0
190	190	CD	0
nm	nm	NN	B-NP
and	and	CC	0
a	a	DT	0
smaller	smaller	JJR	0
feature	feature	NN	0
at	at	IN	0
215	215	CD	0
nm	nm	NN	B-NP
(	(	-LRB-	0
see	see	VB	0
Additional	Additional	JJ	B-NP
file	file	NN	I-NP
1	1	CD	0
:	:	:	0
CD	CD	NNP	0
spectra	spectra	CD	0
)	)	-RRB-	0
.	.	.	0
These	These	DT	0
features	features	NNS	0
are	are	VBP	0
consistent	consistent	JJ	0
with	with	IN	0
a	a	DT	0
sample	sample	NN	0
with	with	IN	0
significant	significant	JJ	0
α	α	FW	0
/	/	FW	0
β	β	FW	0
content	content	FW	0
.	.	.	0
The	The	DT	0
Compton	Compton	NNP	0
and	and	CC	0
Johnson	Johnson	NNP	B-NP
algorithm	algorithm	NN	I-NP
[	[	-LRB-	0
38	38	CD	0
]	]	-RRB-	0
was	was	VBD	0
used	used	VBN	0
to	to	TO	0
estimate	estimate	VB	0
secondary	secondary	JJ	B-NP
structure	structure	NN	I-NP
in	in	IN	0
the	the	DT	0
samples	samples	NNS	0
;	;	:	0
wild-type	wild-type	NNP	B-NP
L1	L1	NNP	I-NP
was	was	VBD	0
estimated	estimated	VBN	0
to	to	TO	0
have	have	VB	0
38.3	38.3	CD	0
%	%	NN	0
α-helix	α-helix	NN	B-NP
,	,	,	0
26.7	26.7	CD	0
%	%	NN	0
β-structure	β-structure	NN	B-NP
(	(	-LRB-	0
9.3	9.3	CD	0
%	%	NN	0
antiparallel	antiparallel	NN	B-NP
β-sheet	β-sheet	NN	I-NP
,	,	,	0
2.1	2.1	CD	0
%	%	NN	0
parallel	parallel	NN	B-NP
β-sheet	β-sheet	NN	I-NP
,	,	,	0
and	and	CC	0
15.3	15.3	CD	0
%	%	NN	0
β-turn	β-turn	NN	B-NP
)	)	-RRB-	0
,	,	,	0
and	and	CC	0
34.9	34.9	CD	0
%	%	NN	0
other	other	JJ	0
structure	structure	NN	0
.	.	.	0
These	These	DT	0
estimates	estimates	NNS	0
are	are	VBP	0
in	in	IN	0
excellent	excellent	JJ	0
agreement	agreement	NN	0
with	with	IN	0
the	the	DT	0
crystallographically	crystallographically	NN	0
determined	determined	VBN	0
secondary	secondary	JJ	B-NP
structure	structure	NN	I-NP
of	of	IN	0
~40	~40	CD	0
%	%	NN	0
α-helix	α-helix	NN	B-NP
and	and	CC	0
30	30	CD	0
%	%	NN	0
β-structure	β-structure	NN	B-NP
[	[	-LRB-	0
37	37	CD	0
]	]	-RRB-	0
.	.	.	0
Metal	Metal	NN	0
analyses	analyses	NNS	0
on	on	IN	0
multiple	multiple	JJ	0
wild-type	wild-type	NNP	B-NP
l1	l1	NN	I-NP
preparation	preparation	NN	I-NP
demonstrated	demonstrated	VBD	0
that	that	IN	0
the	the	DT	0
enzyme	enzyme	JJ	B-NP
bind	bind	NN	I-NP
1.9	1.9	CD	0
±	±	CD	0
0.2	0.2	CD	0
zn(ii)	zn(ii)	NN	B-NP
ion	ion	NN	I-NP
per	per	FW	0
monomer	monomer	NN	B-NP
(	(	-LRB-	0
Table	Table	NNP	0
2	2	CD	0
)	)	-RRB-	0
,	,	,	0
in	in	IN	0
agreement	agreement	NN	0
with	with	IN	0
previous	previous	JJ	0
results	results	NNS	0
[	[	-LRB-	0
36	36	CD	0
]	]	-RRB-	0
.	.	.	0
Steady	Steady	JJ	0
state	state	NN	0
kinetic	kinetic	NN	0
studies	studies	NNS	0
were	were	VBD	0
performed	performed	VBN	0
on	on	IN	0
multiple	multiple	JJ	0
preparations	preparations	NNS	0
of	of	IN	0
wild	wild	JJ	0
type	type	NN	0
L1	L1	NN	0
,	,	,	0
and	and	CC	0
the	the	DT	0
resulting	resulting	VBG	0
kinetic	kinetic	JJ	0
data	data	NNS	0
are	are	VBP	0
shown	shown	VBN	0
in	in	IN	0
Tables	Tables	NNP	0
3	3	CD	0
,	,	,	0
4	4	CD	0
,	,	,	0
5	5	CD	0
.	.	.	0
When	When	WRB	0
using	using	VBG	0
nitrocefin	nitrocefin	NN	0
as	as	IN	0
substrate	substrate	NN	0
and	and	CC	0
50	50	CD	0
mM	mM	JJ	0
cacodylate	cacodylate	NN	0
,	,	,	0
pH	pH	JJ	0
7.0	7.0	CD	0
,	,	,	0
as	as	IN	0
buffer	buffer	NN	0
,	,	,	0
wild-type	wild-type	FW	0
L1	L1	FW	0
exhibited	exhibited	FW	0
a	a	FW	0
k	k	FW	0
cat	cat	FW	0
value	value	NN	0
of	of	IN	0
38	38	CD	0
±	±	CD	0
1	1	CD	0
s	s	CD	0
-1and	-1and	CD	0
a	a	DT	0
K	K	NNP	0
m	m	JJ	0
value	value	NN	0
of	of	IN	0
12	12	CD	0
±	±	CD	0
1	1	CD	0
μM	μM	NN	0
.	.	.	0
The	The	DT	0
inclusion	inclusion	NN	0
of	of	IN	0
100	100	CD	0
μM	μM	JJ	0
ZnCl	ZnCl	JJ	0
2	2	CD	0
in	in	IN	0
the	the	DT	0
assay	assay	JJ	0
buffer	buffer	NN	0
resulted	resulted	VBD	0
in	in	IN	0
slightly	slightly	RB	0
lower	lower	JJR	0
values	values	NNS	0
of	of	IN	0
K	K	NNP	0
m	m	NN	0
and	and	CC	0
higher	higher	JJR	0
values	values	NNS	0
for	for	IN	0
k	k	JJ	0
cat	cat	NNS	0
[	[	-LRB-	0
36	36	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
inclusion	inclusion	NN	0
of	of	IN	0
higher	higher	JJR	0
concentrations	concentrations	NNS	0
of	of	IN	0
Zn	Zn	NNP	0
(	(	-LRB-	0
II	II	NNP	0
)	)	-RRB-	0
did	did	VBD	0
not	not	RB	0
further	further	RB	0
affect	affect	VB	0
the	the	DT	0
steady-state	steady-state	JJ	0
kinetic	kinetic	JJ	0
constants	constants	NN	0
.	.	.	0
Apparently	Apparently	RB	0
,	,	,	0
the	the	DT	0
purified	purified	NN	0
,	,	,	0
recombinant	recombinant	JJ	0
enzyme	enzyme	NN	0
does	does	VBZ	0
not	not	RB	0
bind	bind	VB	0
its	its	PRP$	0
full	full	JJ	0
complement	complement	NN	0
of	of	IN	0
Zn	Zn	NNP	0
(	(	-LRB-	0
II	II	NNP	0
)	)	-RRB-	0
;	;	:	0
therefore	therefore	RB	0
,	,	,	0
100	100	CD	0
μM	μM	JJ	0
Zn	Zn	NNP	0
(	(	-LRB-	0
II	II	NNP	0
)	)	-RRB-	0
was	was	VBD	0
included	included	VBN	0
in	in	IN	0
all	all	DT	0
subsequent	subsequent	JJ	0
kinetic	kinetic	JJ	0
studies	studies	NNS	0
.	.	.	0
Wild-type	Wild-type	FW	0
L1	L1	FW	0
exhibited	exhibited	FW	0
k	k	FW	0
cat	cat	FW	0
values	values	NNS	0
of	of	IN	0
41	41	CD	0
±	±	CD	0
1	1	CD	0
s	s	CD	0
-1	-1	CD	0
,	,	,	0
1.9	1.9	CD	0
±	±	CD	0
0.1	0.1	CD	0
s	s	CD	0
-1	-1	CD	0
,	,	,	0
42	42	CD	0
±	±	CD	0
1	1	CD	0
s	s	CD	0
-1	-1	CD	0
,	,	,	0
and	and	CC	0
82	82	CD	0
±	±	CD	0
5	5	CD	0
s	s	CD	0
-1for	-1for	CD	0
the	the	DT	0
cephalosporins	cephalosporins	NN	0
,	,	,	0
nitrocefin	nitrocefin	NN	0
,	,	,	0
cefoxitin	cefoxitin	NN	0
,	,	,	0
cefaclor	cefaclor	NN	0
,	,	,	0
and	and	CC	0
cephalothin	cephalothin	NN	0
.	.	.	0
For	For	IN	0
these	these	DT	0
same	same	JJ	0
substrates	substrates	NN	0
,	,	,	0
the	the	DT	0
K	K	NNP	0
m	m	NN	0
values	values	NNS	0
were	were	VBD	0
4	4	CD	0
±	±	CD	0
1	1	CD	0
μM	μM	NN	0
,	,	,	0
1.1	1.1	CD	0
±	±	CD	0
0.1	0.1	CD	0
μM	μM	NN	0
,	,	,	0
13	13	CD	0
±	±	CD	0
1	1	CD	0
μM	μM	NN	0
,	,	,	0
and	and	CC	0
8.9	8.9	CD	0
±	±	CD	0
1.5	1.5	CD	0
μM	μM	NN	0
,	,	,	0
respectively	respectively	RB	0
.	.	.	0
Two	Two	CD	0
penicillins	penicillins	NNS	0
were	were	VBD	0
tested	tested	VBN	0
as	as	IN	0
substrates	substrates	NN	0
,	,	,	0
and	and	CC	0
penicillin	penicillin	JJ	0
G	G	NNP	0
and	and	CC	0
ampicillin	ampicillin	JJ	0
exhibited	exhibited	JJ	0
K	K	NNP	0
m	m	NN	0
values	values	NNS	0
of	of	IN	0
38	38	CD	0
±	±	CD	0
12	12	CD	0
μM	μM	JJ	0
and	and	CC	0
55	55	CD	0
±	±	CD	0
5	5	CD	0
μM	μM	JJ	0
and	and	CC	0
k	k	JJ	0
cat	cat	NN	0
values	values	NNS	0
of	of	IN	0
600	600	CD	0
±	±	CD	0
100	100	CD	0
s	s	CD	0
-1and	-1and	CD	0
520	520	CD	0
±	±	CD	0
10	10	CD	0
s	s	CD	0
-1	-1	CD	0
,	,	,	0
respectively	respectively	RB	0
(	(	-LRB-	0
Table	Table	NNP	0
4	4	CD	0
)	)	-RRB-	0
.	.	.	0
Three	Three	CD	0
carbapenems	carbapenems	NNS	0
were	were	VBD	0
also	also	RB	0
used	used	VBN	0
as	as	IN	0
substrates	substrates	NN	0
for	for	IN	0
L1	L1	NNP	0
,	,	,	0
and	and	CC	0
biapenem	biapenem	NN	0
,	,	,	0
imipenem	imipenem	NN	0
,	,	,	0
and	and	CC	0
meropenem	meropenem	JJ	0
exhibited	exhibited	JJ	0
K	K	NNP	0
m	m	NN	0
values	values	NNS	0
of	of	IN	0
32	32	CD	0
±	±	CD	0
1	1	CD	0
μM	μM	NN	0
,	,	,	0
57	57	CD	0
±	±	CD	0
7	7	CD	0
μM	μM	NN	0
,	,	,	0
and	and	CC	0
15	15	CD	0
±	±	CD	0
4	4	CD	0
μM	μM	JJ	0
and	and	CC	0
k	k	JJ	0
cat	cat	NN	0
values	values	NNS	0
of	of	IN	0
134	134	CD	0
±	±	CD	0
4	4	CD	0
s	s	CD	0
-1	-1	CD	0
,	,	,	0
370	370	CD	0
±	±	CD	0
5	5	CD	0
s	s	CD	0
-1	-1	CD	0
,	,	,	0
and	and	CC	0
157	157	CD	0
±	±	CD	0
9	9	CD	0
s	s	CD	0
-1	-1	CD	0
,	,	,	0
respectively	respectively	RB	0
(	(	-LRB-	0
Table	Table	NNP	0
5	5	CD	0
)	)	-RRB-	0
.	.	.	0
L1	L1	NNP	0
's	's	POS	0
preference	preference	NN	0
for	for	IN	0
penicillins	penicillins	NN	0
and	and	CC	0
carbapenems	carbapenems	NN	0
over	over	IN	0
cephalosporins	cephalosporins	NN	0
,	,	,	0
as	as	IN	0
exemplified	exemplified	NN	0
by	by	IN	0
the	the	DT	0
k	k	JJ	0
cat	cat	NN	0
values	values	NNS	0
,	,	,	0
is	is	VBZ	0
in	in	IN	0
agreement	agreement	NN	0
with	with	IN	0
previous	previous	JJ	0
studies	studies	NNS	0
and	and	CC	0
supports	supports	VBZ	0
L1	L1	NNP	0
's	's	POS	0
placement	placement	NN	0
in	in	IN	0
the	the	DT	0
β-lactamase	β-lactamase	JJ	0
3c	3c	CD	0
family	family	NN	0
[	[	-LRB-	0
9	9	CD	0
]	]	-RRB-	0
.	.	.	0
Rapid-scanning	Rapid-scanning	JJ	0
visible	visible	JJ	0
spectra	spectra	NN	0
of	of	IN	0
25	25	CD	0
μM	μM	JJ	B-NP
wild-type	wild-type	JJ	I-NP
L1	L1	NN	I-NP
with	with	IN	0
5	5	CD	0
μM	μM	JJ	B-NP
nitrocefin	nitrocefin	NN	I-NP
demonstrated	demonstrated	VBD	0
a	a	DT	0
decrease	decrease	NN	0
in	in	IN	0
absorbance	absorbance	NN	B-NP
at	at	IN	0
390	390	CD	0
nm	nm	NN	B-NP
,	,	,	0
an	an	DT	0
increase	increase	NN	0
at	at	IN	0
485	485	CD	0
nm	nm	NN	B-NP
,	,	,	0
and	and	CC	0
a	a	DT	0
rapid	rapid	JJ	B-NP
increase	increase	NN	I-NP
and	and	CC	0
slower	slower	JJR	0
decrease	decrease	NN	0
in	in	IN	0
absorbance	absorbance	NN	B-NP
at	at	IN	0
665	665	CD	0
nm	nm	NN	B-NP
.	.	.	0
These	These	DT	0
spectra	spectra	NNS	0
are	are	VBP	0
similar	similar	JJ	0
to	to	TO	0
those	those	DT	0
previously	previously	RB	0
reported	reported	VBN	0
for	for	IN	0
wild-type	wild-type	NNP	B-NP
L1	L1	NNP	I-NP
and	and	CC	0
nitrocefin	nitrocefin	NN	B-NP
[	[	-LRB-	0
39	39	CD	0
]	]	-RRB-	0
,	,	,	0
and	and	CC	0
the	the	DT	0
features	features	NNS	0
can	can	MD	0
be	be	VB	0
attributed	attributed	VBN	0
to	to	TO	0
substrate	substrate	VB	B-NP
decay	decay	NN	I-NP
,	,	,	0
product	product	NN	B-NP
formation	formation	NN	I-NP
,	,	,	0
and	and	CC	0
intermediate	intermediate	JJ	0
formation	formation	NN	0
and	and	CC	0
decay	decay	NN	0
,	,	,	0
respectively	respectively	RB	0
.	.	.	0
Under	Under	IN	0
these	these	DT	0
conditions	conditions	NNS	0
,	,	,	0
2.2	2.2	CD	0
μM	μM	JJ	B-NP
intermediate	intermediate	NN	I-NP
was	was	VBD	0
formed	formed	VBN	0
during	during	IN	0
the	the	DT	0
first	first	JJ	0
10	10	CD	0
millisecond	millisecond	NN	B-NP
of	of	IN	0
the	the	DT	0
reaction	reaction	NN	0
(	(	-LRB-	0
Figure	Figure	NNP	0
2	2	CD	0
)	)	-RRB-	0
,	,	,	0
and	and	CC	0
the	the	DT	0
rate	rate	NN	0
of	of	IN	0
decay	decay	NN	0
of	of	IN	0
this	this	DT	0
intermediate	intermediate	JJ	0
corresponds	corresponds	NN	0
to	to	TO	0
the	the	DT	0
steady-state	steady-state	JJ	B-NP
k	k	NN	I-NP
cat	cat	NN	I-NP
(	(	-LRB-	0
Table	Table	NNP	0
3	3	CD	0
)	)	-RRB-	0
.	.	.	0
To	To	TO	0
probe	probe	VB	0
further	further	RBR	0
the	the	DT	0
binding	binding	NN	0
of	of	IN	0
nitrocefin	nitrocefin	VBG	0
to	to	TO	0
wild-type	wild-type	NNP	B-NP
L1	L1	NNP	I-NP
,	,	,	0
stopped-flow	stopped-flow	JJ	B-NP
fluorescence	fluorescence	JJ	I-NP
study	study	NN	I-NP
were	were	VBD	0
conducted	conducted	VBN	0
as	as	IN	0
previously	previously	RB	0
described	described	VBN	0
[	[	-LRB-	0
40	40	CD	0
]	]	-RRB-	0
(	(	-LRB-	0
Figure	Figure	NNP	0
3	3	CD	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
reaction	reaction	NN	0
of	of	IN	0
wild-type	wild-type	JJ	B-NP
L1	L1	NN	I-NP
with	with	IN	0
nitrocefin	nitrocefin	NN	B-NP
under	under	IN	0
steady-state	steady-state	JJ	B-NP
condition	condition	NN	I-NP
at	at	IN	0
10°C	10°C	NNP	0
resulted	resulted	VBD	0
in	in	IN	0
a	a	DT	0
rapid	rapid	JJ	B-NP
decrease	decrease	NN	I-NP
in	in	IN	0
fluorescence	fluorescence	VBG	0
followed	followed	VBN	0
by	by	IN	0
a	a	DT	0
rate-limiting	rate-limiting	JJ	0
return	return	NN	0
of	of	IN	0
fluorescence	fluorescence	NNS	0
(	(	-LRB-	0
Figure	Figure	NNP	0
3A	3A	NNP	0
)	)	-RRB-	0
.	.	.	0
Fitting	Fitting	JJ	0
of	of	IN	0
the	the	DT	0
data	data	NNS	0
,	,	,	0
as	as	RB	0
described	described	VBN	0
by	by	IN	0
Spencer	Spencer	NNP	0
et	et	FW	0
al.	al.	FW	0
[	[	-LRB-	0
40	40	CD	0
]	]	-RRB-	0
,	,	,	0
resulted	resulted	VBD	0
in	in	IN	0
a	a	DT	0
K	K	NNP	0
S	S	NNP	0
value	value	NN	0
for	for	IN	0
wild-type	wild-type	JJ	0
L1	L1	NN	0
of	of	IN	0
38	38	CD	0
±	±	CD	0
5	5	CD	0
μM	μM	NNS	0
(	(	-LRB-	0
Figure	Figure	NNP	0
3B	3B	NNP	0
)	)	-RRB-	0
.	.	.	0
ser224	ser224	NN	B-NP
mutant	mutant	NN	I-NP
(	(	-LRB-	0
the	the	DT	0
BBL	BBL	NNP	B-NP
numbering	numbering	JJ	0
scheme	scheme	NN	0
proposed	proposed	VBN	0
in	in	IN	0
reference	reference	CD	0
41	41	CD	0
was	was	VBD	0
used	used	VBN	0
throughout	throughout	IN	0
this	this	DT	0
manuscript	manuscript	NN	0
)	)	-RRB-	0
.	.	.	0
All	All	DT	0
sequenced	sequenced	JJ	0
subclass	subclass	JJ	0
Ba	Ba	NNP	0
and	and	CC	0
bb	bb	NN	B-NP
metallo-β-lactama	metallo-β-lactama	NN	I-NP
(	(	-LRB-	0
except	except	IN	0
VIM-1	VIM-1	CD	B-NP
)	)	-RRB-	0
have	have	VBP	0
a	a	DT	0
lysine	lysine	JJ	0
residue	residue	NN	0
at	at	IN	0
position	position	NN	0
224	224	CD	0
[	[	-LRB-	0
41	41	CD	0
]	]	-RRB-	0
,	,	,	0
and	and	CC	0
all	all	DT	0
computational	computational	JJ	B-NP
model	model	NN	I-NP
for	for	IN	0
substrate	substrate	JJ	0
binding	binding	NN	0
to	to	TO	0
the	the	DT	0
metallo-β-lactama	metallo-β-lactama	NN	B-NP
assume	assume	NN	0
that	that	IN	0
the	the	DT	0
invariant	invariant	JJ	B-NP
carboxylate	carboxylate	NN	I-NP
on	on	IN	0
substrates	substrates	JJ	0
forms	forms	NNS	0
an	an	DT	0
electrostatic	electrostatic	JJ	B-NP
interaction	interaction	NN	I-NP
with	with	IN	0
this	this	DT	0
lysine	lysine	NN	B-NP
.	.	.	0
In	In	IN	0
L1	L1	NNP	0
,	,	,	0
the	the	DT	0
residue	residue	NN	0
at	at	IN	0
position	position	NN	0
224	224	CD	0
is	is	VBZ	0
a	a	DT	0
serine	serine	NN	B-NP
[	[	-LRB-	0
35	35	CD	0
]	]	-RRB-	0
,	,	,	0
and	and	CC	0
the	the	DT	0
substrate-binding	substrate-binding	JJ	0
model	model	NN	0
for	for	IN	0
L1	L1	NNP	0
predicts	predicts	VBZ	0
that	that	IN	0
this	this	DT	0
serine	serine	JJ	B-NP
residue	residue	JJ	I-NP
interacts	interacts	NN	0
with	with	IN	0
the	the	DT	0
carboxylate	carboxylate	NN	B-NP
on	on	IN	0
substrate	substrate	NN	0
via	via	IN	0
a	a	DT	0
water	water	NN	B-NP
molecule	molecule	NN	I-NP
[	[	-LRB-	0
37	37	CD	0
]	]	-RRB-	0
.	.	.	0
To	To	TO	0
test	test	VB	0
the	the	DT	0
proposed	proposed	JJ	0
role	role	NN	0
of	of	IN	0
Ser224	Ser224	CD	B-NP
in	in	IN	0
L1	L1	NNP	0
,	,	,	0
serine	serine	NN	B-NP
was	was	VBD	0
changed	changed	VBN	0
to	to	TO	0
an	an	DT	0
alanine	alanine	NN	B-NP
(	(	-LRB-	0
S224A	S224A	NNP	0
)	)	-RRB-	0
,	,	,	0
aspartic	aspartic	JJ	B-NP
acid	acid	NN	I-NP
(	(	-LRB-	0
S224D	S224D	NNP	0
)	)	-RRB-	0
,	,	,	0
and	and	CC	0
lysine	lysine	NN	B-NP
(	(	-LRB-	0
S224K	S224K	NNP	0
)	)	-RRB-	0
,	,	,	0
and	and	CC	0
these	these	DT	0
mutant	mutant	NN	B-NP
were	were	VBD	0
characterized	characterized	VBN	0
using	using	VBG	0
metal	metal	NN	0
analyses	analyses	NNS	0
,	,	,	0
CD	CD	NNP	0
spectroscopy	spectroscopy	NN	B-NP
,	,	,	0
steady-state	steady-state	JJ	B-NP
kinetics	kinetics	NN	I-NP
,	,	,	0
and	and	CC	0
kinetic	kinetic	NN	B-NP
study	study	NN	I-NP
pre-steady	pre-steady	JJ	I-NP
state	state	NN	I-NP
.	.	.	0
small-scale	small-scale	NN	B-NP
growth	growth	NN	I-NP
culture	culture	NN	I-NP
showed	showed	VBD	0
that	that	IN	0
all	all	DT	0
three	three	CD	0
mutant	mutant	NN	B-NP
were	were	VBD	0
over-expressed	over-expressed	JJ	0
at	at	IN	0
levels	levels	NNS	0
comparable	comparable	JJ	0
to	to	TO	0
those	those	DT	0
of	of	IN	0
wild-type	wild-type	JJ	B-NP
L1	L1	NN	I-NP
.	.	.	0
Large-scale	Large-scale	JJ	0
over-expression	over-expression	JJ	B-NP
and	and	CC	0
mutant	mutant	NN	B-NP
purification	purification	NN	I-NP
showed	showed	VBD	0
that	that	IN	0
all	all	DT	0
three	three	CD	0
mutant	mutant	NN	B-NP
were	were	VBD	0
isolatable	isolatable	VBN	0
at	at	IN	0
levels	levels	NNS	0
comparable	comparable	JJ	0
to	to	TO	0
those	those	DT	0
of	of	IN	0
wild-type	wild-type	JJ	B-NP
L1	L1	NN	I-NP
.	.	.	0
Metal	Metal	NN	0
analyses	analyses	NNS	0
of	of	IN	0
the	the	DT	0
S224A	S224A	NNP	0
and	and	CC	0
S224D	S224D	CD	0
mutants	mutants	NNS	0
showed	showed	VBD	0
that	that	IN	0
both	both	DT	0
mutants	mutants	JJ	B-NP
bind	bind	NN	I-NP
nearly	nearly	RB	0
two	two	CD	0
zn(ii)	zn(ii)	NN	B-NP
ion	ion	NN	I-NP
(	(	-LRB-	0
Table	Table	NNP	0
2	2	CD	0
)	)	-RRB-	0
,	,	,	0
like	like	IN	0
wild-type	wild-type	NNP	B-NP
L1	L1	NNP	I-NP
[	[	-LRB-	0
36	36	CD	0
]	]	-RRB-	0
;	;	:	0
however	however	RB	0
,	,	,	0
the	the	DT	0
S224K	S224K	CD	0
mutant	mutant	NNS	0
binds	binds	VBP	0
only	only	RB	0
1.0	1.0	CD	0
Zn	Zn	NNP	B-NP
(	(	-LRB-	I-NP
II	II	NNP	I-NP
)	)	-RRB-	I-NP
per	per	IN	0
protein	protein	NN	B-NP
.	.	.	0
CD	CD	NNP	0
spectra	spectra	NN	0
of	of	IN	0
the	the	DT	0
mutant	mutant	NN	B-NP
were	were	VBD	0
similar	similar	JJ	0
to	to	TO	0
those	those	DT	0
of	of	IN	0
wild-type	wild-type	NNP	B-NP
L1	L1	NNP	I-NP
(	(	-LRB-	0
see	see	VB	0
Figure	Figure	NN	0
in	in	IN	0
Additional	Additional	JJ	0
materials	materials	NNS	0
)	)	-RRB-	0
.	.	.	0
kinetic	kinetic	JJ	B-NP
study	study	NN	I-NP
steady-state	steady-state	NN	I-NP
were	were	VBD	0
conducted	conducted	VBN	0
with	with	IN	0
all	all	DT	0
three	three	CD	0
mutant	mutant	NN	B-NP
in	in	IN	0
buffer	buffer	NN	B-NP
containing	containing	VBG	0
100	100	CD	0
μM	μM	JJ	0
ZnCl	ZnCl	JJ	B-NP
2	2	CD	0
to	to	TO	0
ensure	ensure	VB	0
that	that	IN	0
both	both	DT	0
Zn	Zn	NNP	B-NP
(	(	-LRB-	I-NP
II	II	NNP	I-NP
)	)	-RRB-	I-NP
binding	binding	JJ	0
sites	sites	NNS	0
were	were	VBD	0
saturated	saturated	VBN	0
in	in	IN	0
these	these	DT	0
studies	studies	NNS	0
.	.	.	0
Addition	Addition	NN	B-NP
of	of	IN	0
higher	higher	JJR	0
zn(ii)	zn(ii)	NN	B-NP
concentration	concentration	NN	I-NP
did	did	VBD	0
not	not	RB	0
result	result	VB	0
in	in	IN	0
different	different	JJ	0
values	values	NNS	0
for	for	IN	0
the	the	DT	0
kinetic	kinetic	JJ	B-NP
constant	constant	JJ	I-NP
steady-state	steady-state	JJ	I-NP
in	in	IN	0
Tables	Tables	NNP	0
3	3	CD	0
,	,	,	0
4	4	CD	0
,	,	,	0
5	5	CD	0
.	.	.	0
When	When	WRB	0
the	the	DT	0
cephalosporins	cephalosporins	NN	0
were	were	VBD	0
used	used	VBN	0
as	as	IN	0
substrates	substrates	NN	0
,	,	,	0
the	the	DT	0
S224A	S224A	NNP	0
and	and	CC	0
S224K	S224K	CD	0
mutants	mutants	CD	0
exhibited	exhibited	CD	0
2-	2-	CD	0
to	to	TO	0
4-fold	4-fold	CD	0
changes	changes	NNS	0
in	in	IN	0
K	K	NNP	0
m	m	NN	0
values	values	NNS	0
(	(	-LRB-	0
Table	Table	NNP	0
3	3	CD	0
)	)	-RRB-	0
.	.	.	0
In	In	IN	0
studies	studies	NNS	0
with	with	IN	0
cefoxitin	cefoxitin	NN	0
,	,	,	0
cefaclor	cefaclor	NN	0
,	,	,	0
and	and	CC	0
cephalothin	cephalothin	NN	0
as	as	IN	0
substrate	substrate	NN	0
,	,	,	0
the	the	DT	0
observed	observed	JJ	0
k	k	JJ	0
cat	cat	NN	0
values	values	NNS	0
for	for	IN	0
the	the	DT	0
S224A	S224A	NNP	0
and	and	CC	0
S224K	S224K	CD	0
mutants	mutants	NNS	0
were	were	VBD	0
2-	2-	CD	0
to	to	TO	0
7-fold	7-fold	CD	0
lower	lower	JJR	0
;	;	:	0
however	however	RB	0
,	,	,	0
the	the	DT	0
k	k	JJ	0
cat	cat	NN	0
values	values	NNS	0
when	when	WRB	0
using	using	VBG	0
nitrocefin	nitrocefin	NN	0
as	as	IN	0
substrate	substrate	NN	0
were	were	VBD	0
slightly	slightly	RB	0
higher	higher	JJR	0
(	(	-LRB-	0
<	<	SYM	0
2-fold	2-fold	NNP	0
)	)	-RRB-	0
.	.	.	0
On	On	IN	0
the	the	DT	0
other	other	JJ	0
hand	hand	NN	0
,	,	,	0
the	the	DT	0
S224D	S224D	FW	0
mutant	mutant	FW	0
exhibited	exhibited	FW	0
3-	3-	FW	0
to	to	TO	0
50-fold	50-fold	CD	0
higher	higher	JJR	0
K	K	NNP	0
m	m	NN	0
values	values	NNS	0
and	and	CC	0
2-	2-	CD	0
to	to	TO	0
20-fold	20-fold	CD	0
lower	lower	JJR	0
k	k	JJ	0
cat	cat	NN	0
values	values	NNS	0
for	for	IN	0
the	the	DT	0
cephalosporins	cephalosporins	NN	0
tested	tested	VBD	0
.	.	.	0
A	A	DT	0
similar	similar	JJ	0
trend	trend	NN	0
was	was	VBD	0
observed	observed	VBN	0
in	in	IN	0
kinetic	kinetic	JJ	0
studies	studies	NNS	0
when	when	WRB	0
using	using	VBG	0
penicillins	penicillins	NN	0
as	as	IN	0
substrates	substrates	NNS	0
(	(	-LRB-	0
Table	Table	NNP	0
4	4	CD	0
)	)	-RRB-	0
.	.	.	0
Generally	Generally	RB	0
,	,	,	0
the	the	DT	0
S224A	S224A	NNP	0
and	and	CC	0
S224K	S224K	NNP	0
mutants	mutants	VBD	0
exhibited	exhibited	VBN	0
small	small	JJ	0
changes	changes	NNS	0
in	in	IN	0
K	K	NNP	0
m	m	NN	0
and	and	CC	0
k	k	JJ	0
cat	cat	NN	0
,	,	,	0
while	while	IN	0
the	the	DT	0
S224D	S224D	CD	0
mutant	mutant	NNS	0
yielded	yielded	VBD	0
20-	20-	CD	0
to	to	TO	0
40-fold	40-fold	CD	0
increased	increased	JJ	0
values	values	NNS	0
for	for	IN	0
K	K	NNP	0
m	m	NN	0
and	and	CC	0
>	>	CD	0
10-fold	10-fold	CD	0
decreases	decreases	NNS	0
in	in	IN	0
k	k	JJ	0
cat	cat	NN	0
when	when	WRB	0
using	using	VBG	0
the	the	DT	0
penicillins	penicillins	NN	0
as	as	IN	0
substrates	substrates	NN	0
.	.	.	0
When	When	WRB	0
the	the	DT	0
carbapenems	carbapenems	NN	0
were	were	VBD	0
used	used	VBN	0
as	as	IN	0
substrates	substrates	VBG	0
however	however	RB	0
,	,	,	0
the	the	DT	0
changes	changes	NNS	0
in	in	IN	0
K	K	NNP	0
m	m	NN	0
values	values	NNS	0
were	were	VBD	0
relatively	relatively	RB	0
smaller	smaller	JJR	0
than	than	IN	0
with	with	IN	0
the	the	DT	0
other	other	JJ	0
substrates	substrates	NN	0
,	,	,	0
and	and	CC	0
2-	2-	CD	0
to	to	TO	0
37-fold	37-fold	CD	0
changes	changes	NNS	0
in	in	IN	0
k	k	JJ	0
cat	cat	NN	0
were	were	VBD	0
observed	observed	VBN	0
(	(	-LRB-	0
Table	Table	NNP	0
5	5	CD	0
)	)	-RRB-	0
.	.	.	0
Rapid-scanning	Rapid-scanning	NNP	0
vis	vis	NNP	B-NP
study	study	NN	I-NP
of	of	IN	0
the	the	DT	0
S224X	S224X	CD	0
mutants	mutants	NNS	0
were	were	VBD	0
conducted	conducted	VBN	0
to	to	TO	0
probe	probe	VB	0
whether	whether	IN	0
the	the	DT	0
mutations	mutations	NN	0
caused	caused	VBD	B-NP
change	change	NN	I-NP
in	in	IN	0
the	the	DT	0
amount	amount	NN	0
of	of	IN	0
intermediate	intermediate	JJ	0
that	that	IN	0
accumulates	accumulates	NN	0
during	during	IN	0
catalysis	catalysis	NN	0
.	.	.	0
When	When	WRB	0
50	50	CD	0
μM	μM	JJ	0
S224A	S224A	NN	0
was	was	VBD	0
reacted	reacted	VBN	0
with	with	IN	0
5	5	CD	0
μM	μM	JJ	B-NP
nitrocefin	nitrocefin	NN	I-NP
,	,	,	0
1.7	1.7	CD	0
μM	μM	JJ	B-NP
intermediate	intermediate	NN	I-NP
formed	formed	VBN	0
during	during	IN	0
the	the	DT	0
first	first	JJ	0
10	10	CD	0
millisecond	millisecond	NN	B-NP
of	of	IN	0
the	the	DT	0
reaction	reaction	NN	0
(	(	-LRB-	0
Figure	Figure	NNP	0
2	2	CD	0
)	)	-RRB-	0
,	,	,	0
and	and	CC	0
rate	rate	NN	0
of	of	IN	0
decay	decay	NN	0
of	of	IN	0
this	this	DT	0
intermediate	intermediate	NN	0
was	was	VBD	0
equal	equal	JJ	0
to	to	TO	0
the	the	DT	0
steady-state	steady-state	JJ	B-NP
k	k	NN	I-NP
cat	cat	NN	I-NP
(	(	-LRB-	0
Table	Table	NNP	0
3	3	CD	0
)	)	-RRB-	0
.	.	.	0
In	In	IN	0
spite	spite	NN	0
of	of	IN	0
utilizing	utilizing	VBG	0
a	a	DT	0
number	number	NN	0
of	of	IN	0
reaction	reaction	NN	B-NP
condition	condition	NN	I-NP
,	,	,	0
the	the	DT	0
S224K	S224K	NNP	0
and	and	CC	0
S224D	S224D	CD	0
mutants	mutants	NNS	0
yielded	yielded	VBD	0
rapid-scan	rapid-scan	JJ	0
spectra	spectra	NN	0
with	with	IN	0
no	no	DT	0
detectable	detectable	JJ	0
absorbance	absorbance	NN	B-NP
at	at	IN	0
665	665	CD	0
nm	nm	NN	B-NP
(	(	-LRB-	0
Figure	Figure	NNP	0
2	2	CD	0
)	)	-RRB-	0
,	,	,	0
indicating	indicating	VBG	0
that	that	IN	0
the	the	DT	0
intermediate	intermediate	NN	0
is	is	VBZ	0
not	not	RB	0
stabilized	stabilized	VBN	0
as	as	IN	0
well	well	RB	0
in	in	IN	0
these	these	DT	0
mutant	mutant	NN	B-NP
as	as	IN	0
in	in	IN	0
wild-type	wild-type	JJ	B-NP
L1	L1	NN	I-NP
.	.	.	0
stopped-flow	stopped-flow	NN	B-NP
fluorescence	fluorescence	JJ	I-NP
study	study	NN	I-NP
at	at	IN	0
10°C	10°C	CD	0
with	with	IN	0
the	the	DT	0
S224A	S224A	NNP	0
,	,	,	0
S224D	S224D	NNP	0
,	,	,	0
and	and	CC	0
S224K	S224K	CD	0
mutants	mutants	NNS	0
and	and	CC	0
nitrocefin	nitrocefin	NN	B-NP
as	as	IN	0
the	the	DT	0
substrate	substrate	NN	0
resulted	resulted	VBD	0
in	in	IN	0
k	k	NN	B-NP
		NN	I-NP
value	value	NN	I-NP
of	of	IN	0
39	39	CD	0
±	±	CD	0
10	10	CD	0
,	,	,	0
213	213	CD	0
±	±	CD	0
63	63	CD	0
,	,	,	0
and	and	CC	0
33	33	CD	0
±	±	CD	0
5	5	CD	0
μM	μM	NN	B-NP
,	,	,	0
respectively	respectively	RB	0
.	.	.	0
two-thirds	two-thirds	NN	B-NP
asn233	asn233	NN	I-NP
mutant	mutant	NN	I-NP
of	of	IN	0
all	all	DT	0
sequenced	sequenced	JJ	B-NP
metallo-β-lactama	metallo-β-lactama	NN	I-NP
have	have	VBP	0
an	an	DT	0
Asn	Asn	NNP	B-NP
at	at	IN	0
position	position	NN	0
233	233	CD	0
[	[	-LRB-	0
41	41	CD	0
]	]	-RRB-	0
,	,	,	0
and	and	CC	0
this	this	DT	0
residue	residue	NN	0
was	was	VBD	0
predicted	predicted	VBN	0
[	[	-LRB-	0
42	42	CD	0
]	]	-RRB-	0
and	and	CC	0
shown	shown	VBN	0
[	[	-LRB-	0
43	43	CD	0
]	]	-RRB-	0
to	to	TO	0
be	be	VB	0
involved	involved	VBN	0
with	with	IN	0
substrate	substrate	JJ	0
binding	binding	NN	0
and	and	CC	0
activation	activation	NN	B-NP
by	by	IN	0
interacting	interacting	JJ	0
electrostatically	electrostatically	NN	0
with	with	IN	0
the	the	DT	0
substrate	substrate	JJ	B-NP
β-lactam	β-lactam	JJ	I-NP
carbonyl	carbonyl	NN	I-NP
.	.	.	0
However	However	RB	0
,	,	,	0
in	in	IN	0
L1	L1	NNP	0
,	,	,	0
Asn233	Asn233	NNP	B-NP
is	is	VBZ	0
14	14	CD	0
Å	Å	NNS	0
away	away	RB	0
from	from	IN	0
the	the	DT	0
modeled	modeled	JJ	0
position	position	NN	0
of	of	IN	0
the	the	DT	0
substrate	substrate	JJ	B-NP
β-lactam	β-lactam	JJ	I-NP
carbonyl	carbonyl	NN	I-NP
[	[	-LRB-	0
37	37	CD	0
]	]	-RRB-	0
.	.	.	0
To	To	TO	0
test	test	VB	0
the	the	DT	0
role	role	NN	0
of	of	IN	0
Asn233	Asn233	CD	B-NP
in	in	IN	0
substrate	substrate	JJ	0
binding	binding	NN	0
,	,	,	0
the	the	DT	0
Asn	Asn	NNP	B-NP
was	was	VBD	0
changed	changed	VBN	0
to	to	TO	0
a	a	DT	0
leucine	leucine	NN	B-NP
(	(	-LRB-	0
N233L	N233L	NNP	0
)	)	-RRB-	0
and	and	CC	0
to	to	TO	0
an	an	DT	0
aspartic	aspartic	JJ	B-NP
acid	acid	NN	I-NP
(	(	-LRB-	0
N233D	N233D	NNP	0
)	)	-RRB-	0
,	,	,	0
and	and	CC	0
these	these	DT	0
mutant	mutant	NN	B-NP
were	were	VBD	0
characterized	characterized	VBN	0
by	by	IN	0
using	using	VBG	0
metal	metal	NN	0
analyses	analyses	NNS	0
,	,	,	0
CD	CD	NNP	0
spectroscopy	spectroscopy	NN	B-NP
,	,	,	0
steady-state	steady-state	JJ	B-NP
kinetics	kinetics	NN	I-NP
,	,	,	0
and	and	CC	0
kinetic	kinetic	NN	B-NP
study	study	NN	I-NP
pre-steady	pre-steady	JJ	I-NP
state	state	NN	I-NP
.	.	.	0
small-scale	small-scale	NN	B-NP
growth	growth	NN	I-NP
culture	culture	NN	I-NP
showed	showed	VBD	0
that	that	IN	0
both	both	DT	0
mutant	mutant	NN	B-NP
were	were	VBD	0
over-expressed	over-expressed	JJ	0
at	at	IN	0
levels	levels	NNS	0
comparable	comparable	JJ	0
to	to	TO	0
that	that	DT	0
of	of	IN	0
wild-type	wild-type	JJ	B-NP
L1	L1	NN	I-NP
.	.	.	0
Large-scale	Large-scale	JJ	0
over-expression	over-expression	JJ	B-NP
and	and	CC	0
mutant	mutant	NN	B-NP
purification	purification	NN	I-NP
showed	showed	VBD	0
that	that	IN	0
both	both	DT	0
mutant	mutant	NN	B-NP
were	were	VBD	0
isolatable	isolatable	VBN	0
at	at	IN	0
levels	levels	NNS	0
comparable	comparable	JJ	0
to	to	TO	0
that	that	DT	0
of	of	IN	0
wild-type	wild-type	JJ	B-NP
L1	L1	NN	I-NP
.	.	.	0
Metal	Metal	NN	0
analyses	analyses	NNS	0
of	of	IN	0
the	the	DT	0
N233L	N233L	NNP	0
and	and	CC	0
N233D	N233D	CD	0
mutants	mutants	NNS	0
showed	showed	VBD	0
that	that	IN	0
both	both	DT	0
bind	bind	NN	0
nearly	nearly	RB	0
two	two	CD	0
zn(ii)	zn(ii)	NN	B-NP
ion	ion	NN	I-NP
(	(	-LRB-	0
Table	Table	NNP	0
2	2	CD	0
)	)	-RRB-	0
,	,	,	0
like	like	IN	0
wild-type	wild-type	NNP	B-NP
L1	L1	NNP	I-NP
[	[	-LRB-	0
36	36	CD	0
]	]	-RRB-	0
.	.	.	0
CD	CD	NNP	0
spectra	spectra	NN	0
of	of	IN	0
the	the	DT	0
mutant	mutant	NN	B-NP
were	were	VBD	0
similar	similar	JJ	0
to	to	TO	0
those	those	DT	0
of	of	IN	0
wild-type	wild-type	JJ	B-NP
L1	L1	NN	I-NP
.	.	.	0
kinetic	kinetic	JJ	B-NP
study	study	NN	I-NP
steady-state	steady-state	NN	I-NP
were	were	VBD	0
conducted	conducted	VBN	0
with	with	IN	0
both	both	DT	0
mutant	mutant	NN	B-NP
in	in	IN	0
buffer	buffer	NN	B-NP
containing	containing	VBG	0
100	100	CD	0
μM	μM	JJ	0
ZnCl	ZnCl	JJ	B-NP
2	2	CD	0
to	to	TO	0
ensure	ensure	VB	0
that	that	IN	0
both	both	DT	0
Zn	Zn	NNP	B-NP
(	(	-LRB-	I-NP
II	II	NNP	I-NP
)	)	-RRB-	I-NP
binding	binding	JJ	0
sites	sites	NNS	0
were	were	VBD	0
saturated	saturated	VBN	0
in	in	IN	0
these	these	DT	0
studies	studies	NNS	0
.	.	.	0
Addition	Addition	NN	B-NP
of	of	IN	0
higher	higher	JJR	0
zn(ii)	zn(ii)	NN	B-NP
concentration	concentration	NN	I-NP
did	did	VBD	0
not	not	RB	0
result	result	VB	0
in	in	IN	0
different	different	JJ	0
values	values	NNS	0
for	for	IN	0
the	the	DT	0
kinetic	kinetic	JJ	B-NP
constant	constant	JJ	I-NP
steady-state	steady-state	JJ	I-NP
in	in	IN	0
Tables	Tables	NNP	0
3	3	CD	0
,	,	,	0
4	4	CD	0
,	,	,	0
5	5	CD	0
.	.	.	0
With	With	IN	0
all	all	DT	0
substrates	substrates	JJ	0
tested	tested	NN	0
,	,	,	0
the	the	DT	0
N233L	N233L	NNP	0
and	and	CC	0
N233D	N233D	FW	0
mutants	mutants	FW	0
exhibited	exhibited	FW	0
K	K	NNP	0
m	m	NN	0
values	values	NNS	0
that	that	WDT	0
differed	differed	VBZ	0
less	less	JJR	0
than	than	IN	0
a	a	DT	0
factor	factor	NN	0
of	of	IN	0
4	4	CD	0
than	than	IN	0
that	that	WDT	0
observed	observed	VBD	0
for	for	IN	0
wild-type	wild-type	NNP	0
L1	L1	NNP	0
(	(	-LRB-	0
Tables	Tables	NNP	0
3	3	CD	0
,	,	,	0
4	4	CD	0
,	,	,	0
5	5	CD	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
k	k	JJ	0
cat	cat	NN	0
values	values	VBZ	0
exhibited	exhibited	VBN	0
by	by	IN	0
these	these	DT	0
mutants	mutants	NN	0
for	for	IN	0
all	all	DT	0
substrates	substrates	NN	0
also	also	RB	0
differed	differed	VBN	0
by	by	IN	0
less	less	JJR	0
than	than	IN	0
a	a	DT	0
factor	factor	NN	0
of	of	IN	0
4	4	CD	0
,	,	,	0
except	except	IN	0
when	when	WRB	0
biapenem	biapenem	NNS	0
and	and	CC	0
meropenem	meropenem	NNS	0
were	were	VBD	0
used	used	VBN	0
as	as	IN	0
substrates	substrates	NN	0
for	for	IN	0
the	the	DT	0
N233D	N233D	JJ	0
mutant	mutant	NN	0
.	.	.	0
With	With	IN	0
these	these	DT	0
two	two	CD	0
substrates	substrates	NN	0
,	,	,	0
there	there	EX	0
was	was	VBD	0
a	a	DT	0
19-fold	19-fold	NNP	0
and	and	CC	0
45-fold	45-fold	CD	0
decrease	decrease	NN	0
in	in	IN	0
the	the	DT	0
k	k	JJ	0
cat	cat	NN	0
values	values	NNS	0
when	when	WRB	0
using	using	VBG	0
biapenem	biapenem	NNS	0
and	and	CC	0
meropenem	meropenem	NN	0
,	,	,	0
respectively	respectively	RB	0
(	(	-LRB-	0
Table	Table	NNP	0
5	5	CD	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
steady-state	steady-state	JJ	0
kinetic	kinetic	JJ	0
data	data	NNS	0
generally	generally	RB	0
support	support	VB	0
the	the	DT	0
prediction	prediction	NN	0
that	that	IN	0
Asn233	Asn233	NNP	0
does	does	VBZ	0
not	not	RB	0
play	play	VB	0
a	a	DT	0
large	large	JJ	0
role	role	NN	0
in	in	IN	0
binding	binding	JJ	0
or	or	CC	0
catalysis	catalysis	NN	0
.	.	.	0
However	However	RB	0
,	,	,	0
rapid-scanning	rapid-scanning	NNP	0
vis	vis	NNP	B-NP
study	study	NN	I-NP
of	of	IN	0
N233L	N233L	NNP	0
and	and	CC	0
N233D	N233D	CD	0
with	with	IN	0
nitrocefin	nitrocefin	JJ	0
demonstrate	demonstrate	NN	0
that	that	IN	0
no	no	DT	0
detectable	detectable	JJ	0
amounts	amounts	NNS	0
of	of	IN	0
intermediate	intermediate	NNS	0
are	are	VBP	0
formed	formed	VBN	0
during	during	IN	0
the	the	DT	0
reaction	reaction	NN	0
,	,	,	0
even	even	RB	0
when	when	WRB	0
using	using	VBG	0
a	a	DT	0
wide	wide	JJ	0
number	number	NN	0
of	of	IN	0
reaction	reaction	NN	B-NP
condition	condition	NN	I-NP
(	(	-LRB-	0
Figure	Figure	NNP	0
2	2	CD	0
)	)	-RRB-	0
.	.	.	0
Stopped-flow	Stopped-flow	JJ	0
fluorescence	fluorescence	JJ	0
studies	studies	NNS	0
at	at	IN	0
10°C	10°C	CD	0
with	with	IN	0
the	the	DT	0
N233L	N233L	NNP	0
and	and	CC	0
N233D	N233D	CD	0
mutants	mutants	NNS	0
and	and	CC	0
nitrocefin	nitrocefin	NN	0
as	as	IN	0
substrate	substrate	NN	0
resulted	resulted	VBD	0
in	in	IN	0
K	K	NNP	0
S	S	NNP	0
values	values	NNS	0
of	of	IN	0
26	26	CD	0
±	±	CD	0
9	9	CD	0
and	and	CC	0
25	25	CD	0
±	±	CD	0
8	8	CD	0
μM	μM	NN	0
,	,	,	0
respectively	respectively	RB	0
.	.	.	0
Tyr228	Tyr228	NNP	B-NP
mutants	mutants	VBD	0
The	The	DT	0
substrate-binding	substrate-binding	JJ	0
model	model	NN	0
showed	showed	VBD	0
that	that	IN	0
Tyr228	Tyr228	CD	B-NP
in	in	IN	0
L1	L1	NNP	0
was	was	VBD	0
position-conserved	position-conserved	JJ	0
with	with	IN	0
Asn233	Asn233	CD	B-NP
in	in	IN	0
the	the	DT	0
other	other	JJ	0
crystallographically	crystallographically	NN	0
characterized	characterized	VBD	B-NP
metallo-β-lactama	metallo-β-lactama	NN	I-NP
[	[	-LRB-	0
37	37	CD	0
42	42	CD	0
44	44	CD	0
45	45	CD	0
46	46	CD	0
]	]	-RRB-	0
.	.	.	0
Spencer	Spencer	NNP	0
and	and	CC	0
coworkers	coworkers	JJ	B-NP
postulated	postulated	NN	I-NP
that	that	IN	0
Tyr228	Tyr228	NNP	B-NP
is	is	VBZ	0
part	part	NN	0
of	of	IN	0
an	an	DT	0
oxyanion	oxyanion	JJ	B-NP
hole	hole	NN	I-NP
that	that	IN	0
interacts	interacts	NN	0
with	with	IN	0
the	the	DT	0
β-lactam	β-lactam	JJ	B-NP
carbonyl	carbonyl	NN	I-NP
on	on	IN	0
substrate	substrate	NN	0
and	and	CC	0
helps	helps	VBZ	0
to	to	TO	0
stabilize	stabilize	VB	0
the	the	DT	0
putative	putative	JJ	B-NP
tetrahedral	tetrahedral	NN	I-NP
intermediate	intermediate	VBP	I-NP
formed	formed	VBN	0
during	during	IN	0
substrate	substrate	JJ	B-NP
turnover	turnover	NN	I-NP
[	[	-LRB-	0
37	37	CD	0
]	]	-RRB-	0
.	.	.	0
To	To	TO	0
test	test	VB	0
this	this	DT	0
hypothesis	hypothesis	NN	0
,	,	,	0
Tyr228	Tyr228	NNP	B-NP
was	was	VBD	0
changed	changed	VBN	0
to	to	TO	0
an	an	DT	0
alanine	alanine	NN	B-NP
and	and	CC	0
to	to	TO	0
a	a	DT	0
phenylalanine	phenylalanine	NN	B-NP
to	to	TO	0
afford	afford	VB	0
the	the	DT	0
Y228A	Y228A	NNP	0
and	and	CC	0
Y228F	Y228F	CD	0
mutants	mutants	NN	0
,	,	,	0
respectively	respectively	RB	0
.	.	.	0
small-scale	small-scale	NN	B-NP
growth	growth	NN	I-NP
culture	culture	NN	I-NP
showed	showed	VBD	0
that	that	IN	0
both	both	DT	0
mutant	mutant	NN	B-NP
were	were	VBD	0
over-expressed	over-expressed	JJ	0
at	at	IN	0
levels	levels	NNS	0
comparable	comparable	JJ	0
to	to	TO	0
those	those	DT	0
of	of	IN	0
wild-type	wild-type	JJ	B-NP
L1	L1	NN	I-NP
.	.	.	0
Large-scale	Large-scale	JJ	0
over-expression	over-expression	JJ	B-NP
and	and	CC	0
purification	purification	NN	B-NP
of	of	IN	0
the	the	DT	0
Y228A	Y228A	NNP	0
and	and	CC	0
Y228F	Y228F	CD	0
mutants	mutants	NNS	0
showed	showed	VBD	0
that	that	IN	0
both	both	DT	0
mutant	mutant	NN	B-NP
were	were	VBD	0
isolatable	isolatable	VBN	0
at	at	IN	0
levels	levels	NNS	0
comparable	comparable	JJ	0
to	to	TO	0
those	those	DT	0
of	of	IN	0
wild-type	wild-type	JJ	B-NP
L1	L1	NN	I-NP
.	.	.	0
Metal	Metal	NN	0
analyses	analyses	NNS	0
of	of	IN	0
the	the	DT	0
mutant	mutant	NN	B-NP
showed	showed	VBD	0
that	that	IN	0
both	both	DT	0
bind	bind	NN	0
nearly	nearly	RB	0
two	two	CD	0
zn(ii)	zn(ii)	NN	B-NP
ion	ion	NN	I-NP
(	(	-LRB-	0
Table	Table	NNP	0
2	2	CD	0
)	)	-RRB-	0
,	,	,	0
like	like	IN	0
wild-type	wild-type	NNP	B-NP
L1	L1	NNP	I-NP
[	[	-LRB-	0
36	36	CD	0
]	]	-RRB-	0
,	,	,	0
and	and	CC	0
CD	CD	NNP	0
spectra	spectra	NN	0
of	of	IN	0
the	the	DT	0
mutant	mutant	NN	B-NP
were	were	VBD	0
similar	similar	JJ	0
to	to	TO	0
those	those	DT	0
of	of	IN	0
wild-type	wild-type	JJ	B-NP
L1	L1	NN	I-NP
.	.	.	0
kinetic	kinetic	JJ	B-NP
study	study	NN	I-NP
steady-state	steady-state	NN	I-NP
were	were	VBD	0
conducted	conducted	VBN	0
with	with	IN	0
both	both	DT	0
mutant	mutant	NN	B-NP
in	in	IN	0
buffer	buffer	NN	B-NP
containing	containing	VBG	0
100	100	CD	0
μM	μM	JJ	0
ZnCl	ZnCl	JJ	B-NP
2	2	CD	0
to	to	TO	0
ensure	ensure	VB	0
that	that	IN	0
both	both	DT	0
Zn	Zn	NNP	B-NP
(	(	-LRB-	I-NP
II	II	NNP	I-NP
)	)	-RRB-	I-NP
binding	binding	JJ	0
sites	sites	NNS	0
were	were	VBD	0
saturated	saturated	VBN	0
in	in	IN	0
these	these	DT	0
studies	studies	NNS	0
.	.	.	0
Addition	Addition	NN	B-NP
of	of	IN	0
higher	higher	JJR	0
zn(ii)	zn(ii)	NN	B-NP
concentration	concentration	NN	I-NP
did	did	VBD	0
not	not	RB	0
result	result	VB	0
in	in	IN	0
different	different	JJ	0
values	values	NNS	0
for	for	IN	0
the	the	DT	0
kinetic	kinetic	JJ	B-NP
constant	constant	JJ	I-NP
steady-state	steady-state	JJ	I-NP
in	in	IN	0
Tables	Tables	NNP	0
3	3	CD	0
,	,	,	0
4	4	CD	0
,	,	,	0
5	5	CD	0
.	.	.	0
When	When	WRB	0
cephalosporin	cephalosporin	NN	B-NP
were	were	VBD	0
used	used	VBN	0
as	as	IN	0
substrates	substrates	NN	0
,	,	,	0
the	the	DT	0
Y228A	Y228A	NNP	0
and	and	CC	0
Y228F	Y228F	FW	0
mutants	mutants	FW	0
exhibited	exhibited	VBN	B-NP
K	K	NNP	I-NP
m	m	NN	I-NP
values	values	NNS	0
that	that	WDT	0
were	were	VBD	0
6-	6-	CD	0
to	to	TO	0
45-fold	45-fold	CD	0
higher	higher	JJR	0
than	than	IN	0
those	those	DT	0
observed	observed	NN	0
for	for	IN	0
wild-type	wild-type	NNP	B-NP
L1	L1	NNP	I-NP
(	(	-LRB-	0
Table	Table	NNP	0
3	3	CD	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
largest	largest	JJS	0
change	change	NN	0
in	in	IN	0
K	K	NNP	0
m	m	NN	0
was	was	VBD	0
observed	observed	VBN	0
when	when	WRB	0
cefaclor	cefaclor	NNS	0
was	was	VBD	0
used	used	VBN	0
as	as	IN	0
substrate	substrate	NN	0
,	,	,	0
and	and	CC	0
the	the	DT	0
smallest	smallest	JJS	0
change	change	NN	0
was	was	VBD	0
observed	observed	VBN	0
when	when	WRB	0
nitrocefin	nitrocefin	NNS	0
was	was	VBD	0
used	used	VBN	0
as	as	IN	0
substrate	substrate	NN	0
.	.	.	0
The	The	DT	0
Tyr228	Tyr228	FW	0
mutants	mutants	FW	0
exhibited	exhibited	FW	0
<	<	SYM	0
4-fold	4-fold	FW	0
change	change	NN	0
in	in	IN	0
k	k	JJ	0
cat	cat	NN	0
values	values	NNS	0
for	for	IN	0
the	the	DT	0
cephalosporins	cephalosporins	JJ	0
tested	tested	NNS	0
(	(	-LRB-	0
Table	Table	NNP	0
3	3	CD	0
)	)	-RRB-	0
,	,	,	0
suggesting	suggesting	VBG	0
that	that	IN	0
Tyr228	Tyr228	NNP	0
is	is	VBZ	0
not	not	RB	0
playing	playing	VBG	0
a	a	DT	0
large	large	JJ	0
role	role	NN	0
in	in	IN	0
catalysis	catalysis	NN	0
.	.	.	0
When	When	WRB	0
penicillins	penicillins	NNS	0
were	were	VBD	0
used	used	VBN	0
as	as	IN	0
substrates	substrates	NN	0
,	,	,	0
the	the	DT	0
Tyr228	Tyr228	FW	0
mutants	mutants	FW	0
exhibited	exhibited	FW	0
3-	3-	FW	0
to	to	TO	0
13-fold	13-fold	NNP	0
increased	increased	VBD	0
K	K	NNP	0
m	m	NN	0
values	values	NNS	0
and	and	CC	0
<	<	SYM	0
2-fold	2-fold	CD	0
changes	changes	NNS	0
in	in	IN	0
k	k	JJ	0
cat	cat	NN	0
,	,	,	0
as	as	RB	0
compared	compared	VBN	0
to	to	TO	0
the	the	DT	0
values	values	NNS	0
ascertained	ascertained	VBP	0
using	using	VBG	0
wild-type	wild-type	JJ	0
L1	L1	NNP	0
(	(	-LRB-	0
Table	Table	NNP	0
4	4	CD	0
)	)	-RRB-	0
.	.	.	0
On	On	IN	0
the	the	DT	0
other	other	JJ	0
hand	hand	NN	0
when	when	WRB	0
carbapenems	carbapenems	NNS	0
were	were	VBD	0
used	used	VBN	0
as	as	IN	0
substrates	substrates	NN	0
,	,	,	0
the	the	DT	0
Tyr228	Tyr228	CD	0
mutants	mutants	CD	0
exhibited	exhibited	CD	0
<	<	SYM	0
6-fold	6-fold	CD	0
increases	increases	NNS	0
in	in	IN	0
K	K	NNP	0
m	m	NN	0
values	values	VBZ	0
as	as	RB	0
compared	compared	VBN	0
to	to	TO	0
those	those	DT	0
values	values	NNS	0
for	for	IN	0
wild-type	wild-type	NNP	0
L1	L1	NNP	0
(	(	-LRB-	0
Table	Table	NNP	0
5	5	CD	0
)	)	-RRB-	0
.	.	.	0
Interestingly	Interestingly	RB	0
,	,	,	0
there	there	EX	0
was	was	VBD	0
a	a	DT	0
2-	2-	NN	0
to	to	TO	0
8-fold	8-fold	CD	0
drop	drop	NN	0
in	in	IN	0
k	k	JJ	0
cat	cat	NN	0
values	values	NNS	0
for	for	IN	0
the	the	DT	0
Tyr228	Tyr228	JJ	0
mutants	mutants	NN	0
,	,	,	0
as	as	RB	0
compared	compared	VBN	0
to	to	TO	0
values	values	NNS	0
observed	observed	VBD	0
for	for	IN	0
wild-type	wild-type	NNP	0
L1	L1	NNP	0
,	,	,	0
when	when	WRB	0
using	using	VBG	0
the	the	DT	0
carbapenems	carbapenems	NN	0
as	as	IN	0
substrates	substrates	NN	0
.	.	.	0
Rapid-scanning	Rapid-scanning	NNP	0
Vis	Vis	NNP	0
spectra	spectra	NN	0
of	of	IN	0
the	the	DT	0
reaction	reaction	NN	0
of	of	IN	0
the	the	DT	0
Y228A	Y228A	NNP	0
and	and	CC	0
Y228F	Y228F	CD	0
mutants	mutants	NN	0
with	with	IN	0
nitrocefin	nitrocefin	NN	B-NP
demonstrated	demonstrated	VBD	0
a	a	DT	0
marked	marked	JJ	0
decrease	decrease	NN	0
in	in	IN	0
the	the	DT	0
amount	amount	NN	0
of	of	IN	0
intermediate	intermediate	JJ	0
formed	formed	VBN	0
with	with	IN	0
these	these	DT	0
mutant	mutant	NN	B-NP
(	(	-LRB-	0
Figure	Figure	NNP	0
2	2	CD	0
)	)	-RRB-	0
.	.	.	0
In	In	IN	0
reactions	reactions	NNS	0
with	with	IN	0
50	50	CD	0
μM	μM	JJ	B-NP
mutant	mutant	NN	I-NP
and	and	CC	0
5	5	CD	0
μM	μM	JJ	B-NP
nitrocefin	nitrocefin	NN	I-NP
,	,	,	0
only	only	RB	0
0.75	0.75	CD	0
and	and	CC	0
<	<	SYM	0
0.30	0.30	CD	0
μM	μM	JJ	B-NP
intermediate	intermediate	NN	I-NP
formed	formed	VBN	0
for	for	IN	0
the	the	DT	0
Y228F	Y228F	NNP	0
and	and	CC	0
Y228A	Y228A	CD	0
mutants	mutants	NN	0
,	,	,	0
respectively	respectively	RB	0
.	.	.	0
The	The	DT	0
mutant	mutant	NN	B-NP
concentration	concentration	NN	I-NP
were	were	VBD	0
varied	varied	VBN	0
between	between	IN	0
25	25	CD	0
to	to	TO	0
150	150	CD	0
μM	μM	JJ	0
to	to	TO	0
ensure	ensure	VB	0
that	that	IN	0
all	all	DT	0
of	of	IN	0
the	the	DT	0
substrate	substrate	NN	0
was	was	VBD	0
bound	bound	VBN	0
;	;	:	0
however	however	RB	0
,	,	,	0
none	none	NN	0
of	of	IN	0
the	the	DT	0
reactions	reactions	NNS	0
resulted	resulted	VBD	0
in	in	IN	0
the	the	DT	0
detection	detection	NN	0
of	of	IN	0
intermediate	intermediate	JJ	0
at	at	IN	0
levels	levels	NNS	0
observed	observed	VBD	0
for	for	IN	0
wild-type	wild-type	NNP	B-NP
L1	L1	NNP	I-NP
(	(	-LRB-	0
data	data	NNS	0
not	not	RB	0
shown	shown	VBN	0
)	)	-RRB-	0
.	.	.	0
stopped-flow	stopped-flow	NN	B-NP
fluorescence	fluorescence	JJ	I-NP
study	study	NN	I-NP
at	at	IN	0
10°C	10°C	CD	0
of	of	IN	0
nitrocefin	nitrocefin	JJ	B-NP
hydrolysi	hydrolysi	NN	I-NP
by	by	IN	0
Y191A	Y191A	NNP	0
and	and	CC	0
Y191F	Y191F	NNP	0
resulted	resulted	VBD	0
in	in	IN	0
k	k	NN	B-NP
		NN	I-NP
value	value	NN	I-NP
of	of	IN	0
85	85	CD	0
±	±	CD	0
9	9	CD	0
and	and	CC	0
22	22	CD	0
±	±	CD	0
6	6	CD	0
μM	μM	NN	B-NP
,	,	,	0
respectively	respectively	RB	0
.	.	.	0
Ile164	Ile164	NNP	B-NP
and	and	CC	0
Phe158	Phe158	NNP	B-NP
mutants	mutants	VBD	0
All	All	DT	0
crystallographically	crystallographically	JJ	B-NP
characterized	characterized	JJ	I-NP
metallo-β-lactama	metallo-β-lactama	NN	I-NP
have	have	VBP	0
a	a	DT	0
flexible	flexible	JJ	0
amino	amino	JJ	0
acid	acid	NN	B-NP
chain	chain	NN	I-NP
that	that	WDT	0
extends	extends	VBZ	0
over	over	IN	0
the	the	DT	0
active	active	JJ	0
site	site	NN	0
[	[	-LRB-	0
37	37	CD	0
42	42	CD	0
44	44	CD	0
45	45	CD	0
46	46	CD	0
47	47	CD	0
48	48	CD	0
49	49	CD	0
]	]	-RRB-	0
.	.	.	0
previous	previous	JJ	B-NP
nmr	nmr	NN	I-NP
study	study	NN	I-NP
on	on	IN	0
CcrA	CcrA	NN	B-NP
have	have	VBP	0
shown	shown	VBN	0
that	that	IN	0
this	this	DT	0
loop	loop	JJ	0
"clamps	"clamps	NN	0
down	down	IN	0
"	"	``	0
on	on	IN	0
substrate	substrate	NN	0
or	or	CC	0
inhibitor	inhibitor	NN	0
upon	upon	IN	0
binding	binding	JJ	0
,	,	,	0
and	and	CC	0
there	there	EX	0
is	is	VBZ	0
speculation	speculation	NN	0
that	that	IN	0
the	the	DT	0
distortion	distortion	NN	0
of	of	IN	0
substrate	substrate	NN	0
upon	upon	IN	0
clamping	clamping	VBG	0
down	down	RP	0
of	of	IN	0
the	the	DT	0
loop	loop	NN	0
may	may	MD	0
drive	drive	VB	0
catalysis	catalysis	NNS	0
[	[	-LRB-	0
50	50	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
crystal	crystal	NN	0
structure	structure	NN	0
of	of	IN	0
L1	L1	NNP	0
showed	showed	VBD	0
that	that	IN	0
there	there	EX	0
is	is	VBZ	0
a	a	DT	0
large	large	JJ	0
loop	loop	NN	0
that	that	WDT	0
extends	extends	VBZ	0
over	over	IN	0
the	the	DT	0
active	active	JJ	0
site	site	NN	0
,	,	,	0
and	and	CC	0
modeling	modeling	JJ	0
studies	studies	NNS	0
have	have	VBP	0
predicted	predicted	VBN	0
that	that	IN	0
two	two	CD	0
residues	residues	NNS	0
,	,	,	0
Ile164	Ile164	NNP	B-NP
and	and	CC	0
Phe158	Phe158	NNP	B-NP
,	,	,	0
make	make	VB	0
significant	significant	JJ	0
contacts	contacts	NNS	0
with	with	IN	0
large	large	JJ	0
,	,	,	0
hydrophobic	hydrophobic	JJ	B-NP
substituent	substituent	NN	I-NP
at	at	IN	0
the	the	DT	0
2	2	CD	0
'	'	''	0
or	or	CC	0
6	6	CD	0
'	'	POS	0
positions	positions	NNS	0
on	on	IN	0
penicillins	penicillins	NN	0
,	,	,	0
cephalosporin	cephalosporin	NN	B-NP
,	,	,	0
or	or	CC	0
carbapenem	carbapenem	NN	B-NP
[	[	-LRB-	0
37	37	CD	0
]	]	-RRB-	0
.	.	.	0
To	To	TO	0
test	test	VB	0
this	this	DT	0
prediction	prediction	NN	0
,	,	,	0
Ile	Ile	NNP	B-NP
164	164	CD	0
and	and	CC	0
Phe158	Phe158	NNP	B-NP
were	were	VBD	0
changed	changed	VBN	0
from	from	IN	0
large	large	JJ	0
,	,	,	0
hydrophobic	hydrophobic	JJ	B-NP
residue	residue	NN	I-NP
to	to	TO	0
alanines	alanines	VB	0
to	to	TO	0
afford	afford	VB	0
the	the	DT	0
I164A	I164A	NNP	0
and	and	CC	0
F158A	F158A	CD	0
mutants	mutants	NNS	0
.	.	.	0
small-scale	small-scale	NN	B-NP
growth	growth	NN	I-NP
culture	culture	NN	I-NP
demonstrated	demonstrated	VBD	0
the	the	DT	0
I164A	I164A	NNP	0
and	and	CC	0
F158A	F158A	CD	0
mutants	mutants	NNS	0
were	were	VBD	0
over-expressed	over-expressed	JJ	0
at	at	IN	0
levels	levels	NNS	0
comparable	comparable	JJ	0
to	to	TO	0
that	that	DT	0
of	of	IN	0
wild-type	wild-type	NNP	B-NP
L1	L1	NNP	I-NP
(	(	-LRB-	0
data	data	NNS	0
not	not	RB	0
shown	shown	VBN	0
)	)	-RRB-	0
.	.	.	0
Large-scale	Large-scale	JJ	0
over-expression	over-expression	JJ	B-NP
and	and	CC	0
mutant	mutant	NN	B-NP
purification	purification	NN	I-NP
resulted	resulted	VBD	0
in	in	IN	0
comparable	comparable	JJ	0
quantities	quantities	NNS	0
of	of	IN	0
isolatable	isolatable	JJ	B-NP
enzyme	enzyme	NN	I-NP
,	,	,	0
which	which	WDT	0
had	had	VBD	0
identical	identical	JJ	0
CD	CD	NN	0
spectra	spectra	NN	0
as	as	IN	0
wild-type	wild-type	NNP	B-NP
L1	L1	NNP	I-NP
and	and	CC	0
bound	bound	VBN	0
slightly	slightly	RB	0
less	less	JJR	0
Zn	Zn	NNP	B-NP
(	(	-LRB-	I-NP
II	II	NNP	I-NP
)	)	-RRB-	I-NP
than	than	IN	0
wild-type	wild-type	NNP	B-NP
L1	L1	NNP	I-NP
(	(	-LRB-	0
Table	Table	NNP	0
2	2	CD	0
)	)	-RRB-	0
.	.	.	0
All	All	DT	0
kinetic	kinetic	JJ	B-NP
study	study	NN	I-NP
steady-state	steady-state	JJ	I-NP
were	were	VBD	0
conducted	conducted	VBN	0
in	in	IN	0
buffers	buffers	NNS	0
containing	containing	VBG	0
100	100	CD	0
μM	μM	JJ	0
ZnCl	ZnCl	JJ	B-NP
2	2	CD	0
to	to	TO	0
ensure	ensure	VB	0
that	that	IN	0
both	both	DT	0
metal	metal	NN	0
binding	binding	JJ	0
sites	sites	NNS	0
were	were	VBD	0
saturated	saturated	VBN	0
during	during	IN	0
the	the	DT	0
studies	studies	NNS	0
.	.	.	0
When	When	WRB	0
using	using	VBG	0
the	the	DT	0
cephalosporins	cephalosporins	NN	0
,	,	,	0
nitrocefin	nitrocefin	NN	0
,	,	,	0
cefoxitin	cefoxitin	NN	0
,	,	,	0
and	and	CC	0
cephalothin	cephalothin	NN	0
,	,	,	0
as	as	IN	0
substrates	substrates	NN	0
and	and	CC	0
the	the	DT	0
I164A	I164A	JJ	0
mutant	mutant	NN	0
,	,	,	0
there	there	EX	0
were	were	VBD	0
2-	2-	CD	0
to	to	TO	0
10-fold	10-fold	CD	0
(	(	-LRB-	0
only	only	RB	0
for	for	IN	0
cefoxitin	cefoxitin	CD	0
)	)	-RRB-	0
increases	increases	NNS	0
in	in	IN	0
K	K	NNP	0
m	m	NN	0
and	and	CC	0
2-	2-	CD	0
to	to	TO	0
4-fold	4-fold	CD	0
increases	increases	NNS	0
in	in	IN	0
k	k	FW	0
cat	cat	FW	0
observed	observed	FW	0
(	(	-LRB-	0
Table	Table	NNP	0
3	3	CD	0
)	)	-RRB-	0
.	.	.	0
However	However	RB	0
when	when	WRB	0
cefaclor	cefaclor	NNS	0
was	was	VBD	0
used	used	VBN	0
as	as	IN	0
substrate	substrate	NN	0
,	,	,	0
the	the	DT	0
I164A	I164A	FW	0
mutant	mutant	FW	0
exhibited	exhibited	FW	0
a	a	FW	0
3-fold	3-fold	FW	0
decrease	decrease	NN	0
in	in	IN	0
K	K	NNP	0
m	m	NN	0
and	and	CC	0
a	a	DT	0
1.5-fold	1.5-fold	JJ	0
decrease	decrease	NN	0
in	in	IN	0
k	k	JJ	0
cat	cat	NNS	0
(	(	-LRB-	0
Table	Table	NNP	0
3	3	CD	0
)	)	-RRB-	0
.	.	.	0
On	On	IN	0
the	the	DT	0
other	other	JJ	0
hand	hand	NN	0
,	,	,	0
the	the	DT	0
K	K	NNP	0
m	m	NN	0
and	and	CC	0
k	k	JJ	0
cat	cat	NN	0
values	values	NNS	0
for	for	IN	0
the	the	DT	0
I164A	I164A	JJ	0
mutant	mutant	NN	0
when	when	WRB	0
the	the	DT	0
penicillins	penicillins	NN	0
or	or	CC	0
carbapenems	carbapenems	NNS	0
were	were	VBD	0
used	used	VBN	0
as	as	IN	0
substrates	substrates	NN	0
were	were	VBD	0
very	very	RB	0
similar	similar	JJ	0
to	to	TO	0
those	those	DT	0
numbers	numbers	NNS	0
exhibited	exhibited	VBN	0
by	by	IN	0
wild-type	wild-type	NNP	0
L1	L1	NNP	0
(	(	-LRB-	0
Tables	Tables	NNP	0
4and	4and	CD	0
5	5	CD	0
)	)	-RRB-	0
.	.	.	0
When	When	WRB	0
the	the	DT	0
cephalosporins	cephalosporins	NN	0
were	were	VBD	0
used	used	VBN	0
as	as	IN	0
substrates	substrates	NN	0
for	for	IN	0
the	the	DT	0
F158A	F158A	JJ	0
mutant	mutant	NN	0
,	,	,	0
the	the	DT	0
K	K	NNP	0
m	m	NN	0
values	values	NNS	0
observed	observed	VBD	0
were	were	VBD	0
7-	7-	CD	0
to	to	TO	0
31-fold	31-fold	CD	0
higher	higher	JJR	0
than	than	IN	0
those	those	DT	0
determined	determined	VBN	0
for	for	IN	0
wild-type	wild-type	NNP	0
L1	L1	NNP	0
,	,	,	0
and	and	CC	0
surprisingly	surprisingly	RB	0
,	,	,	0
the	the	DT	0
k	k	JJ	0
cat	cat	NN	0
values	values	NNS	0
were	were	VBD	0
2-	2-	CD	0
to	to	TO	0
31-fold	31-fold	CD	0
higher	higher	JJR	0
than	than	IN	0
those	those	DT	0
exhibited	exhibited	NN	0
by	by	IN	0
wild-type	wild-type	NNP	0
L1	L1	NNP	0
(	(	-LRB-	0
Table	Table	NNP	0
3	3	CD	0
)	)	-RRB-	0
.	.	.	0
As	As	RB	0
with	with	IN	0
the	the	DT	0
I164A	I164A	JJ	0
mutant	mutant	NN	0
,	,	,	0
the	the	DT	0
changes	changes	NNS	0
in	in	IN	0
K	K	NNP	0
m	m	NN	0
and	and	CC	0
k	k	JJ	0
cat	cat	NN	0
for	for	IN	0
the	the	DT	0
penicillins	penicillins	NN	0
and	and	CC	0
carbapenems	carbapenems	NNS	0
were	were	VBD	0
relatively	relatively	RB	0
small	small	JJ	0
,	,	,	0
as	as	RB	0
compared	compared	VBN	0
with	with	IN	0
the	the	DT	0
values	values	NNS	0
obtained	obtained	VBN	0
with	with	IN	0
the	the	DT	0
cephalosporins	cephalosporins	NN	0
(	(	-LRB-	0
Table	Table	NNP	0
4	4	CD	0
)	)	-RRB-	0
.	.	.	0
Rapid-scanning	Rapid-scanning	NNP	0
vis	vis	NNP	B-NP
study	study	NN	I-NP
on	on	IN	0
nitrocefin	nitrocefin	JJ	B-NP
hydrolysi	hydrolysi	NN	I-NP
by	by	IN	0
I164A	I164A	NNP	0
and	and	CC	0
F158A	F158A	NNP	0
showed	showed	VBD	0
a	a	DT	0
marked	marked	JJ	0
decrease	decrease	NN	0
in	in	IN	0
intermediate	intermediate	JJ	0
accumulation	accumulation	NN	B-NP
,	,	,	0
with	with	IN	0
the	the	DT	0
I164A	I164A	FW	0
mutant	mutant	FW	0
generating	generating	FW	0
<	<	SYM	0
0.30	0.30	FW	0
μM	μM	NN	B-NP
intermediate	intermediate	JJ	I-NP
and	and	CC	0
the	the	DT	0
F158A	F158A	NN	0
producing	producing	VBG	0
no	no	DT	0
detectable	detectable	JJ	0
intermediate	intermediate	NNS	0
(	(	-LRB-	0
Figure	Figure	NNP	0
2	2	CD	0
)	)	-RRB-	0
.	.	.	0
stopped-flow	stopped-flow	NN	B-NP
fluorescence	fluorescence	JJ	I-NP
study	study	NN	I-NP
at	at	IN	0
10°C	10°C	NNP	0
resulted	resulted	VBD	0
in	in	IN	0
a	a	DT	0
K	K	NNP	B-NP
S	S	NNP	I-NP
value	value	NN	I-NP
of	of	IN	0
31	31	CD	0
±	±	CD	0
11	11	CD	0
μM	μM	NN	B-NP
for	for	IN	0
the	the	DT	0
I164A	I164A	JJ	0
mutant	mutant	NN	0
.	.	.	0
The	The	DT	0
reaction	reaction	NN	0
of	of	IN	0
F158A	F158A	CD	0
with	with	IN	0
nitrocefin	nitrocefin	NN	B-NP
was	was	VBD	0
so	so	RB	0
rapid	rapid	JJ	0
,	,	,	0
we	we	PRP	0
could	could	MD	0
not	not	RB	0
determine	determine	VB	0
a	a	DT	0
K	K	NNP	B-NP
S	S	NNP	I-NP
value	value	NN	I-NP
for	for	IN	0
this	this	DT	0
mutant	mutant	NN	B-NP
.	.	.	0
containing	containing	VBG	B-NP
antibiotic	antibiotic	JJ	I-NP
discussion	discussion	NN	I-NP
β-lactam	β-lactam	NN	I-NP
constitute	constitute	VBP	0
the	the	DT	0
largest	largest	JJS	0
class	class	NN	0
of	of	IN	0
antibiotics	antibiotics	NN	0
,	,	,	0
and	and	CC	0
these	these	DT	0
compounds	compounds	NNS	0
are	are	VBP	0
relatively	relatively	RB	0
inexpensive	inexpensive	JJ	0
to	to	TO	0
produce	produce	VB	0
,	,	,	0
cause	cause	VB	0
minor	minor	JJ	0
side	side	NN	B-NP
effect	effect	NN	I-NP
,	,	,	0
and	and	CC	0
are	are	VBP	0
effective	effective	JJ	0
towards	towards	IN	0
a	a	DT	0
number	number	NN	0
of	of	IN	0
bacterial	bacterial	JJ	B-NP
strain	strain	NN	I-NP
.	.	.	0
Nonetheless	Nonetheless	RB	0
,	,	,	0
bacterial	bacterial	JJ	B-NP
resistance	resistance	NN	I-NP
to	to	TO	0
these	these	DT	0
antibiotics	antibiotics	NN	0
is	is	VBZ	0
extensive	extensive	JJ	0
,	,	,	0
most	most	RBS	0
commonly	commonly	RB	0
due	due	JJ	0
to	to	TO	0
the	the	DT	0
β-lactama	β-lactama	NN	B-NP
bacterial	bacterial	JJ	I-NP
production	production	NN	I-NP
[	[	-LRB-	0
10	10	CD	0
51	51	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
fact	fact	NN	0
,	,	,	0
there	there	EX	0
have	have	VBP	0
been	been	VBN	0
over	over	IN	0
300	300	CD	0
distinct	distinct	JJ	0
β-lactama	β-lactama	NN	B-NP
reported	reported	VBD	0
,	,	,	0
and	and	CC	0
most	most	JJS	0
of	of	IN	0
these	these	DT	0
enzymes	enzymes	NN	0
utilize	utilize	VBD	0
an	an	DT	0
active	active	JJ	0
site	site	NN	B-NP
serine	serine	NN	I-NP
group	group	NN	I-NP
to	to	TO	0
nucleophilically	nucleophilically	VB	0
attack	attack	VB	0
the	the	DT	0
β-lactam	β-lactam	JJ	B-NP
carbonyl	carbonyl	NN	I-NP
,	,	,	0
resulting	resulting	VBG	0
in	in	IN	0
a	a	DT	0
hydrolyzed	hydrolyzed	JJ	B-NP
product	product	NN	I-NP
that	that	WDT	0
is	is	VBZ	0
covalently	covalently	VBN	0
attached	attached	VBN	0
to	to	TO	0
the	the	DT	0
active	active	JJ	0
site	site	NN	0
.	.	.	0
To	To	TO	0
combat	combat	VB	0
these	these	DT	0
enzymes	enzymes	NN	0
,	,	,	0
β-lactamase	β-lactamase	JJ	B-NP
inhibitor	inhibitor	NN	I-NP
such	such	JJ	0
as	as	IN	0
clavulanic	clavulanic	JJ	B-NP
acid	acid	NN	I-NP
,	,	,	0
sulbactam	sulbactam	NN	B-NP
,	,	,	0
and	and	CC	0
tazobactam	tazobactam	NN	B-NP
have	have	VBP	0
been	been	VBN	0
given	given	VBN	0
in	in	IN	0
combination	combination	NN	0
with	with	IN	0
a	a	DT	0
β-lactam	β-lactam	JJ	B-NP
containing	containing	JJ	0
antibiotic	antibiotic	NN	0
to	to	TO	0
treat	treat	VB	0
bacterial	bacterial	JJ	B-NP
infection	infection	NN	I-NP
[	[	-LRB-	0
52	52	CD	0
]	]	-RRB-	0
.	.	.	0
One	One	CD	0
class	class	NN	0
of	of	IN	0
β-lactama	β-lactama	NN	B-NP
that	that	WDT	0
are	are	VBP	0
particularly	particularly	RB	0
unaffected	unaffected	VBN	0
by	by	IN	0
the	the	DT	0
known	known	VBN	0
β-lactamase	β-lactamase	JJ	B-NP
inhibitor	inhibitor	NN	I-NP
and	and	CC	0
have	have	VBP	0
been	been	VBN	0
shown	shown	VBN	0
to	to	TO	0
hydrolyze	hydrolyze	VB	0
almost	almost	RB	0
all	all	RB	0
known	known	VBN	0
containing	containing	NNS	B-NP
antibiotic	antibiotic	JJ	I-NP
β-lactam	β-lactam	JJ	I-NP
including	including	VBG	0
late	late	JJ	0
generation	generation	NN	B-NP
carbapenem	carbapenem	NN	I-NP
at	at	IN	0
high	high	JJ	0
rates	rates	NNS	0
are	are	VBP	0
the	the	DT	0
metallo-β-lactama	metallo-β-lactama	NN	B-NP
[	[	-LRB-	0
14	14	CD	0
15	15	CD	0
16	16	CD	0
17	17	CD	0
18	18	CD	0
19	19	CD	0
]	]	-RRB-	0
.	.	.	0
Although	Although	IN	0
there	there	EX	0
are	are	VBP	0
no	no	DT	0
reports	reports	NNS	0
of	of	IN	0
metallo-β-lactamases	metallo-β-lactamases	JJ	B-NP
isolated	isolated	NN	I-NP
from	from	IN	0
major	major	JJ	0
pathogens	pathogens	NNS	0
[	[	-LRB-	0
51	51	CD	0
53	53	CD	0
]	]	-RRB-	0
,	,	,	0
these	these	DT	0
enzymes	enzymes	NNS	0
are	are	VBP	0
produced	produced	VBN	0
by	by	IN	0
pathogens	pathogens	JJ	0
such	such	JJ	0
as	as	IN	0
b.	b.	NN	B-NP
fragili	fragili	NN	I-NP
,	,	,	0
S.	S.	NNP	B-NP
maltophilia	maltophilia	NN	I-NP
,	,	,	0
and	and	CC	0
P.	P.	NNP	B-NP
aeruginosa	aeruginosa	NN	I-NP
.	.	.	0
It	It	PRP	0
is	is	VBZ	0
inevitable	inevitable	JJ	0
that	that	IN	0
the	the	DT	0
continued	continued	JJ	0
and	and	CC	0
β-lactam	β-lactam	JJ	B-NP
antibiotic	antibiotic	JJ	I-NP
extensive	extensive	JJ	I-NP
use	use	NN	I-NP
will	will	MD	0
result	result	VB	0
in	in	IN	0
a	a	DT	0
major	major	JJ	0
pathogen	pathogen	NN	0
that	that	WDT	0
produces	produces	VBZ	0
a	a	DT	0
metallo-β-lactamase	metallo-β-lactamase	JJ	B-NP
.	.	.	0
Efforts	Efforts	NNS	0
to	to	TO	0
solve	solve	VB	0
the	the	DT	0
crystal	crystal	NN	0
structure	structure	NN	0
of	of	IN	0
one	one	CD	0
of	of	IN	0
the	the	DT	0
metallo-β-lactama	metallo-β-lactama	NN	B-NP
with	with	IN	0
a	a	DT	0
bound	bound	JJ	0
substrate	substrate	JJ	B-NP
molecule	molecule	NN	I-NP
have	have	VBP	0
failed	failed	VBN	0
,	,	,	0
most	most	RBS	0
likely	likely	JJ	0
due	due	JJ	0
to	to	TO	0
the	the	DT	0
high	high	JJ	0
activity	activity	NN	0
of	of	IN	0
the	the	DT	0
enzymes	enzymes	NN	0
towards	towards	IN	0
all	all	DT	0
containing	containing	VBG	B-NP
antibiotic	antibiotic	JJ	I-NP
β-lactam	β-lactam	JJ	I-NP
[	[	-LRB-	0
37	37	CD	0
54	54	CD	0
]	]	-RRB-	0
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
computational	computational	JJ	B-NP
study	study	NN	I-NP
have	have	VBP	0
been	been	VBN	0
used	used	VBN	0
extensively	extensively	RB	0
to	to	TO	0
study	study	VB	0
substrate	substrate	JJ	0
binding	binding	NN	0
,	,	,	0
the	the	DT	0
role	role	NN	0
of	of	IN	0
the	the	DT	0
zn(ii)	zn(ii)	NN	B-NP
ion	ion	NN	I-NP
in	in	IN	0
catalysis	catalysis	NN	0
,	,	,	0
the	the	DT	0
protonation	protonation	JJ	B-NP
state	state	NN	I-NP
of	of	IN	0
the	the	DT	0
active	active	JJ	0
site	site	NN	0
,	,	,	0
and	and	CC	0
inhibitor	inhibitor	JJ	0
binding	binding	NNS	0
[	[	-LRB-	0
37	37	CD	0
42	42	CD	0
55	55	CD	0
56	56	CD	0
57	57	CD	0
58	58	CD	0
59	59	CD	0
]	]	-RRB-	0
.	.	.	0
All	All	DT	0
of	of	IN	0
the	the	DT	0
substrate	substrate	JJ	0
binding	binding	JJ	0
models	models	NNS	0
have	have	VBP	0
made	made	VBN	0
assumptions	assumptions	NNS	0
before	before	IN	0
the	the	DT	0
substrate	substrate	NN	0
was	was	VBD	0
docked	docked	VBN	0
into	into	IN	0
the	the	DT	0
active	active	JJ	0
site	site	NN	0
[	[	-LRB-	0
37	37	CD	0
42	42	CD	0
]	]	-RRB-	0
,	,	,	0
and	and	CC	0
some	some	DT	0
of	of	IN	0
these	these	DT	0
assumptions	assumptions	NNS	0
have	have	VBP	0
been	been	VBN	0
shown	shown	VBN	0
to	to	TO	0
be	be	VB	0
invalid	invalid	VBN	0
for	for	IN	0
certain	certain	JJ	0
substrates	substrates	NNS	0
[	[	-LRB-	0
43	43	CD	0
]	]	-RRB-	0
.	.	.	0
With	With	IN	0
L1	L1	NNP	0
,	,	,	0
two	two	CD	0
key	key	JJ	B-NP
assumption	assumption	NN	I-NP
were	were	VBD	0
made	made	VBN	0
:	:	:	0
(	(	-LRB-	0
1	1	LS	0
)	)	-RRB-	0
the	the	DT	0
bridging	bridging	JJ	0
hydroxide	hydroxide	JJ	B-NP
function	function	NN	I-NP
as	as	IN	0
the	the	DT	0
nucleophile	nucleophile	NN	B-NP
during	during	IN	0
catalysis	catalysis	NN	0
and	and	CC	0
(	(	-LRB-	0
2	2	LS	0
)	)	-RRB-	0
Zn	Zn	NNP	B-NP
1	1	CD	0
coordinates	coordinates	VBZ	0
the	the	DT	0
β-lactam	β-lactam	JJ	B-NP
carbonyl	carbonyl	NN	I-NP
[	[	-LRB-	0
37	37	CD	0
]	]	-RRB-	0
.	.	.	0
With	With	IN	0
these	these	DT	0
assumptions	assumptions	NNS	0
and	and	CC	0
after	after	IN	0
energy	energy	NN	B-NP
minimization	minimization	NN	I-NP
,	,	,	0
Ser224	Ser224	NNP	B-NP
was	was	VBD	0
predicted	predicted	VBN	0
to	to	TO	0
hydrogen	hydrogen	VB	B-NP
bond	bond	NN	I-NP
to	to	TO	0
the	the	DT	0
substrate	substrate	JJ	B-NP
carboxylata	carboxylata	NN	I-NP
[	[	-LRB-	0
37	37	CD	0
]	]	-RRB-	0
,	,	,	0
reminiscent	reminiscent	JJ	0
of	of	IN	0
the	the	DT	0
role	role	NN	0
predicted	predicted	VBD	0
for	for	IN	0
Lys224	Lys224	CD	B-NP
in	in	IN	0
CcrA	CcrA	NNP	B-NP
[	[	-LRB-	0
42	42	CD	0
]	]	-RRB-	0
.	.	.	0
Ullah	Ullah	NNP	0
et	et	NNP	0
al.	al.	NNP	0
predicted	predicted	VBD	0
that	that	IN	0
Phe158	Phe158	NNP	B-NP
and	and	CC	0
Ile	Ile	NNP	B-NP
164	164	CD	0
form	form	NN	B-NP
hydrophobic	hydrophobic	NN	I-NP
interaction	interaction	NN	I-NP
with	with	IN	0
bulky	bulky	JJ	0
substituent	substituent	NN	B-NP
on	on	IN	0
the	the	DT	0
substrate	substrate	NN	0
,	,	,	0
suggesting	suggesting	VBG	0
that	that	IN	0
the	the	DT	0
loss	loss	NN	0
of	of	IN	0
these	these	DT	0
residues	residues	NN	0
would	would	MD	0
only	only	RB	0
affect	affect	VB	0
binding	binding	VBN	0
of	of	IN	0
substrates	substrates	NN	0
with	with	IN	0
large	large	JJ	0
aromatic	aromatic	JJ	B-NP
substituent	substituent	NN	I-NP
[	[	-LRB-	0
37	37	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
the	the	DT	0
modeling	modeling	JJ	0
studies	studies	NNS	0
on	on	IN	0
CcrA	CcrA	NNP	B-NP
[	[	-LRB-	0
42	42	CD	0
]	]	-RRB-	0
,	,	,	0
Asn233	Asn233	NNP	B-NP
was	was	VBD	0
predicted	predicted	VBN	0
to	to	TO	0
interact	interact	VB	0
with	with	IN	0
the	the	DT	0
β-lactam	β-lactam	JJ	B-NP
carbonyl	carbonyl	NN	I-NP
on	on	IN	0
substrate	substrate	NN	0
,	,	,	0
and	and	CC	0
mutagenesis	mutagenesis	JJ	B-NP
study	study	NN	I-NP
have	have	VBP	0
supported	supported	VBN	0
this	this	DT	0
prediction	prediction	NN	0
[	[	-LRB-	0
43	43	CD	0
]	]	-RRB-	0
.	.	.	0
Although	Although	IN	0
Asn233	Asn233	NNP	B-NP
is	is	VBZ	0
sequence	sequence	JJ	0
conserved	conserved	NN	0
in	in	IN	0
L1	L1	NNP	0
[	[	-LRB-	0
35	35	CD	0
]	]	-RRB-	0
,	,	,	0
it	it	PRP	0
is	is	VBZ	0
located	located	VBN	0
14Å	14Å	RB	0
away	away	RB	0
from	from	IN	0
the	the	DT	0
modeled	modeled	JJ	0
position	position	NN	0
of	of	IN	0
the	the	DT	0
β-lactam	β-lactam	JJ	B-NP
carbonyl	carbonyl	NN	I-NP
and	and	CC	0
was	was	VBD	0
predicted	predicted	VBN	0
not	not	RB	0
to	to	TO	0
play	play	VB	0
a	a	DT	0
role	role	NN	0
in	in	IN	0
substrate	substrate	JJ	0
binding	binding	NN	0
to	to	TO	0
L1	L1	CD	0
[	[	-LRB-	0
37	37	CD	0
]	]	-RRB-	0
.	.	.	0
On	On	IN	0
the	the	DT	0
other	other	JJ	0
hand	hand	NN	0
,	,	,	0
the	the	DT	0
substrate-binding	substrate-binding	JJ	0
model	model	NN	0
predicted	predicted	VBD	0
that	that	IN	0
Tyr228	Tyr228	NNP	B-NP
was	was	VBD	0
in	in	IN	0
position	position	NN	0
to	to	TO	0
offer	offer	VB	0
a	a	DT	0
hydrogen	hydrogen	NN	B-NP
bond	bond	NN	I-NP
to	to	TO	0
the	the	DT	0
β-lactam	β-lactam	JJ	B-NP
carbonyl	carbonyl	NN	I-NP
and	and	CC	0
participate	participate	VB	0
in	in	IN	0
an	an	DT	0
oxyanion	oxyanion	JJ	B-NP
hole	hole	NN	I-NP
that	that	WDT	0
was	was	VBD	0
proposed	proposed	VBN	0
to	to	TO	0
form	form	VB	0
as	as	IN	0
the	the	DT	0
substrate	substrate	NN	0
was	was	VBD	0
hydrolyzed	hydrolyzed	NN	B-NP
[	[	-LRB-	0
37	37	CD	0
]	]	-RRB-	0
.	.	.	0
By	By	IN	0
using	using	VBG	0
the	the	DT	0
crystal	crystal	NN	0
structure	structure	NN	0
and	and	CC	0
modeling	modeling	JJ	0
studies	studies	NNS	0
on	on	IN	0
L1	L1	NNP	0
,	,	,	0
Ullah	Ullah	NNP	0
et	et	NNP	0
al.	al.	NNP	0
proposed	proposed	VBD	0
a	a	DT	0
enzyme	enzyme	NN	B-NP
reaction	reaction	NN	I-NP
mechanism	mechanism	NN	I-NP
[	[	-LRB-	0
37	37	CD	0
]	]	-RRB-	0
.	.	.	0
To	To	TO	0
test	test	VB	0
this	this	DT	0
proposed	proposed	JJ	0
mechanism	mechanism	NN	0
and	and	CC	0
the	the	DT	0
proposed	proposed	JJ	0
roles	roles	NNS	0
of	of	IN	0
the	the	DT	0
amino	amino	JJ	0
acids	acids	NNS	0
discussed	discussed	VBN	0
above	above	IN	0
,	,	,	0
site-directed	site-directed	JJ	0
mutagenesis	mutagenesis	JJ	B-NP
study	study	NN	I-NP
were	were	VBD	0
conducted	conducted	VBN	0
on	on	IN	0
metallo-β-lactamase	metallo-β-lactamase	NNP	B-NP
L1	L1	NNP	I-NP
and	and	CC	0
reported	reported	VBD	0
herein	herein	VBN	0
.	.	.	0
The	The	DT	0
overlap	overlap	JJ	0
extension	extension	NN	0
method	method	NN	0
[	[	-LRB-	0
60	60	CD	0
]	]	-RRB-	0
was	was	VBD	0
used	used	VBN	0
to	to	TO	0
prepare	prepare	VB	0
the	the	DT	0
site-directed	site-directed	JJ	0
mutant	mutant	NN	B-NP
,	,	,	0
and	and	CC	0
a	a	DT	0
variety	variety	NN	0
of	of	IN	0
studies	studies	NNS	0
were	were	VBD	0
used	used	VBN	0
to	to	TO	0
probe	probe	VB	0
whether	whether	IN	0
the	the	DT	0
single	single	JJ	0
point	point	NN	B-NP
mutation	mutation	NN	I-NP
resulted	resulted	VBD	0
in	in	IN	0
large	large	JJ	0
structural	structural	JJ	B-NP
change	change	NN	I-NP
in	in	IN	0
the	the	DT	0
mutant	mutant	JJ	B-NP
enzyme	enzyme	NN	I-NP
(	(	-LRB-	0
1	1	LS	0
)	)	-RRB-	0
The	The	DT	0
mutant	mutant	NN	B-NP
over-expression	over-expression	JJ	I-NP
level	level	JJ	I-NP
were	were	VBD	0
analyzed	analyzed	VBN	0
with	with	IN	0
SDS-PAGE	SDS-PAGE	JJ	B-NP
to	to	TO	0
ensure	ensure	VB	0
that	that	IN	0
the	the	DT	0
mutations	mutations	NN	0
did	did	VBD	0
not	not	RB	0
result	result	VB	0
in	in	IN	0
changes	changes	NNS	0
in	in	IN	0
the	the	DT	0
over-expression	over-expression	JJ	B-NP
level	level	JJ	I-NP
of	of	IN	0
the	the	DT	0
enzymes	enzymes	NN	0
.	.	.	0
With	With	IN	0
a	a	DT	0
few	few	JJ	0
l1	l1	NN	B-NP
mutant	mutant	NN	I-NP
and	and	CC	0
with	with	IN	0
other	other	JJ	0
enzyme	enzyme	JJ	B-NP
system	system	NN	I-NP
in	in	IN	0
the	the	DT	0
lab	lab	NN	0
,	,	,	0
single	single	JJ	0
point	point	NN	B-NP
mutation	mutation	NN	I-NP
often	often	RB	0
result	result	VB	0
in	in	IN	0
depressed	depressed	JJ	0
levels	levels	NNS	0
of	of	IN	0
over-expression	over-expression	NNP	B-NP
[	[	-LRB-	0
61	61	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
the	the	DT	0
case	case	NN	0
of	of	IN	0
the	the	DT	0
mutant	mutant	NN	B-NP
described	described	VBD	0
here	here	RB	0
,	,	,	0
all	all	DT	0
of	of	IN	0
the	the	DT	0
mutants	mutants	JJ	B-NP
over-expressed	over-expressed	NN	I-NP
at	at	IN	0
levels	levels	NNS	0
comparable	comparable	JJ	0
to	to	TO	0
wild-type	wild-type	NNP	B-NP
L1	L1	NNP	I-NP
(	(	-LRB-	0
data	data	NNS	0
not	not	RB	0
shown	shown	VBN	0
)	)	-RRB-	0
.	.	.	0
(	(	-LRB-	0
2	2	LS	0
)	)	-RRB-	0
The	The	DT	0
mutants	mutants	JJ	B-NP
isolatable	isolatable	NN	I-NP
total	total	JJ	I-NP
amount	amount	NN	I-NP
after	after	IN	0
chromatography	chromatography	NN	B-NP
were	were	VBD	0
compared	compared	VBN	0
with	with	IN	0
wild-type	wild-type	JJ	B-NP
l1	l1	NN	I-NP
level	level	JJ	I-NP
.	.	.	0
We	We	PRP	0
have	have	VBP	0
found	found	VBN	0
,	,	,	0
in	in	IN	0
particular	particular	JJ	0
with	with	IN	0
metal	metal	NN	0
binding	binding	JJ	0
mutant	mutant	NN	B-NP
of	of	IN	0
L1	L1	NNP	0
(	(	-LRB-	0
G	G	NNP	0
.	.	.	0
Periyannan	Periyannan	NNP	B-NP
,	,	,	0
R.B.	R.B.	NNP	B-NP
Yates	Yates	NNP	0
,	,	,	0
and	and	CC	0
M.W.	M.W.	NNP	B-NP
Crowder	Crowder	NNP	0
,	,	,	0
unpublished	unpublished	JJ	0
results	results	NNS	0
)	)	-RRB-	0
and	and	CC	0
glyoxalase	glyoxalase	JJ	0
II	II	NNP	0
[	[	-LRB-	0
61	61	CD	0
]	]	-RRB-	0
,	,	,	0
that	that	DT	0
single	single	JJ	0
point	point	NN	B-NP
mutation	mutation	NN	I-NP
can	can	MD	0
result	result	VB	0
in	in	IN	0
over-expressed	over-expressed	JJ	0
mutant	mutant	NN	B-NP
being	being	VBG	0
processed	processed	VBN	0
into	into	IN	0
inclusion	inclusion	NN	B-NP
body	body	NN	I-NP
and	and	CC	0
unisolatable	unisolatable	NN	B-NP
as	as	IN	0
soluble	soluble	JJ	0
proteins	proteins	NNS	0
.	.	.	0
In	In	IN	0
the	the	DT	0
case	case	NN	0
of	of	IN	0
the	the	DT	0
mutant	mutant	NN	B-NP
described	described	VBD	0
here	here	RB	0
,	,	,	0
all	all	DT	0
of	of	IN	0
the	the	DT	0
mutant	mutant	NN	B-NP
were	were	VBD	0
isolated	isolated	VBN	0
at	at	IN	0
levels	levels	NNS	0
comparable	comparable	JJ	0
to	to	TO	0
wild-type	wild-type	NNP	B-NP
L1.	L1.	NNP	I-NP
(	(	-LRB-	0
3	3	LS	0
)	)	-RRB-	0
CD	CD	NN	0
spectra	spectra	NNS	0
were	were	VBD	0
collected	collected	VBN	0
for	for	IN	0
all	all	DT	0
mutant	mutant	NN	B-NP
and	and	CC	0
compared	compared	VBN	0
to	to	TO	0
the	the	DT	0
wild-type	wild-type	JJ	B-NP
l1	l1	NN	I-NP
spectrum	spectrum	NN	I-NP
.	.	.	0
Although	Although	IN	0
we	we	PRP	0
did	did	VBD	0
not	not	RB	0
expect	expect	VB	0
a	a	DT	0
large	large	JJ	0
change	change	NN	0
in	in	IN	0
the	the	DT	0
secondary	secondary	JJ	B-NP
structure	structure	NN	I-NP
of	of	IN	0
L1	L1	CD	0
upon	upon	IN	0
single	single	JJ	0
point	point	NN	B-NP
mutation	mutation	NN	I-NP
,	,	,	0
CD	CD	NNP	0
spectroscopy	spectroscopy	NN	B-NP
is	is	VBZ	0
the	the	DT	0
most	most	RBS	0
common	common	JJ	0
structural	structural	JJ	B-NP
technique	technique	NN	I-NP
to	to	TO	0
characterize	characterize	VB	0
site-directed	site-directed	JJ	0
mutant	mutant	NN	B-NP
.	.	.	0
All	All	DT	0
of	of	IN	0
the	the	DT	0
mutant	mutant	NN	B-NP
described	described	VBD	0
here	here	RB	0
exhibited	exhibited	JJ	0
CD	CD	NN	0
spectra	spectra	NNS	0
that	that	WDT	0
were	were	VBD	0
very	very	RB	0
similar	similar	JJ	0
,	,	,	0
or	or	CC	0
identical	identical	JJ	0
,	,	,	0
to	to	TO	0
that	that	DT	0
of	of	IN	0
wild-type	wild-type	NNP	B-NP
L1	L1	NNP	I-NP
(	(	-LRB-	0
see	see	VB	0
Additional	Additional	JJ	B-NP
file	file	NN	I-NP
1	1	CD	0
:	:	:	0
CD	CD	NNP	0
spectra	spectra	CD	0
)	)	-RRB-	0
.	.	.	0
(	(	-LRB-	0
4	4	LS	0
)	)	-RRB-	0
Metal	Metal	NNP	0
analyses	analyses	NNS	0
on	on	IN	0
the	the	DT	0
mutant	mutant	NN	B-NP
were	were	VBD	0
used	used	VBN	0
to	to	TO	0
probe	probe	VB	0
whether	whether	IN	0
point	point	NN	B-NP
mutation	mutation	NN	I-NP
caused	caused	VBD	0
a	a	DT	0
significant	significant	JJ	0
change	change	NN	0
to	to	TO	0
the	the	DT	0
metal	metal	NN	0
binding	binding	JJ	0
site	site	NN	0
as	as	IN	0
to	to	TO	0
preclude	preclude	VB	0
metal	metal	NN	0
binding	binding	NN	0
.	.	.	0
The	The	DT	0
crystal	crystal	NN	0
structures	structures	NNS	0
of	of	IN	0
the	the	DT	0
metallo-β-lactama	metallo-β-lactama	NN	B-NP
reveal	reveal	VBP	0
a	a	DT	0
complex	complex	JJ	0
and	and	CC	0
far-reaching	far-reaching	JJ	0
hydrogen-bonding	hydrogen-bonding	JJ	0
network	network	NN	0
around	around	IN	0
the	the	DT	0
metal	metal	NN	0
binding	binding	JJ	0
sites	sites	NNS	0
,	,	,	0
and	and	CC	0
disruption	disruption	NN	0
of	of	IN	0
this	this	DT	0
network	network	NN	0
is	is	VBZ	0
predicted	predicted	VBN	0
to	to	TO	0
affect	affect	VB	0
metal	metal	NN	0
binding	binding	NNS	0
[	[	-LRB-	0
37	37	CD	0
42	42	CD	0
44	44	CD	0
45	45	CD	0
48	48	CD	0
49	49	CD	0
62	62	CD	0
63	63	CD	0
]	]	-RRB-	0
.	.	.	0
With	With	IN	0
all	all	DT	0
of	of	IN	0
the	the	DT	0
mutant	mutant	NN	B-NP
described	described	VBD	0
here	here	RB	0
except	except	IN	0
the	the	DT	0
S224K	S224K	JJ	0
mutant	mutant	NN	0
,	,	,	0
each	each	DT	0
wild-type	wild-type	JJ	B-NP
mutant	mutant	JJ	I-NP
bind	bind	NN	I-NP
or	or	CC	0
zn(ii)	zn(ii)	NN	B-NP
near-wild-type	near-wild-type	JJ	I-NP
level	level	JJ	I-NP
after	after	IN	0
purification	purification	NN	B-NP
.	.	.	0
The	The	DT	0
S224K	S224K	NNP	0
mutant	mutant	VBD	0
exhibited	exhibited	VBN	0
a	a	DT	0
50	50	CD	0
%	%	NN	0
reduction	reduction	NN	0
in	in	IN	0
metal	metal	NN	0
binding	binding	NNS	0
(	(	-LRB-	0
Table	Table	NNP	0
2	2	CD	0
)	)	-RRB-	0
,	,	,	0
and	and	CC	0
we	we	PRP	0
postulate	postulate	VBD	0
this	this	DT	0
is	is	VBZ	0
due	due	JJ	0
to	to	TO	0
electrostatic	electrostatic	VB	B-NP
repulsion	repulsion	NN	I-NP
between	between	IN	0
the	the	DT	0
newly	newly	RB	0
introduced	introduced	VBN	B-NP
ly	ly	NNP	I-NP
with	with	IN	0
Zn	Zn	NNP	B-NP
2	2	CD	0
.	.	.	0
In	In	IN	0
spite	spite	NN	0
of	of	IN	0
the	the	DT	0
zn(ii)	zn(ii)	NN	B-NP
mutants	mutants	JJ	I-NP
binding	binding	JJ	I-NP
significant	significant	JJ	I-NP
amount	amount	NN	I-NP
,	,	,	0
we	we	PRP	0
included	included	VBD	0
100	100	CD	0
μM	μM	JJ	0
ZnCl	ZnCl	JJ	B-NP
2	2	CD	0
in	in	IN	0
all	all	DT	0
of	of	IN	0
the	the	DT	0
kinetic	kinetic	JJ	B-NP
buffer	buffer	NN	I-NP
to	to	TO	0
ensure	ensure	VB	0
saturation	saturation	VBN	0
of	of	IN	0
the	the	DT	0
metal	metal	NN	0
binding	binding	JJ	0
sites	sites	NNS	0
and	and	CC	0
to	to	TO	0
facilitate	facilitate	VB	0
direct	direct	JJ	0
comparison	comparison	NN	0
of	of	IN	0
the	the	DT	0
kinetic	kinetic	JJ	B-NP
data.	data.	NNP	I-NP
(	(	-LRB-	0
5	5	LS	0
)	)	-RRB-	0
All	All	DT	0
mutant	mutant	NN	B-NP
were	were	VBD	0
stable	stable	JJ	0
to	to	TO	0
multiple	multiple	JJ	0
freeze/thaw	freeze/thaw	NN	B-NP
cycle	cycle	NN	I-NP
and	and	CC	0
to	to	TO	0
prolonged	prolonged	JJ	0
storage	storage	NN	0
(	(	-LRB-	0
>	>	CD	0
3	3	CD	0
weeks	weeks	NNS	0
)	)	-RRB-	0
at	at	IN	0
4°C	4°C	NNP	0
,	,	,	0
retaining	retaining	VBG	0
>	>	CD	0
95	95	CD	0
%	%	NN	0
of	of	IN	0
their	their	PRP$	0
activity	activity	NN	0
.	.	.	0
With	With	IN	0
these	these	DT	0
five	five	CD	0
lines	lines	NNS	0
of	of	IN	0
evidence	evidence	NN	0
,	,	,	0
we	we	PRP	0
were	were	VBD	0
confident	confident	JJ	0
that	that	IN	0
none	none	NN	0
of	of	IN	0
the	the	DT	0
point	point	NN	B-NP
mutation	mutation	NN	I-NP
resulted	resulted	VBD	0
in	in	IN	0
large	large	JJ	0
structural	structural	JJ	B-NP
change	change	NN	I-NP
in	in	IN	0
L1	L1	NNP	0
and	and	CC	0
that	that	IN	0
any	any	DT	0
kinetic	kinetic	JJ	B-NP
difference	difference	NN	I-NP
could	could	MD	0
be	be	VB	0
attributed	attributed	VBN	0
to	to	TO	0
the	the	DT	0
changed	changed	JJ	0
amino	amino	JJ	0
acid	acid	NN	B-NP
.	.	.	0
As	As	IN	0
a	a	DT	0
first	first	JJ	0
approximation	approximation	NN	B-NP
of	of	IN	0
substrate	substrate	JJ	0
binding	binding	NN	0
,	,	,	0
we	we	PRP	0
examined	examined	VBD	0
the	the	DT	0
steady-state	steady-state	JJ	B-NP
kinetics	kinetics	NN	I-NP
of	of	IN	0
4	4	CD	0
cephalosporin	cephalosporin	NN	B-NP
,	,	,	0
2	2	CD	0
penicillins	penicillins	NN	0
,	,	,	0
and	and	CC	0
3	3	CD	0
carbapenem	carbapenem	NN	B-NP
(	(	-LRB-	0
Tables	Tables	NNP	0
3	3	CD	0
,	,	,	0
4	4	CD	0
,	,	,	0
5	5	CD	0
)	)	-RRB-	0
and	and	CC	0
compared	compared	VBN	0
the	the	DT	0
K	K	NNP	0
m	m	NN	0
values	values	NNS	0
of	of	IN	0
the	the	DT	0
mutant	mutant	NN	B-NP
with	with	IN	0
those	those	DT	0
of	of	IN	0
wild-type	wild-type	JJ	B-NP
L1	L1	NN	I-NP
.	.	.	0
The	The	DT	0
substrates	substrates	JJ	0
tested	tested	NN	0
were	were	VBD	0
chosen	chosen	VBN	0
because	because	IN	0
they	they	PRP	0
exhibited	exhibited	VBP	0
low	low	JJ	0
K	K	NNP	0
m	m	NN	0
values	values	NNS	0
in	in	IN	0
previous	previous	JJ	0
kinetic	kinetic	JJ	B-NP
study	study	NN	I-NP
[	[	-LRB-	0
36	36	CD	0
]	]	-RRB-	0
,	,	,	0
and	and	CC	0
we	we	PRP	0
believed	believed	VBD	0
that	that	IN	0
we	we	PRP	0
could	could	MD	0
saturate	saturate	VB	0
the	the	DT	0
enzymes	enzymes	NN	0
with	with	IN	0
substrate	substrate	VBG	0
even	even	RB	0
if	if	IN	0
there	there	EX	0
was	was	VBD	0
large	large	JJ	0
change	change	NN	0
in	in	IN	0
binding	binding	VBG	0
with	with	IN	0
the	the	DT	0
point	point	NN	B-NP
mutation	mutation	NN	I-NP
.	.	.	0
The	The	DT	0
tyr228	tyr228	NN	B-NP
mutant	mutant	NN	I-NP
exhibited	exhibited	VBP	0
increased	increased	VBN	B-NP
K	K	NNP	I-NP
m	m	NN	I-NP
values	values	NNS	0
for	for	IN	0
8	8	CD	0
of	of	IN	0
the	the	DT	0
9	9	CD	0
substrates	substrates	NNS	0
tested	tested	VBN	0
,	,	,	0
with	with	IN	0
the	the	DT	0
smallest	smallest	JJS	0
changes	changes	NNS	0
in	in	IN	0
K	K	NNP	0
m	m	NN	0
observed	observed	VBD	0
when	when	WRB	0
the	the	DT	0
carbapenem	carbapenem	NN	B-NP
were	were	VBD	0
used	used	VBN	0
as	as	IN	0
the	the	DT	0
substrate	substrate	NN	0
.	.	.	0
This	This	DT	0
result	result	NN	0
supports	supports	VBZ	0
the	the	DT	0
proposed	proposed	JJ	0
role	role	NN	0
of	of	IN	0
Tyr228	Tyr228	CD	B-NP
in	in	IN	0
substrate	substrate	JJ	0
binding	binding	NN	0
.	.	.	0
In	In	IN	0
contrast	contrast	NN	0
,	,	,	0
the	the	DT	0
results	results	NNS	0
on	on	IN	0
the	the	DT	0
ser224	ser224	NN	B-NP
mutant	mutant	NN	I-NP
suggest	suggest	VBP	0
that	that	IN	0
this	this	DT	0
residue	residue	NN	0
is	is	VBZ	0
not	not	RB	0
important	important	JJ	0
in	in	IN	0
substrate	substrate	JJ	0
binding	binding	NN	0
,	,	,	0
since	since	IN	0
the	the	DT	0
S224A	S224A	NNP	0
and	and	CC	0
S224K	S224K	CD	0
mutants	mutants	NNS	0
did	did	VBD	0
not	not	RB	0
exhibit	exhibit	VB	0
any	any	DT	0
significant	significant	JJ	0
increases	increases	NNS	0
(	(	-LRB-	0
by	by	IN	0
a	a	DT	0
factor	factor	NN	B-NP
of	of	IN	0
≥	≥	CD	0
10	10	CD	0
)	)	-RRB-	0
in	in	IN	0
K	K	NNP	0
m	m	NN	0
for	for	IN	0
any	any	DT	0
of	of	IN	0
the	the	DT	0
substrates	substrates	NN	0
tested	tested	VBD	0
.	.	.	0
Only	Only	RB	0
when	when	WRB	0
Ser224	Ser224	NNP	B-NP
was	was	VBD	0
replaced	replaced	VBN	0
with	with	IN	0
an	an	DT	0
Asp	Asp	JJ	0
residue	residue	NN	0
was	was	VBD	0
there	there	RB	0
significant	significant	JJ	0
increases	increases	NNS	0
in	in	IN	0
the	the	DT	0
observed	observed	JJ	0
K	K	NNP	B-NP
m	m	JJ	I-NP
value	value	NN	I-NP
for	for	IN	0
6	6	CD	0
of	of	IN	0
the	the	DT	0
9	9	CD	0
substrates	substrates	NNS	0
tested	tested	VBN	0
,	,	,	0
and	and	CC	0
the	the	DT	0
largest	largest	JJS	0
changes	changes	NNS	0
were	were	VBD	0
exhibited	exhibited	VBN	0
when	when	WRB	0
the	the	DT	0
penicillins	penicillins	NN	0
were	were	VBD	0
used	used	VBN	0
as	as	IN	0
substrates	substrates	NN	0
.	.	.	0
This	This	DT	0
result	result	NN	0
supports	supports	VBZ	0
the	the	DT	0
observation	observation	NN	0
of	of	IN	0
differential	differential	JJ	B-NP
binding	binding	JJ	I-NP
mode	mode	NN	I-NP
of	of	IN	0
substrates	substrates	VBG	0
to	to	TO	0
the	the	DT	0
β-lactama	β-lactama	NN	B-NP
,	,	,	0
depending	depending	VBG	0
on	on	IN	0
the	the	DT	0
structure	structure	NN	0
of	of	IN	0
the	the	DT	0
substrate	substrate	NN	0
[	[	-LRB-	0
43	43	CD	0
64	64	CD	0
65	65	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
only	only	RB	0
remaining	remaining	VBG	B-NP
mutant	mutant	NN	I-NP
that	that	IN	0
exhibited	exhibited	JJ	0
significant	significant	JJ	0
changes	changes	NNS	0
in	in	IN	0
the	the	DT	0
K	K	NNP	0
m	m	NN	0
values	values	NNS	0
were	were	VBD	0
the	the	DT	0
I164A	I164A	NNP	0
and	and	CC	0
F158A	F158A	CD	0
mutants	mutants	NNS	0
.	.	.	0
The	The	DT	0
I164A	I164A	CD	0
mutant	mutant	NNS	0
exhibited	exhibited	VBP	0
increased	increased	VBN	B-NP
K	K	NNP	I-NP
m	m	NN	I-NP
values	values	VBZ	0
only	only	RB	0
when	when	WRB	0
using	using	VBG	0
cefoxitin	cefoxitin	NN	B-NP
as	as	IN	0
the	the	DT	0
substrate	substrate	NN	0
,	,	,	0
suggesting	suggesting	VBG	0
an	an	DT	0
interaction	interaction	NN	0
of	of	IN	0
the	the	DT	0
isoleucine	isoleucine	JJ	B-NP
group	group	NN	I-NP
with	with	IN	0
the	the	DT	0
methoxy	methoxy	JJ	B-NP
group	group	NN	I-NP
on	on	IN	0
cefoxitin	cefoxitin	NN	B-NP
.	.	.	0
The	The	DT	0
F158A	F158A	NNP	0
mutant	mutant	VBD	0
exhibited	exhibited	VBN	0
higher	higher	JJR	0
K	K	NNP	0
m	m	NN	0
values	values	NNS	0
when	when	WRB	0
using	using	VBG	0
the	the	DT	0
cephalosporin	cephalosporin	NN	B-NP
as	as	IN	0
substrates	substrates	NN	0
,	,	,	0
suggesting	suggesting	VBG	0
an	an	DT	0
interaction	interaction	NN	0
of	of	IN	0
the	the	DT	0
cephalosporin	cephalosporin	NN	B-NP
'	'	POS	0
substituent	substituent	NN	B-NP
with	with	IN	0
the	the	DT	0
phenylalanine	phenylalanine	NN	B-NP
on	on	IN	0
the	the	DT	0
loop	loop	NN	0
that	that	WDT	0
extends	extends	VBZ	0
over	over	IN	0
the	the	DT	0
active	active	JJ	0
site	site	NN	0
.	.	.	0
None	None	NN	0
of	of	IN	0
the	the	DT	0
other	other	JJ	0
mutant	mutant	NN	B-NP
exhibited	exhibited	VBP	0
vastly	vastly	RB	0
different	different	JJ	0
values	values	NNS	0
for	for	IN	0
K	K	NNP	0
m	m	NN	0
with	with	IN	0
any	any	DT	0
of	of	IN	0
the	the	DT	0
substrates	substrates	NN	0
tested	tested	VBD	0
.	.	.	0
An	An	DT	0
examination	examination	NN	0
of	of	IN	0
the	the	DT	0
mutant	mutant	NN	B-NP
k	k	JJ	I-NP
cat	cat	NN	I-NP
value	value	NN	I-NP
revealed	revealed	VBD	0
some	some	DT	0
surprising	surprising	JJ	0
results	results	NNS	0
.	.	.	0
The	The	DT	0
S224D	S224D	FW	0
mutants	mutants	FW	0
displayed	displayed	FW	0
decreased	decreased	VBN	B-NP
k	k	NN	I-NP
cat	cat	NN	I-NP
value	value	NN	I-NP
for	for	IN	0
7	7	CD	0
of	of	IN	0
the	the	DT	0
9	9	CD	0
substrates	substrates	NNS	0
tested	tested	VBD	0
.	.	.	0
Since	Since	IN	0
similar	similar	JJ	0
results	results	NNS	0
were	were	VBD	0
not	not	RB	0
observed	observed	VBN	0
with	with	IN	0
the	the	DT	0
S224K	S224K	NNP	0
and	and	CC	0
S224A	S224A	CD	0
mutants	mutants	NN	0
,	,	,	0
we	we	PRP	0
do	do	VBP	0
not	not	RB	0
propose	propose	VB	0
a	a	DT	0
ser224	ser224	NN	B-NP
catalytic	catalytic	JJ	I-NP
role	role	NN	I-NP
.	.	.	0
Instead	Instead	RB	0
,	,	,	0
we	we	PRP	0
predict	predict	VBP	0
that	that	IN	0
the	the	DT	0
insertion	insertion	NN	0
of	of	IN	0
an	an	DT	0
aspartic	aspartic	JJ	B-NP
acid	acid	NN	I-NP
into	into	IN	0
the	the	DT	0
active	active	JJ	0
site	site	NN	0
at	at	IN	0
position	position	NN	0
224	224	CD	0
results	results	NNS	0
in	in	IN	0
a	a	DT	0
change	change	NN	0
in	in	IN	0
the	the	DT	0
hydrogen	hydrogen	NN	B-NP
bonding	bonding	NN	I-NP
network	network	NN	I-NP
in	in	IN	0
L1	L1	CD	0
;	;	:	0
this	this	DT	0
hydrogen	hydrogen	NN	B-NP
bonding	bonding	NN	I-NP
network	network	NN	I-NP
is	is	VBZ	0
extensive	extensive	JJ	0
in	in	IN	0
all	all	DT	0
metallo-β-lactama	metallo-β-lactama	NN	B-NP
that	that	WDT	0
have	have	VBP	0
been	been	VBN	0
characterized	characterized	VBN	0
crystallographically	crystallographically	NNS	0
[	[	-LRB-	0
37	37	CD	0
42	42	CD	0
44	44	CD	0
45	45	CD	0
48	48	CD	0
49	49	CD	0
62	62	CD	0
63	63	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
N233D	N233D	NNP	0
mutant	mutant	VBD	0
also	also	RB	0
exhibited	exhibited	VBN	0
greatly	greatly	RB	0
reduced	reduced	VBN	0
biapenem	biapenem	NN	B-NP
k	k	JJ	I-NP
cat	cat	NN	I-NP
value	value	NN	I-NP
and	and	CC	0
meropenem	meropenem	NN	B-NP
but	but	CC	0
not	not	RB	0
for	for	IN	0
imipenem	imipenem	NN	B-NP
or	or	CC	0
any	any	DT	0
of	of	IN	0
the	the	DT	0
other	other	JJ	0
substrates	substrates	NN	0
tested	tested	VBD	0
.	.	.	0
This	This	DT	0
mutation	mutation	NN	0
is	is	VBZ	0
also	also	RB	0
predicted	predicted	VBN	0
to	to	TO	0
affect	affect	VB	0
the	the	DT	0
hydrogen	hydrogen	NN	B-NP
bonding	bonding	NN	I-NP
network	network	NN	I-NP
around	around	IN	0
the	the	DT	0
active	active	JJ	0
site	site	NN	0
,	,	,	0
and	and	CC	0
apparently	apparently	RB	0
,	,	,	0
enzyme	enzyme	NN	B-NP
interaction	interaction	NN	I-NP
with	with	IN	0
the	the	DT	0
4	4	CD	0
'	'	POS	0
carbapenem	carbapenem	NN	B-NP
substituent	substituent	NN	I-NP
has	has	VBZ	0
an	an	DT	0
effect	effect	NN	0
on	on	IN	0
catalysis	catalysis	NN	0
.	.	.	0
More	More	RBR	0
surprisingly	surprisingly	RB	0
are	are	VBP	0
the	the	DT	0
increases	increases	NNS	0
in	in	IN	0
k	k	JJ	B-NP
cat	cat	NN	I-NP
of	of	IN	0
the	the	DT	0
F158A	F158A	JJ	0
mutants	mutants	NN	0
.	.	.	0
We	We	PRP	0
are	are	VBP	0
uncertain	uncertain	JJ	0
why	why	WRB	0
the	the	DT	0
mutation	mutation	NN	0
of	of	IN	0
residues	residues	NNS	0
on	on	IN	0
the	the	DT	0
loop	loop	NN	0
that	that	WDT	0
extends	extends	VBZ	0
over	over	IN	0
the	the	DT	0
active	active	JJ	0
site	site	NN	0
would	would	MD	0
affect	affect	VB	0
k	k	JJ	B-NP
cat	cat	NN	I-NP
,	,	,	0
since	since	IN	0
substrate	substrate	NN	0
and	and	CC	0
product	product	NN	0
binding	binding	NNS	0
have	have	VBP	0
been	been	VBN	0
predicted	predicted	VBN	0
to	to	TO	0
be	be	VB	0
very	very	RB	0
fast	fast	RB	0
in	in	IN	0
the	the	DT	0
reaction	reaction	NN	0
of	of	IN	0
nitrocefin	nitrocefin	NN	B-NP
with	with	IN	0
L1	L1	CD	0
.	.	.	0
However	However	RB	0
,	,	,	0
we	we	PRP	0
do	do	VBP	0
note	note	NN	0
that	that	IN	0
the	the	DT	0
k	k	JJ	B-NP
cat	cat	JJ	I-NP
/	/	NNP	0
K	K	NNP	0
m	m	NN	0
values	values	NNS	0
of	of	IN	0
wild-type	wild-type	NNP	B-NP
L1	L1	NNP	I-NP
and	and	CC	0
F158A	F158A	CD	0
differ	differ	NN	0
by	by	IN	0
a	a	DT	0
factor	factor	NN	B-NP
less	less	RBR	0
than	than	IN	0
2	2	CD	0
.	.	.	0
The	The	DT	0
inability	inability	NN	0
to	to	TO	0
propose	propose	VB	0
a	a	DT	0
consistent	consistent	JJ	0
binding	binding	JJ	0
model	model	NN	0
also	also	RB	0
supports	supports	VBZ	0
the	the	DT	0
recent	recent	JJ	0
proposal	proposal	NN	0
that	that	IN	0
different	different	JJ	0
substrates	substrates	NN	0
of	of	IN	0
L1	L1	NNP	0
are	are	VBP	0
hydrolyzed	hydrolyzed	VBN	0
by	by	IN	0
different	different	JJ	0
mechanisms	mechanisms	NNS	0
and	and	CC	0
further	further	RB	0
suggests	suggests	VBZ	0
that	that	IN	0
using	using	VBG	0
steady-state	steady-state	JJ	0
kinetic	kinetic	JJ	0
constants	constants	NN	0
may	may	MD	0
not	not	RB	0
be	be	VB	0
a	a	DT	0
valid	valid	JJ	0
way	way	NN	0
to	to	TO	0
probe	probe	VB	0
substrate	substrate	JJ	0
binding	binding	NN	0
to	to	TO	0
L1	L1	CD	0
.	.	.	0
In	In	IN	0
addition	addition	NN	0
,	,	,	0
the	the	DT	0
minimal	minimal	JJ	0
kinetic	kinetic	JJ	0
mechanism	mechanism	NN	0
of	of	IN	0
nitrocefin	nitrocefin	JJ	0
hydrolysis	hydrolysis	NN	0
by	by	IN	0
L1	L1	NNP	0
has	has	VBZ	0
been	been	VBN	0
reported	reported	VBN	0
,	,	,	0
and	and	CC	0
this	this	DT	0
mechanism	mechanism	NN	0
predicts	predicts	VBZ	0
that	that	IN	0
K	K	NNP	0
m	m	NN	0
does	does	VBZ	0
not	not	RB	0
accurately	accurately	RB	0
reflect	reflect	VB	0
substrate	substrate	JJ	0
binding	binding	NN	0
.	.	.	0
By	By	IN	0
using	using	VBG	0
this	this	DT	0
mechanism	mechanism	NN	0
[	[	-LRB-	0
39	39	CD	0
]	]	-RRB-	0
,	,	,	0
K	K	NNP	0
m	m	NN	0
is	is	VBZ	0
equal	equal	JJ	0
to	to	TO	0
{	{	CD	0
(	(	-LRB-	0
k	k	FW	0
-1	-1	FW	0
+	+	FW	0
k	k	FW	0
2	2	LS	0
)	)	-RRB-	0
k	k	VBD	0
3	3	CD	0
k	k	CD	0
4	4	CD	0
}	}	-RRB-	0
/	/	NNP	0
{	{	-LRB-	0
k	k	CD	0
1	1	CD	0
(	(	-LRB-	0
k	k	CD	0
3	3	CD	0
k	k	CD	0
4	4	CD	0
+	+	CD	0
k	k	CD	0
2	2	CD	0
k	k	CD	0
4	4	CD	0
+	+	CD	0
k	k	CD	0
2	2	CD	0
k	k	CD	0
3	3	CD	0
}	}	-RRB-	0
.	.	.	0
To	To	TO	0
probe	probe	VB	0
more	more	RBR	0
directly	directly	RB	0
the	the	DT	0
reaction	reaction	NN	0
,	,	,	0
stopped-flow	stopped-flow	JJ	0
absorbance	absorbance	JJ	0
studies	studies	NNS	0
were	were	VBD	0
conducted	conducted	VBN	0
,	,	,	0
and	and	CC	0
the	the	DT	0
substrate	substrate	JJ	0
decay	decay	NN	0
rates	rates	NNS	0
(	(	-LRB-	0
390	390	CD	0
nm	nm	CD	0
)	)	-RRB-	0
were	were	VBD	0
studied	studied	VBN	0
as	as	IN	0
a	a	DT	0
function	function	NN	0
of	of	IN	0
nitrocefin	nitrocefin	JJ	0
concentration	concentration	NN	0
.	.	.	0
While	While	IN	0
nitrocefin	nitrocefin	NN	0
is	is	VBZ	0
a	a	DT	0
nontypical	nontypical	JJ	0
substrate	substrate	NN	0
,	,	,	0
as	as	IN	0
a	a	DT	0
result	result	NN	0
of	of	IN	0
the	the	DT	0
dinitro-substituted	dinitro-substituted	JJ	0
styryl	styryl	JJ	0
substituent	substituent	NNS	0
[	[	-LRB-	0
40	40	CD	0
]	]	-RRB-	0
,	,	,	0
it	it	PRP	0
is	is	VBZ	0
the	the	DT	0
substrate	substrate	NN	0
about	about	IN	0
which	which	WDT	0
the	the	DT	0
most	most	JJS	0
is	is	VBZ	0
known	known	VBN	0
about	about	IN	0
its	its	PRP$	0
hydrolysis	hydrolysis	JJ	0
mechanism	mechanism	NN	0
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
kinetic	kinetic	JJ	0
studies	studies	NNS	0
with	with	IN	0
nitrocefin	nitrocefin	NN	0
as	as	IN	0
substrate	substrate	VBG	0
allowed	allowed	VBN	0
for	for	IN	0
us	us	PRP	0
to	to	TO	0
evaluate	evaluate	VB	0
the	the	DT	0
effect	effect	NN	0
of	of	IN	0
point	point	NN	0
mutations	mutations	NNS	0
on	on	IN	0
the	the	DT	0
reaction	reaction	NN	0
mechanism	mechanism	NN	0
of	of	IN	0
L1	L1	CD	0
.	.	.	0
There	There	EX	0
was	was	VBD	0
no	no	DT	0
clear	clear	JJ	0
dependence	dependence	NN	0
on	on	IN	0
substrate	substrate	JJ	B-NP
decay	decay	NN	I-NP
rate	rate	NN	I-NP
with	with	IN	0
nitrocefin	nitrocefin	JJ	B-NP
concentration	concentration	NN	I-NP
(	(	-LRB-	0
data	data	NNS	0
not	not	RB	0
shown	shown	VBN	0
)	)	-RRB-	0
.	.	.	0
We	We	PRP	0
did	did	VBD	0
note	note	NN	0
though	though	IN	0
that	that	IN	0
the	the	DT	0
amount	amount	NN	0
of	of	IN	0
intermediate	intermediate	JJ	0
formed	formed	VBN	0
during	during	IN	0
the	the	DT	0
reactions	reactions	NNS	0
varied	varied	VBD	0
considerably	considerably	RB	0
depending	depending	VBG	0
upon	upon	IN	0
which	which	WDT	0
mutant	mutant	VBZ	0
of	of	IN	0
L1	L1	NNP	0
was	was	VBD	0
used	used	VBN	0
in	in	IN	0
the	the	DT	0
study	study	NN	0
.	.	.	0
All	All	DT	0
of	of	IN	0
the	the	DT	0
mutants	mutants	JJ	B-NP
exhibited	exhibited	JJ	I-NP
decrease	decrease	NN	I-NP
in	in	IN	0
intermediate	intermediate	JJ	0
formation	formation	NN	0
,	,	,	0
and	and	CC	0
the	the	DT	0
S224D	S224D	NNP	0
,	,	,	0
S224K	S224K	NNP	0
,	,	,	0
F158A	F158A	NNP	0
,	,	,	0
N233D	N233D	NNP	0
,	,	,	0
and	and	CC	0
N233L	N233L	CD	0
mutants	mutants	NNS	0
yielded	yielded	VBD	0
rapid-scanning	rapid-scanning	JJ	0
data	data	NNS	0
consistent	consistent	JJ	0
with	with	IN	0
no	no	DT	0
detectable	detectable	JJ	0
intermediate	intermediate	NN	0
.	.	.	0
These	These	DT	0
same	same	JJ	0
mutant	mutant	NN	B-NP
exhibited	exhibited	VBP	0
vastly	vastly	RB	0
differing	differing	VBG	B-NP
K	K	NNP	I-NP
m	m	NN	I-NP
values	values	NNS	0
.	.	.	0
Clearly	Clearly	RB	0
there	there	EX	0
is	is	VBZ	0
no	no	DT	0
correlation	correlation	NN	0
of	of	IN	0
K	K	NNP	0
m	m	NN	0
with	with	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
the	the	DT	0
reaction	reaction	NN	B-NP
intermediate	intermediate	NN	I-NP
.	.	.	0
Apparently	Apparently	RB	0
,	,	,	0
the	the	DT	0
ability	ability	NN	B-NP
to	to	TO	0
observe	observe	VB	0
the	the	DT	0
intermediate	intermediate	NN	0
is	is	VBZ	0
not	not	RB	0
governed	governed	VBN	0
entirely	entirely	RB	0
by	by	IN	0
the	the	DT	0
choice	choice	NN	0
of	of	IN	0
substrate	substrate	NNS	0
[	[	-LRB-	0
40	40	CD	0
]	]	-RRB-	0
,	,	,	0
and	and	CC	0
it	it	PRP	0
also	also	RB	0
depends	depends	VBZ	0
on	on	IN	0
precise	precise	JJ	0
arrangement	arrangement	NN	0
of	of	IN	0
active	active	JJ	0
site	site	NN	0
residues	residues	NNS	0
.	.	.	0
It	It	PRP	0
is	is	VBZ	0
also	also	RB	0
possible	possible	JJ	0
that	that	IN	0
the	the	DT	0
site-directed	site-directed	JJ	0
mutant	mutant	NN	B-NP
could	could	MD	0
be	be	VB	0
utilizing	utilizing	VBN	0
a	a	DT	0
different	different	JJ	0
mechanism	mechanism	NN	0
to	to	TO	0
hydrolyze	hydrolyze	VB	0
nitrocefin	nitrocefin	NN	B-NP
[	[	-LRB-	0
66	66	CD	0
]	]	-RRB-	0
.	.	.	0
Recently	Recently	RB	0
,	,	,	0
Spencer	Spencer	NNP	0
and	and	CC	0
co-worker	co-worker	NN	B-NP
reported	reported	VBD	0
that	that	DT	0
stopped-flow	stopped-flow	JJ	B-NP
fluorescence	fluorescence	JJ	I-NP
study	study	NN	I-NP
can	can	MD	0
be	be	VB	0
used	used	VBN	0
to	to	TO	0
monitor	monitor	VB	0
the	the	DT	0
reaction	reaction	NN	0
of	of	IN	0
L1	L1	CD	0
with	with	IN	0
nitrocefin	nitrocefin	NN	B-NP
and	and	CC	0
that	that	IN	0
an	an	DT	0
initial	initial	JJ	0
binding	binding	JJ	0
step	step	NN	0
can	can	MD	0
be	be	VB	0
directly	directly	RB	0
monitored	monitored	VBN	0
[	[	-LRB-	0
40	40	CD	0
]	]	-RRB-	0
.	.	.	0
By	By	IN	0
increasing	increasing	VBG	0
the	the	DT	0
nitrocefin	nitrocefin	NN	B-NP
concentration	concentration	NN	I-NP
,	,	,	0
the	the	DT	0
rate	rate	NN	0
of	of	IN	0
the	the	DT	0
initial	initial	JJ	0
binding	binding	JJ	0
step	step	NN	0
increased	increased	VBD	0
to	to	TO	0
a	a	DT	0
maximum	maximum	NN	B-NP
,	,	,	0
and	and	CC	0
fitting	fitting	JJ	0
of	of	IN	0
these	these	DT	0
data	data	NNS	0
yielded	yielded	VBD	0
a	a	DT	0
binding	binding	JJ	0
constant	constant	JJ	0
(	(	-LRB-	0
called	called	VBN	B-NP
K	K	NNP	I-NP
S	S	NNP	I-NP
herein	herein	CD	0
)	)	-RRB-	0
for	for	IN	0
nitrocefin	nitrocefin	NN	B-NP
.	.	.	0
Each	Each	DT	0
of	of	IN	0
the	the	DT	0
l1	l1	NN	B-NP
mutant	mutant	NN	I-NP
were	were	VBD	0
studied	studied	VBN	0
using	using	VBG	0
the	the	DT	0
stopped-flow	stopped-flow	JJ	B-NP
fluorescence	fluorescence	JJ	I-NP
study	study	NN	I-NP
,	,	,	0
and	and	CC	0
the	the	DT	0
resulting	resulting	VBG	B-NP
data	data	NN	I-NP
were	were	VBD	0
fitted	fitted	VBN	0
as	as	RB	0
reported	reported	VBN	0
by	by	IN	0
Spencer	Spencer	NNP	0
et	et	FW	0
al.	al.	FW	0
[	[	-LRB-	0
40	40	CD	0
]	]	-RRB-	0
(	(	-LRB-	0
Table	Table	NNP	0
6	6	CD	0
)	)	-RRB-	0
.	.	.	0
All	All	DT	0
of	of	IN	0
the	the	DT	0
mutants	mutants	JJ	B-NP
exhibited	exhibited	JJ	I-NP
K	K	NNP	I-NP
S	S	NNP	I-NP
values	values	VBZ	0
identical	identical	JJ	0
,	,	,	0
within	within	IN	0
error	error	NN	0
,	,	,	0
to	to	TO	0
wild-type	wild-type	NNP	B-NP
L1	L1	NNP	I-NP
,	,	,	0
except	except	IN	0
the	the	DT	0
S224D	S224D	NNP	0
and	and	CC	0
the	the	DT	0
Y228A	Y228A	JJ	0
mutants	mutants	NN	0
.	.	.	0
The	The	DT	0
placement	placement	NN	0
of	of	IN	0
a	a	DT	0
negative	negative	JJ	B-NP
charge	charge	NN	I-NP
at	at	IN	0
position	position	NN	0
224	224	CD	0
drastically	drastically	NN	0
affects	affects	VBZ	0
nitrocefin	nitrocefin	JJ	B-NP
binding	binding	NN	I-NP
and	and	CC	0
results	results	NNS	0
in	in	IN	0
a	a	DT	0
6-fold	6-fold	JJ	0
decrease	decrease	NN	0
in	in	IN	0
binding	binding	JJ	0
affinity	affinity	NN	B-NP
(	(	-LRB-	0
Table	Table	NNP	0
6	6	CD	0
)	)	-RRB-	0
.	.	.	0
To	To	TO	0
a	a	DT	0
lesser	lesser	JJR	0
degree	degree	NN	0
,	,	,	0
the	the	DT	0
tyr228	tyr228	NN	B-NP
aromatic	aromatic	JJ	I-NP
portion	portion	NN	I-NP
must	must	MD	0
have	have	VB	0
an	an	DT	0
effect	effect	NN	0
on	on	IN	0
the	the	DT	0
binding	binding	JJ	0
site	site	NN	0
as	as	IN	0
the	the	DT	0
nitrocefin	nitrocefin	JJ	B-NP
binding	binding	NN	I-NP
k	k	NN	I-NP
		NN	I-NP
value	value	NN	I-NP
to	to	TO	0
this	this	DT	0
mutant	mutant	NN	B-NP
is	is	VBZ	0
decreased	decreased	VBN	0
by	by	IN	0
a	a	DT	0
factor	factor	NN	B-NP
of	of	IN	0
2	2	CD	0
;	;	:	0
however	however	RB	0
,	,	,	0
the	the	DT	0
hydroxyl	hydroxyl	JJ	B-NP
group	group	NN	I-NP
probably	probably	RB	0
does	does	VBZ	0
not	not	RB	0
form	form	VB	0
a	a	DT	0
hydrogen	hydrogen	NN	B-NP
bond	bond	NN	I-NP
to	to	TO	0
the	the	DT	0
substrate	substrate	NN	0
as	as	IN	0
proposed	proposed	VBN	0
.	.	.	0
By	By	IN	0
using	using	VBG	0
nitrocefin	nitrocefin	NN	B-NP
as	as	IN	0
substrate	substrate	NN	0
and	and	CC	0
K	K	NNP	0
m	m	NN	0
values	values	VBZ	0
alone	alone	RB	0
,	,	,	0
a	a	DT	0
completely	completely	RB	0
different	different	JJ	0
conclusion	conclusion	NN	0
is	is	VBZ	0
reached	reached	VBN	0
regarding	regarding	VBG	0
important	important	JJ	0
substrate	substrate	JJ	0
binding	binding	JJ	0
residues	residues	NNS	0
.	.	.	0
The	The	DT	0
results	results	NNS	0
presented	presented	VBD	0
here	here	RB	0
suggests	suggests	VBZ	0
that	that	DT	0
none	none	NN	0
of	of	IN	0
the	the	DT	0
residues	residues	NN	0
in	in	IN	0
this	this	DT	0
study	study	NN	0
are	are	VBP	0
essential	essential	JJ	0
for	for	IN	0
tight	tight	JJ	0
nitrocefin	nitrocefin	JJ	B-NP
binding	binding	NN	I-NP
,	,	,	0
possibly	possibly	RB	0
because	because	IN	0
other	other	JJ	0
parts	parts	NNS	0
of	of	IN	0
the	the	DT	0
active	active	JJ	0
site	site	NN	0
accommodate	accommodate	VB	0
the	the	DT	0
loss	loss	NN	0
of	of	IN	0
certain	certain	JJ	0
binding	binding	JJ	0
contacts	contacts	NNS	0
.	.	.	0
Spencer	Spencer	NNP	0
et	et	NNP	0
al.	al.	NNP	0
also	also	RB	0
reported	reported	VBD	B-NP
stopped-flow	stopped-flow	JJ	I-NP
fluorescence	fluorescence	JJ	I-NP
study	study	NN	I-NP
when	when	WRB	0
using	using	VBG	0
cefaclor	cefaclor	NN	B-NP
and	and	CC	0
meropenem	meropenem	NN	B-NP
as	as	IN	0
substrates	substrates	NN	0
,	,	,	0
and	and	CC	0
k	k	NN	B-NP
		NN	I-NP
value	value	NN	I-NP
for	for	IN	0
these	these	DT	0
substrates	substrates	NN	0
were	were	VBD	0
reported	reported	VBN	0
to	to	TO	0
be	be	VB	0
710	710	CD	0
±	±	CD	0
180	180	CD	0
and	and	CC	0
272	272	CD	0
±	±	CD	0
112	112	CD	0
μM	μM	NN	B-NP
,	,	,	0
respectively	respectively	RB	0
[	[	-LRB-	0
40	40	CD	0
]	]	-RRB-	0
.	.	.	0
However	However	RB	0
in	in	IN	0
our	our	PRP$	0
hands	hands	NNS	0
,	,	,	0
the	the	DT	0
rates	rates	NNS	0
of	of	IN	0
substrate	substrate	JJ	B-NP
hydrolysi	hydrolysi	NN	I-NP
were	were	VBD	0
so	so	RB	0
fast	fast	RB	0
when	when	WRB	0
using	using	VBG	0
wild-type	wild-type	JJ	B-NP
L1	L1	NN	I-NP
that	that	IN	0
we	we	PRP	0
could	could	MD	0
not	not	RB	0
use	use	VB	0
substrate	substrate	JJ	B-NP
concentration	concentration	NN	I-NP
high	high	JJ	0
enough	enough	JJ	0
to	to	TO	0
saturate	saturate	VB	0
the	the	DT	0
enzyme	enzyme	NN	B-NP
.	.	.	0
Similarly	Similarly	RB	0
,	,	,	0
we	we	PRP	0
could	could	MD	0
not	not	RB	0
determine	determine	VB	0
penicillin	penicillin	JJ	B-NP
g	g	NN	I-NP
k	k	NN	I-NP
		NN	I-NP
value	value	NN	I-NP
or	or	CC	0
ampicillin	ampicillin	NN	B-NP
because	because	IN	0
the	the	DT	0
observed	observed	JJ	0
rates	rates	NNS	0
of	of	IN	0
hydrolysi	hydrolysi	NN	B-NP
at	at	IN	0
low	low	JJ	0
substrate	substrate	JJ	B-NP
concentration	concentration	NN	I-NP
were	were	VBD	0
too	too	RB	0
fast	fast	RB	0
to	to	TO	0
observe	observe	VB	0
data	data	NNS	0
,	,	,	0
even	even	RB	0
at	at	IN	0
10°C	10°C	CD	0
.	.	.	0
Conclusions	Conclusions	NNS	0
The	The	DT	0
results	results	NNS	0
presented	presented	VBD	0
herein	herein	RB	0
indicate	indicate	VB	0
that	that	DT	0
none	none	NN	0
of	of	IN	0
the	the	DT	0
active	active	JJ	0
site	site	NN	0
residues	residues	VBZ	0
identified	identified	VBN	0
with	with	IN	0
computational	computational	JJ	B-NP
study	study	NN	I-NP
are	are	VBP	0
essential	essential	JJ	0
for	for	IN	0
tight	tight	JJ	0
substrate	substrate	JJ	0
binding	binding	NN	0
.	.	.	0
These	These	DT	0
data	data	NNS	0
also	also	RB	0
indicate	indicate	VB	0
that	that	IN	0
the	the	DT	0
use	use	NN	0
of	of	IN	0
K	K	NNP	0
m	m	NN	0
values	values	NNS	0
to	to	TO	0
describe	describe	VB	0
substrate	substrate	JJ	0
binding	binding	NN	0
to	to	TO	0
L1	L1	NNP	0
is	is	VBZ	0
unreliable	unreliable	JJ	0
and	and	CC	0
that	that	IN	0
there	there	EX	0
is	is	VBZ	0
no	no	DT	0
correlation	correlation	NN	0
between	between	IN	0
intermediate	intermediate	JJ	0
accumulation	accumulation	NN	B-NP
and	and	CC	0
substrate	substrate	JJ	0
binding	binding	JJ	0
affinity	affinity	NN	B-NP
.	.	.	0
These	These	DT	0
results	results	NNS	0
demonstrate	demonstrate	VBP	0
that	that	IN	0
new	new	JJ	0
computational	computational	JJ	B-NP
study	study	NN	I-NP
are	are	VBP	0
now	now	RB	0
needed	needed	VBN	0
to	to	TO	0
probe	probe	VB	0
substrate	substrate	JJ	0
binding	binding	NN	0
to	to	TO	0
L1	L1	CD	0
,	,	,	0
and	and	CC	0
these	these	DT	0
studies	studies	NNS	0
are	are	VBP	0
currently	currently	RB	0
underway	underway	VBN	0
.	.	.	0
The	The	DT	0
results	results	NNS	0
presented	presented	VBN	0
herein	herein	NNS	0
can	can	MD	0
be	be	VB	0
used	used	VBN	0
to	to	TO	0
guide	guide	VB	0
these	these	DT	0
new	new	JJ	0
computational	computational	JJ	B-NP
study	study	NN	I-NP
,	,	,	0
which	which	WDT	0
will	will	MD	0
lead	lead	VB	0
to	to	TO	0
the	the	DT	0
design	design	NN	0
of	of	IN	0
potential	potential	JJ	B-NP
inhibitor	inhibitor	NN	I-NP
and	and	CC	0
hopefully	hopefully	RB	0
a	a	DT	0
way	way	NN	0
to	to	TO	0
combat	combat	VB	0
penicillin	penicillin	JJ	B-NP
resistance	resistance	NN	I-NP
in	in	IN	0
bacteria	bacteria	NNS	0
.	.	.	0
Materials	Materials	NNS	0
and	and	CC	0
Methods	Methods	NNP	0
Materials	Materials	NNPS	0
dh5α	dh5α	NN	B-NP
e.	e.	NN	I-NP
coli	coli	NN	I-NP
strain	strain	NN	I-NP
and	and	CC	0
bl21(de3)	bl21(de3)	NN	B-NP
plys	plys	NNP	I-NP
were	were	VBD	0
obtained	obtained	VBN	0
from	from	IN	0
Gibco	Gibco	NNP	B-NP
BRL	BRL	NNP	I-NP
and	and	CC	0
Novagen	Novagen	NNP	B-NP
,	,	,	0
respectively	respectively	RB	0
.	.	.	0
plasmid	plasmid	NN	B-NP
pET26b	pET26b	NNP	0
and	and	CC	0
pUC19	pUC19	NNP	B-NP
were	were	VBD	0
purchased	purchased	VBN	0
from	from	IN	0
Novagen	Novagen	NNP	B-NP
.	.	.	0
Primers	Primers	NNP	0
for	for	IN	0
sequencing	sequencing	NN	B-NP
and	and	CC	0
mutagenesis	mutagenesis	JJ	B-NP
study	study	NN	I-NP
were	were	VBD	0
purchased	purchased	VBN	0
from	from	IN	0
Integrated	Integrated	NNP	0
DNA	DNA	NNP	0
Technologies	Technologies	NNPS	0
.	.	.	0
deoxynucleotide	deoxynucleotide	NN	B-NP
triphosphate	triphosphate	NN	I-NP
(	(	-LRB-	0
dNTP	dNTP	NNP	0
's	's	POS	0
)	)	-RRB-	0
,	,	,	0
MgSO	MgSO	JJ	B-NP
4	4	CD	0
,	,	,	0
thermopol	thermopol	JJ	B-NP
buffer	buffer	NN	I-NP
,	,	,	0
Deep	Deep	NNP	0
Vent	Vent	NNP	B-NP
DNA	DNA	NNP	I-NP
polymerase	polymerase	NN	I-NP
,	,	,	0
and	and	CC	0
restriction	restriction	NN	B-NP
enzymes	enzymes	NN	0
were	were	VBD	0
purchased	purchased	VBN	0
from	from	IN	0
Promega	Promega	NNP	B-NP
or	or	CC	0
new	new	JJ	B-NP
england	england	NNP	I-NP
biolab	biolab	NN	I-NP
.	.	.	0
Polymerase	Polymerase	JJ	B-NP
chain	chain	NN	I-NP
reaction	reaction	NN	I-NP
was	was	VBD	0
conducted	conducted	VBN	0
using	using	VBG	0
a	a	DT	0
Thermolyne	Thermolyne	NNP	B-NP
Amplitron	Amplitron	NNP	I-NP
II	II	NNP	I-NP
unit	unit	NN	0
.	.	.	0
DNA	DNA	NNP	B-NP
was	was	VBD	0
purified	purified	VBN	0
using	using	VBG	0
the	the	DT	0
Qiagen	Qiagen	JJ	B-NP
QIAQuick	QIAQuick	JJ	I-NP
gel	gel	JJ	I-NP
extraction	extraction	JJ	I-NP
kit	kit	NN	I-NP
or	or	CC	0
Plasmid	Plasmid	NNP	B-NP
Purification	Purification	NNP	I-NP
kit	kit	NN	I-NP
with	with	IN	0
QIAGEN-tip	QIAGEN-tip	JJ	B-NP
100	100	CD	0
(	(	-LRB-	0
Midi	Midi	NNP	B-NP
)	)	-RRB-	0
columns	columns	NNS	0
.	.	.	0
Wizard	Wizard	NNP	0
Plus	Plus	NNP	0
miniprep	miniprep	NN	B-NP
were	were	VBD	0
acquired	acquired	VBN	0
from	from	IN	0
Promega	Promega	NNP	B-NP
.	.	.	0
Luria-Bertani	Luria-Bertani	NNP	B-NP
(	(	-LRB-	0
luria-bertani	luria-bertani	NN	B-NP
)	)	-RRB-	0
media	media	NNS	0
was	was	VBD	0
made	made	VBN	0
following	following	VBG	0
published	published	VBN	B-NP
procedure	procedure	NN	I-NP
[	[	-LRB-	0
67	67	CD	0
]	]	-RRB-	0
.	.	.	0
Isopropyl-β-thiogalactoside	Isopropyl-β-thiogalactoside	NNP	B-NP
(	(	-LRB-	0
IPTG	IPTG	NNP	0
)	)	-RRB-	0
,	,	,	0
Biotech	Biotech	NNP	B-NP
grade	grade	NN	I-NP
,	,	,	0
was	was	VBD	0
procured	procured	VBN	0
from	from	IN	0
Anatrace	Anatrace	NNP	B-NP
.	.	.	0
Phenylmethylsulfonylfluoride	Phenylmethylsulfonylfluoride	NNP	B-NP
(	(	-LRB-	0
phenylmethylsulfonylfluoride	phenylmethylsulfonylfluoride	NN	B-NP
)	)	-RRB-	0
was	was	VBD	0
purchased	purchased	VBN	0
from	from	IN	0
Sigma	Sigma	NNP	B-NP
.	.	.	0
protein	protein	NN	B-NP
solution	solution	NN	I-NP
were	were	VBD	0
concentrated	concentrated	VBN	0
with	with	IN	0
an	an	DT	0
Amicon	Amicon	JJ	B-NP
ultrafiltration	ultrafiltration	JJ	I-NP
cell	cell	NN	I-NP
equipped	equipped	VBN	0
with	with	IN	0
ym-10	ym-10	NN	B-NP
diaflo	diaflo	NN	I-NP
membrane	membrane	NN	I-NP
from	from	IN	0
Amicon	Amicon	NNP	B-NP
,	,	,	0
Inc	Inc	NNP	0
.	.	.	0
Dialysis	Dialysis	JJ	B-NP
tubing	tubing	NN	I-NP
was	was	VBD	0
prepared	prepared	VBN	0
using	using	VBG	0
regenerated	regenerated	VBN	B-NP
cellulose	cellulose	NN	I-NP
spectra/por	spectra/por	NN	I-NP
molecular	molecular	JJ	B-NP
porous	porous	JJ	I-NP
membrane	membrane	NN	I-NP
with	with	IN	0
a	a	DT	0
molecular	molecular	JJ	B-NP
weight	weight	NN	I-NP
cut-off	cut-off	NN	0
of	of	IN	0
6-8,000	6-8,000	FW	0
g	g	NN	B-NP
/	/	NN	I-NP
mol	mol	NN	I-NP
.	.	.	0
Q-Sepharose	Q-Sepharose	NNP	B-NP
Fast	Fast	NNP	0
Flow	Flow	NNP	0
was	was	VBD	0
purchased	purchased	VBN	0
from	from	IN	0
Amersham	Amersham	NNP	B-NP
Pharmacia	Pharmacia	NNP	I-NP
Biotech	Biotech	NNP	I-NP
.	.	.	0
Nitrocefin	Nitrocefin	NNP	B-NP
was	was	VBD	0
purchased	purchased	VBN	0
from	from	IN	0
Becton	Becton	NNP	0
Dickinson	Dickinson	NNP	0
,	,	,	0
and	and	CC	0
solutions	solutions	NNS	0
of	of	IN	0
nitrocefin	nitrocefin	NN	B-NP
were	were	VBD	0
filtered	filtered	VBN	0
through	through	IN	0
a	a	DT	0
Fisherbrand	Fisherbrand	NNP	B-NP
0.45	0.45	FW	0
micron	micron	FW	0
syringe	syringe	FW	0
filter	filter	FW	0
.	.	.	0
Cefaclor	Cefaclor	NNP	B-NP
,	,	,	0
cefoxitin	cefoxitin	NN	B-NP
,	,	,	0
and	and	CC	0
cephalothin	cephalothin	NN	B-NP
were	were	VBD	0
purchased	purchased	VBN	0
from	from	IN	0
Sigma	Sigma	NNP	B-NP
;	;	:	0
penicillin	penicillin	JJ	B-NP
G	G	NNP	I-NP
and	and	CC	0
ampicillin	ampicillin	NN	B-NP
were	were	VBD	0
purchased	purchased	VBN	0
from	from	IN	0
Fisher	Fisher	NNP	0
.	.	.	0
Imipenem	Imipenem	NNP	B-NP
,	,	,	0
meropenem	meropenem	NN	B-NP
,	,	,	0
and	and	CC	0
biapenem	biapenem	NN	B-NP
were	were	VBD	0
generously	generously	RB	0
supplied	supplied	VBN	0
by	by	IN	0
Merck	Merck	NNP	0
,	,	,	0
Zeneca	Zeneca	NNP	0
Pharmaceuticals	Pharmaceuticals	NNP	0
,	,	,	0
and	and	CC	0
Lederle	Lederle	NNP	B-NP
(	(	-LRB-	0
Japan	Japan	NNP	0
)	)	-RRB-	0
,	,	,	0
respectively	respectively	RB	0
.	.	.	0
All	All	DT	0
buffers	buffers	NN	0
and	and	CC	0
media	media	NNS	0
were	were	VBD	0
prepared	prepared	VBN	0
using	using	VBG	0
Barnstead	Barnstead	JJ	B-NP
NANOpure	NANOpure	JJ	I-NP
ultrapure	ultrapure	JJ	I-NP
water	water	NN	I-NP
.	.	.	0
Generation	Generation	NN	0
of	of	IN	0
site-directed	site-directed	JJ	0
mutants	mutants	NN	0
of	of	IN	0
L1	L1	CD	0
The	The	DT	0
over-expression	over-expression	JJ	0
plasmid	plasmid	NN	0
for	for	IN	0
L1	L1	NNP	0
,	,	,	0
pUB5832	pUB5832	NNP	0
,	,	,	0
was	was	VBD	0
digested	digested	VBN	0
with	with	IN	0
Nde	Nde	NNP	0
I	I	NNP	0
and	and	CC	0
Hind	Hind	NNP	0
III	III	NNP	0
,	,	,	0
and	and	CC	0
the	the	DT	0
resulting	resulting	VBG	0
ca.	ca.	CD	0
900	900	CD	0
bp	bp	JJ	0
piece	piece	NN	0
was	was	VBD	0
gel	gel	JJ	0
purified	purified	NN	0
and	and	CC	0
ligated	ligated	VBP	0
using	using	VBG	0
T4	T4	CD	0
ligase	ligase	NN	0
into	into	IN	0
pUC19	pUC19	NNP	0
,	,	,	0
which	which	WDT	0
was	was	VBD	0
also	also	RB	0
digested	digested	VBN	0
with	with	IN	0
Nde	Nde	NNP	0
I	I	NNP	0
and	and	CC	0
Hind	Hind	NNP	0
III	III	NNP	0
,	,	,	0
to	to	TO	0
yield	yield	VB	0
the	the	DT	0
cloning	cloning	JJ	0
plasmid	plasmid	JJ	0
pL1PUC19	pL1PUC19	NN	0
.	.	.	0
Mutations	Mutations	NNP	0
were	were	VBD	0
introduced	introduced	VBN	0
into	into	IN	0
the	the	DT	0
L1	L1	JJ	0
gene	gene	NN	0
by	by	IN	0
using	using	VBG	0
the	the	DT	0
overlap	overlap	JJ	0
extension	extension	NN	0
method	method	NN	0
of	of	IN	0
Ho	Ho	NNP	0
et	et	FW	0
al.	al.	FW	0
[	[	-LRB-	0
60	60	CD	0
]	]	-RRB-	0
,	,	,	0
as	as	RB	0
described	described	VBN	0
previously	previously	RB	0
[	[	-LRB-	0
68	68	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
oligonucleotides	oligonucleotides	NN	0
used	used	VBN	0
for	for	IN	0
the	the	DT	0
preparation	preparation	NN	0
of	of	IN	0
the	the	DT	0
mutants	mutants	NNS	0
are	are	VBP	0
shown	shown	VBN	0
in	in	IN	0
Table	Table	NNP	0
1	1	CD	0
.	.	.	0
The	The	DT	0
ca.	ca.	CD	0
900	900	CD	0
bp	bp	JJ	0
PCR	PCR	NN	0
products	products	NNS	0
were	were	VBD	0
digested	digested	VBN	0
with	with	IN	0
Nde	Nde	NNP	0
I	I	NNP	0
and	and	CC	0
Hind	Hind	NNP	0
III	III	NNP	0
and	and	CC	0
ligated	ligated	NN	0
into	into	IN	0
pUC19	pUC19	CD	0
.	.	.	0
The	The	DT	0
dna	dna	NN	B-NP
sequence	sequence	NN	I-NP
were	were	VBD	0
analyzed	analyzed	VBN	0
by	by	IN	0
the	the	DT	0
biosynthesi	biosynthesi	NN	B-NP
and	and	CC	0
Sequencing	Sequencing	NNP	B-NP
Facility	Facility	NNP	I-NP
in	in	IN	0
the	the	DT	0
Department	Department	NNP	0
of	of	IN	0
Biological	Biological	NNP	B-NP
Chemistry	Chemistry	NNP	I-NP
at	at	IN	0
Johns	Johns	NNP	0
Hopkins	Hopkins	NNP	0
University	University	NNP	0
.	.	.	0
After	After	IN	0
confirmation	confirmation	NN	B-NP
of	of	IN	0
the	the	DT	0
sequence	sequence	NN	0
,	,	,	0
the	the	DT	0
mutated	mutated	JJ	0
pL1PUC19	pL1PUC19	CD	0
plasmid	plasmid	NNS	0
was	was	VBD	0
digested	digested	VBN	0
with	with	IN	0
Nde	Nde	NNP	B-NP
I	I	NNP	I-NP
and	and	CC	0
Hind	Hind	NNP	0
III	III	NNP	0
,	,	,	0
and	and	CC	0
the	the	DT	0
900	900	CD	0
bp	bp	NN	B-NP
,	,	,	0
mutated	mutated	CD	0
L1	L1	CD	B-NP
gene	gene	NN	I-NP
was	was	VBD	0
gel	gel	JJ	0
purified	purified	NN	0
and	and	CC	0
ligated	ligated	NN	0
into	into	IN	0
pET26b	pET26b	CD	0
to	to	TO	0
create	create	VB	0
the	the	DT	0
mutant	mutant	JJ	B-NP
overexpression	overexpression	JJ	I-NP
plasmid	plasmid	NN	I-NP
.	.	.	0
To	To	TO	0
test	test	VB	0
for	for	IN	0
mutant	mutant	JJ	B-NP
enzyme	enzyme	NN	I-NP
overexpression	overexpression	NN	I-NP
,	,	,	0
e.	e.	NN	B-NP
coli	coli	NN	I-NP
bl21(de3)plys	bl21(de3)plys	NN	I-NP
cell	cell	NN	I-NP
were	were	VBD	0
transformed	transformed	VBN	0
with	with	IN	0
the	the	DT	0
mutated	mutated	JJ	B-NP
over-expression	over-expression	JJ	I-NP
plasmid	plasmid	NN	I-NP
,	,	,	0
and	and	CC	0
small	small	JJ	0
scale	scale	NN	B-NP
growth	growth	NN	I-NP
culture	culture	NN	I-NP
were	were	VBD	0
used	used	VBN	0
[	[	-LRB-	0
68	68	CD	0
]	]	-RRB-	0
.	.	.	0
Large-scale	Large-scale	JJ	0
(	(	-LRB-	0
4	4	CD	0
L	L	NNP	0
)	)	-RRB-	0
l1	l1	NN	B-NP
mutant	mutant	NN	I-NP
preparation	preparation	NN	I-NP
were	were	VBD	0
performed	performed	VBN	0
as	as	RB	0
described	described	VBN	0
previously	previously	RB	0
[	[	-LRB-	0
36	36	CD	0
]	]	-RRB-	0
.	.	.	0
Protein	Protein	NN	B-NP
purity	purity	NN	I-NP
was	was	VBD	0
ascertained	ascertained	VBN	0
by	by	IN	0
SDS-PAGE	SDS-PAGE	JJ	B-NP
.	.	.	0
Metal	Metal	NNP	0
content	content	VBD	0
The	The	DT	0
concentration	concentration	NN	B-NP
of	of	IN	0
L1	L1	NNP	0
and	and	CC	0
the	the	DT	0
mutant	mutant	NN	B-NP
were	were	VBD	0
determined	determined	VBN	0
by	by	IN	0
measuring	measuring	VBG	0
the	the	DT	0
proteins	proteins	NNS	0
'	'	POS	0
absorbance	absorbance	NN	B-NP
at	at	IN	0
280	280	CD	0
nm	nm	NN	B-NP
and	and	CC	0
using	using	VBG	0
the	the	DT	0
published	published	JJ	0
extinction	extinction	NN	0
coefficient	coefficient	NN	0
of	of	IN	0
ε	ε	CD	0
280	280	CD	0
nm	nm	CD	B-NP
=	=	SYM	0
54,804	54,804	NNP	0
M	M	NNP	0
-1•cm	-1•cm	NNP	0
-1	-1	NNP	0
[	[	-LRB-	0
36	36	CD	0
]	]	-RRB-	0
or	or	CC	0
by	by	IN	0
using	using	VBG	0
the	the	DT	0
method	method	NN	0
of	of	IN	0
Pace	Pace	NNP	0
[	[	-LRB-	0
69	69	CD	0
]	]	-RRB-	0
.	.	.	0
Before	Before	IN	0
metal	metal	NN	0
analyses	analyses	NNS	0
,	,	,	0
the	the	DT	0
protein	protein	NN	0
samples	samples	NNS	0
were	were	VBD	0
dialyzed	dialyzed	VBN	0
versus	versus	IN	0
3	3	CD	0
×	×	CD	0
1	1	CD	0
L	L	NNP	0
of	of	IN	0
metal-free	metal-free	NNP	B-NP
,	,	,	0
50	50	CD	0
mm	mm	NN	B-NP
hepe	hepe	NN	I-NP
,	,	,	0
pH	pH	JJ	0
7.5	7.5	CD	0
over	over	IN	0
96	96	CD	0
hours	hours	NNS	0
at	at	IN	0
4°C	4°C	CD	0
.	.	.	0
A	A	DT	0
Varian	Varian	NNP	0
Inductively	Inductively	NNP	B-NP
Coupled	Coupled	NNP	I-NP
Plasma	Plasma	NNP	I-NP
Spectrometer	Spectrometer	NNP	I-NP
with	with	IN	I-NP
atomic	atomic	JJ	I-NP
emission	emission	NN	I-NP
spectroscopy	spectroscopy	NN	I-NP
detection	detection	FW	0
(	(	-LRB-	0
inductively	inductively	NN	B-NP
coupled	coupled	VBN	I-NP
plasma	plasma	NN	I-NP
spectrometer	spectrometer	NN	I-NP
with	with	IN	I-NP
atomic	atomic	JJ	I-NP
emission	emission	NN	I-NP
spectroscopy	spectroscopy	NN	I-NP
)	)	-RRB-	0
was	was	VBD	0
used	used	VBN	0
to	to	TO	0
determine	determine	VB	0
metal	metal	NN	0
content	content	NN	0
of	of	IN	0
multiple	multiple	JJ	0
preparation	preparation	NN	B-NP
of	of	IN	0
wild	wild	JJ	0
type	type	NN	B-NP
L1	L1	NN	I-NP
and	and	CC	0
l1	l1	NN	B-NP
mutant	mutant	NN	I-NP
.	.	.	0
calibration	calibration	NN	B-NP
curve	curve	NN	I-NP
were	were	VBD	0
based	based	VBN	0
on	on	IN	0
three	three	CD	0
standards	standards	NNS	0
and	and	CC	0
had	had	VBD	0
correlation	correlation	JJ	B-NP
coefficient	coefficient	JJ	I-NP
limit	limit	NN	I-NP
of	of	IN	0
at	at	IN	0
least	least	JJS	0
0.9950	0.9950	CD	0
.	.	.	0
The	The	DT	0
final	final	JJ	B-NP
dialysis	dialysis	NN	I-NP
buffer	buffer	NN	I-NP
was	was	VBD	0
used	used	VBN	0
as	as	IN	0
a	a	DT	0
blank	blank	JJ	0
,	,	,	0
and	and	CC	0
the	the	DT	0
Zn	Zn	NNP	B-NP
(	(	-LRB-	I-NP
II	II	NNP	I-NP
)	)	-RRB-	I-NP
content	content	NN	I-NP
in	in	IN	0
the	the	DT	0
final	final	JJ	B-NP
dialysis	dialysis	NN	I-NP
buffer	buffer	NN	I-NP
was	was	VBD	0
shown	shown	VBN	0
to	to	TO	0
be	be	VB	0
<	<	SYM	0
0.5	0.5	CD	0
μM	μM	NN	B-NP
(	(	-LRB-	0
icp	icp	NN	B-NP
detection	detection	JJ	I-NP
limit	limit	NN	I-NP
)	)	-RRB-	0
in	in	IN	0
separate	separate	JJ	0
ICP	ICP	NN	B-NP
measurements	measurements	NNS	0
.	.	.	0
The	The	DT	0
emission	emission	JJ	B-NP
line	line	NN	I-NP
of	of	IN	0
213.856	213.856	CD	0
nm	nm	NN	B-NP
is	is	VBZ	0
the	the	DT	0
most	most	RBS	0
intense	intense	JJ	0
for	for	IN	0
zinc	zinc	NN	B-NP
and	and	CC	0
was	was	VBD	0
used	used	VBN	0
to	to	TO	0
determine	determine	VB	0
the	the	DT	0
Zn	Zn	JJ	B-NP
content	content	NN	I-NP
in	in	IN	0
the	the	DT	0
samples	samples	NNS	0
.	.	.	0
The	The	DT	0
errors	errors	NNS	0
in	in	IN	0
metal	metal	NN	0
content	content	NN	0
data	data	NNS	0
reflect	reflect	VBP	0
the	the	DT	0
standard	standard	JJ	0
deviation	deviation	NN	0
(	(	-LRB-	0
σ	σ	FW	0
n-1	n-1	FW	0
)	)	-RRB-	0
of	of	IN	0
multiple	multiple	JJ	0
enzyme	enzyme	JJ	B-NP
preparation	preparation	NN	I-NP
.	.	.	0
Steady-state	Steady-state	JJ	0
kinetic	kinetic	JJ	0
studies	studies	NNS	0
Steady-state	Steady-state	JJ	0
kinetic	kinetic	JJ	0
assays	assays	NN	0
were	were	VBD	0
conducted	conducted	VBN	0
at	at	IN	0
25°C	25°C	CD	0
in	in	IN	0
50	50	CD	0
mM	mM	JJ	0
cacodylate	cacodylate	JJ	0
buffer	buffer	NN	0
,	,	,	0
pH	pH	JJ	0
7.0	7.0	CD	0
,	,	,	0
containing	containing	VBG	0
100	100	CD	0
μM	μM	JJ	0
ZnCl	ZnCl	JJ	0
2	2	CD	0
on	on	IN	0
a	a	DT	0
HP	HP	NNP	0
5480A	5480A	NNP	0
diode	diode	JJ	0
array	array	NN	0
UV-Vis	UV-Vis	JJ	0
spectrophotometer	spectrophotometer	NN	0
at	at	IN	0
25°C	25°C	CD	0
.	.	.	0
The	The	DT	0
changes	changes	NNS	0
in	in	IN	0
molar	molar	JJ	0
absorptivities	absorptivities	NNS	0
(	(	-LRB-	0
Δε	Δε	NNP	0
)	)	-RRB-	0
used	used	VBN	0
to	to	TO	0
quantitate	quantitate	VB	0
products	products	NNS	0
were	were	VBD	0
(	(	-LRB-	0
in	in	IN	0
M	M	NNP	0
-1cm	-1cm	NNP	0
-1	-1	NNP	0
)	)	-RRB-	0
:	:	:	0
nitrocefin	nitrocefin	CD	0
,	,	,	0
Δε	Δε	NNP	0
485	485	CD	0
=	=	SYM	0
17,420	17,420	CD	0
;	;	:	0
cephalothin	cephalothin	CD	0
,	,	,	0
Δε	Δε	NNP	0
265	265	CD	0
=	=	SYM	0
-8,790	-8,790	CD	0
;	;	:	0
cefoxitin	cefoxitin	CD	0
,	,	,	0
Δε	Δε	NNP	0
265	265	CD	0
=	=	SYM	0
-7,000	-7,000	CD	0
;	;	:	0
cefaclor	cefaclor	CD	0
,	,	,	0
Δε	Δε	NNP	0
280	280	CD	0
=	=	SYM	0
-6,410	-6,410	CD	0
;	;	:	0
imipenem	imipenem	CD	0
,	,	,	0
Δε	Δε	NNP	0
300	300	CD	0
=	=	SYM	0
-9,000	-9,000	CD	0
;	;	:	0
meropenem	meropenem	CD	0
,	,	,	0
Δε	Δε	NNP	0
293	293	CD	0
=	=	SYM	0
-7,600	-7,600	CD	0
;	;	:	0
biapenem	biapenem	CD	0
,	,	,	0
Δε	Δε	NNP	0
293	293	CD	0
=	=	SYM	0
-8,630	-8,630	CD	0
;	;	:	0
ampicillin	ampicillin	CD	0
,	,	,	0
Δε	Δε	NNP	0
235	235	CD	0
=	=	SYM	0
-809	-809	CD	0
;	;	:	0
and	and	CC	0
penicillin	penicillin	JJ	0
G	G	NNP	0
,	,	,	0
Δε	Δε	NNP	0
235	235	CD	0
=	=	SYM	0
-936	-936	CD	0
.	.	.	0
When	When	WRB	0
possible	possible	JJ	0
,	,	,	0
substrate	substrate	JJ	0
concentrations	concentrations	NNS	0
were	were	VBD	0
varied	varied	VBN	0
between	between	IN	0
0.1	0.1	CD	0
to	to	TO	0
10	10	CD	0
times	times	NNS	0
the	the	DT	0
K	K	NNP	0
m	m	JJ	0
value	value	NN	0
.	.	.	0
In	In	IN	0
kinetic	kinetic	JJ	0
studies	studies	NNS	0
using	using	VBG	0
substrates	substrates	NN	0
with	with	IN	0
low	low	JJ	0
K	K	NNP	0
m	m	NN	0
values	values	NNS	0
(	(	-LRB-	0
cefoxitin	cefoxitin	UH	0
,	,	,	0
nitrocefin	nitrocefin	NN	0
,	,	,	0
and	and	CC	0
cephalothin	cephalothin	CD	0
)	)	-RRB-	0
or	or	CC	0
with	with	IN	0
small	small	JJ	0
Δε	Δε	JJ	0
values	values	NNS	0
(	(	-LRB-	0
penicillin	penicillin	NN	0
and	and	CC	0
ampicillin	ampicillin	CD	0
)	)	-RRB-	0
,	,	,	0
we	we	PRP	0
typically	typically	RB	0
used	used	VBN	0
substrate	substrate	JJ	0
concentrations	concentrations	NNS	0
varied	varied	VBN	0
between	between	IN	0
~	~	NNP	0
K	K	NNP	0
m	m	NN	0
and	and	CC	0
10	10	CD	0
×	×	CD	0
K	K	NNP	0
m	m	NN	0
and	and	CC	0
used	used	VBN	0
as	as	IN	0
much	much	JJ	0
of	of	IN	0
the	the	DT	0
ΔA	ΔA	NNP	0
versus	versus	CC	0
time	time	NN	0
data	data	NNS	0
(	(	-LRB-	0
that	that	WDT	0
was	was	VBD	0
linear	linear	CD	0
)	)	-RRB-	0
as	as	IN	0
possible	possible	JJ	0
to	to	TO	0
determine	determine	VB	0
the	the	DT	0
velocity	velocity	NN	0
.	.	.	0
Steady-state	Steady-state	JJ	0
kinetics	kinetics	JJ	0
constants	constants	NN	0
,	,	,	0
K	K	NNP	0
m	m	NN	0
and	and	CC	0
k	k	JJ	0
cat	cat	NN	0
,	,	,	0
were	were	VBD	0
determined	determined	VBN	0
by	by	IN	0
fitting	fitting	JJ	0
initial	initial	JJ	0
velocity	velocity	NN	0
versus	versus	IN	0
substrate	substrate	JJ	0
concentration	concentration	NN	0
data	data	NNS	0
directly	directly	RB	0
to	to	TO	0
the	the	DT	0
Michaelis	Michaelis	JJ	0
equation	equation	NN	0
using	using	VBG	0
CurveFit	CurveFit	JJ	0
[	[	-LRB-	0
36	36	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
reported	reported	JJ	0
errors	errors	NNS	0
reflect	reflect	VBP	0
fitting	fitting	JJ	0
uncertainties	uncertainties	NNS	0
.	.	.	0
All	All	DT	0
steady-state	steady-state	JJ	0
kinetic	kinetic	JJ	0
studies	studies	NNS	0
were	were	VBD	0
performed	performed	VBN	0
in	in	IN	0
triplicate	triplicate	NN	0
with	with	IN	0
recombinant	recombinant	JJ	0
L1	L1	NN	0
from	from	IN	0
at	at	IN	0
least	least	JJS	0
three	three	CD	0
different	different	JJ	0
enzyme	enzyme	JJ	0
preparations	preparations	NNS	0
.	.	.	0
circular	circular	JJ	B-NP
dichroism	dichroism	NN	I-NP
circular	circular	JJ	I-NP
dichroism	dichroism	NN	I-NP
sample	sample	NN	I-NP
were	were	VBD	0
prepared	prepared	VBN	0
by	by	IN	0
dialyzing	dialyzing	VBG	0
the	the	DT	0
purified	purified	JJ	0
enzyme	enzyme	JJ	0
samples	samples	NNS	0
versus	versus	IN	0
3	3	CD	0
×	×	CD	0
2	2	CD	0
L	L	NNP	0
of	of	IN	0
5	5	CD	0
mM	mM	JJ	B-NP
phosphate	phosphate	JJ	I-NP
buffer	buffer	NN	I-NP
,	,	,	0
pH	pH	JJ	0
7.0	7.0	CD	0
over	over	IN	0
six	six	CD	0
hours	hours	NNS	0
.	.	.	0
The	The	DT	0
samples	samples	NNS	0
were	were	VBD	0
diluted	diluted	VBN	0
with	with	IN	0
final	final	JJ	B-NP
dialysis	dialysis	NN	I-NP
buffer	buffer	NN	I-NP
to	to	TO	0
~75	~75	CD	0
μg	μg	CD	B-NP
/	/	CD	I-NP
mL	mL	NN	I-NP
.	.	.	0
A	A	DT	0
JASCO	JASCO	NNP	B-NP
J-810	J-810	NNP	I-NP
CD	CD	NNP	I-NP
spectropolarimeter	spectropolarimeter	VBZ	0
operating	operating	VBG	0
at	at	IN	0
25°C	25°C	NNP	0
was	was	VBD	0
used	used	VBN	0
to	to	TO	0
collect	collect	VB	0
CD	CD	NN	0
spectra	spectra	NN	0
.	.	.	0
Stopped	Stopped	VBN	0
-	-	:	0
flow	flow	NN	B-NP
/	/	NNP	I-NP
Rapid-Scanning	Rapid-Scanning	NNP	I-NP
UV-Visible	UV-Visible	NNP	I-NP
Spectrophotometry	Spectrophotometry	NNP	I-NP
Rapid-scanning	Rapid-scanning	NNP	0
Vis	Vis	NNP	0
spectra	spectra	NN	0
of	of	IN	0
nitrocefin	nitrocefin	JJ	B-NP
hydrolysi	hydrolysi	NN	I-NP
by	by	IN	0
L1	L1	NNP	0
and	and	CC	0
the	the	DT	0
l1	l1	NN	B-NP
mutant	mutant	NN	I-NP
were	were	VBD	0
collected	collected	VBN	0
on	on	IN	0
a	a	DT	0
Applied	Applied	NNP	B-NP
Photophysics	Photophysics	NNP	I-NP
SX.18MV	SX.18MV	NNP	I-NP
stopped-flow	stopped-flow	NNP	0
spectrophotometer	spectrophotometer	VBD	0
equipped	equipped	VBN	0
with	with	IN	0
an	an	DT	0
Applied	Applied	NNP	B-NP
Photophysics	Photophysics	NNP	I-NP
PD.l	PD.l	NNP	I-NP
photodiode	photodiode	JJ	B-NP
array	array	NN	I-NP
detector	detector	NN	I-NP
and	and	CC	0
a	a	DT	0
1	1	CD	0
cm	cm	NNS	0
pathlength	pathlength	VBP	0
optical	optical	JJ	B-NP
cell	cell	NN	I-NP
.	.	.	0
A	A	DT	0
typical	typical	JJ	0
experiment	experiment	NN	0
consisted	consisted	VBD	0
of	of	IN	0
25	25	CD	0
μM	μM	JJ	B-NP
enzyme	enzyme	NN	I-NP
and	and	CC	0
5	5	CD	0
μM	μM	JJ	B-NP
nitrocefin	nitrocefin	NN	I-NP
in	in	IN	0
50	50	CD	0
mM	mM	JJ	0
cacodylate	cacodylate	JJ	B-NP
buffer	buffer	NN	I-NP
,	,	,	0
pH	pH	JJ	0
7.0	7.0	CD	0
containing	containing	CD	0
100	100	CD	0
μM	μM	JJ	0
ZnCl	ZnCl	JJ	B-NP
2	2	CD	0
,	,	,	0
the	the	DT	0
reaction	reaction	NN	B-NP
temperature	temperature	NN	I-NP
was	was	VBD	0
thermostated	thermostated	VBN	0
at	at	IN	0
25°C	25°C	NNP	0
,	,	,	0
and	and	CC	0
the	the	DT	0
spectra	spectra	NN	0
were	were	VBD	0
collected	collected	VBN	0
between	between	IN	0
300	300	CD	0
and	and	CC	0
725	725	CD	0
nm	nm	NN	B-NP
.	.	.	0
Data	Data	NNS	0
from	from	IN	0
at	at	IN	0
least	least	JJS	0
three	three	CD	0
experiments	experiments	NNS	0
were	were	VBD	0
collected	collected	VBN	0
and	and	CC	0
averaged	averaged	VBD	0
.	.	.	0
Absorbance	Absorbance	JJ	B-NP
data	data	NN	I-NP
were	were	VBD	0
converted	converted	VBN	0
to	to	TO	0
concentration	concentration	VB	B-NP
data	data	NN	I-NP
as	as	RB	0
described	described	VBN	0
previously	previously	RB	0
by	by	IN	0
McMannus	McMannus	JJ	B-NP
and	and	CC	0
Crowder	Crowder	NNP	0
[	[	-LRB-	0
39	39	CD	0
]	]	-RRB-	0
.	.	.	0
nitrocefin	nitrocefin	JJ	B-NP
hydrolysi	hydrolysi	NN	I-NP
stopped-flow	stopped-flow	NN	I-NP
fluorescence	fluorescence	JJ	I-NP
study	study	NN	I-NP
by	by	IN	0
L1	L1	NNP	0
were	were	VBD	0
performed	performed	VBN	0
on	on	IN	0
an	an	DT	0
Applied	Applied	NNP	B-NP
Photophysics	Photophysics	NNP	I-NP
SX.18MV	SX.18MV	NNP	I-NP
spectrophotometer	spectrophotometer	NN	0
,	,	,	0
using	using	VBG	0
an	an	DT	0
excitation	excitation	JJ	B-NP
wavelength	wavelength	NN	I-NP
of	of	IN	0
295	295	CD	0
nm	nm	NN	B-NP
and	and	CC	0
a	a	DT	0
WG320	WG320	JJ	B-NP
nm	nm	JJ	I-NP
cut-off	cut-off	JJ	0
filter	filter	NN	0
on	on	IN	0
the	the	DT	0
photomultiplier	photomultiplier	NN	B-NP
.	.	.	0
These	These	DT	0
experiments	experiments	NNS	0
were	were	VBD	0
conducted	conducted	VBN	0
at	at	IN	0
10°C	10°C	CD	0
using	using	VBG	0
the	the	DT	0
same	same	JJ	0
buffer	buffer	NN	0
in	in	IN	0
the	the	DT	0
rapid-scanning	rapid-scanning	JJ	0
Vis	Vis	JJ	0
studies	studies	NNS	0
.	.	.	0
Fluorescence	Fluorescence	JJ	0
data	data	NNS	0
were	were	VBD	0
fitted	fitted	VBN	0
to	to	TO	0
k	k	VB	0
obs	obs	NNS	0
=	=	SYM	0
{	{	FW	0
(	(	-LRB-	0
k	k	FW	0
f	f	FW	0
[	[	-LRB-	0
S	S	NNP	0
]	]	-RRB-	0
)	)	-RRB-	0
/	/	NNP	0
K	K	NNP	0
S	S	NNP	0
+	+	NNP	0
[	[	-LRB-	0
S	S	NNP	0
]	]	-RRB-	0
)	)	CD	0
}	}	-RRB-	0
+	+	CD	0
k	k	NNS	0
r	r	VBP	0
as	as	RB	0
described	described	VBN	0
previously	previously	RB	0
[	[	-LRB-	0
40	40	CD	0
]	]	-RRB-	0
or	or	CC	0
to	to	TO	0
k	k	VB	0
obs	obs	NNS	0
=	=	SYM	0
k	k	FW	0
f	f	FW	0
[	[	-LRB-	0
S	S	NNP	0
]	]	-RRB-	0
+	+	FW	0
k	k	FW	0
r	r	FW	0
by	by	IN	0
using	using	VBG	0
CurveFit	CurveFit	JJ	0
v.	v.	CC	0
1.0	1.0	CD	0
.	.	.	0
Abbreviations	Abbreviations	NNP	0
AES	AES	NNP	0
,	,	,	0
atomic	atomic	JJ	0
emission	emission	NN	0
spectroscopy	spectroscopy	NNS	0
;	;	:	0
bp	bp	CD	0
,	,	,	0
base	base	NN	0
pairs	pairs	NNS	0
;	;	:	0
CD	CD	NNP	0
,	,	,	0
circular	circular	JJ	0
dichroism	dichroism	NN	0
;	;	:	0
ε	ε	CD	0
,	,	,	0
extinction	extinction	JJ	0
coefficient	coefficient	NN	0
;	;	:	0
ICP	ICP	NNP	0
,	,	,	0
inductively	inductively	VBD	0
coupled	coupled	VBN	0
plasma	plasma	NN	0
;	;	:	0
k	k	JJ	0
cat	cat	NN	0
,	,	,	0
turnover	turnover	NN	0
number	number	NN	0
;	;	:	0
kDa	kDa	NNP	0
,	,	,	0
kilodaltons	kilodaltons	NNS	0
;	;	:	0
K	K	NNP	0
m	m	NN	0
,	,	,	0
Michaelis	Michaelis	NNP	0
constant	constant	JJ	0
;	;	:	0
K	K	NNP	0
S	S	NNP	0
,	,	,	0
substrate	substrate	JJ	0
binding	binding	JJ	0
constant	constant	JJ	0
;	;	:	0
LB	LB	NNP	0
,	,	,	0
Luria-Bertani	Luria-Bertani	JJ	0
media	media	NNS	0
.	.	.	0
